Structural studies of the endotoxin sensing protein Factor C by McClymont, Karen
  
 
 
 
 
 
 
 
 
McClymont, Karen (2017) Structural studies of the endotoxin sensing 
protein Factor C. PhD thesis. 
 
 
 
http://theses.gla.ac.uk/8058/  
 
 
 
 
Copyright and moral rights for this work are retained by the author 
A copy can be downloaded for personal non-commercial research or study, without prior 
permission or charge 
This work cannot be reproduced or quoted extensively from without first obtaining 
permission in writing from the author 
The content must not be changed in any way or sold commercially in any format or 
medium without the formal permission of the author 
When referring to this work, full bibliographic details including the author, title, 
awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
Glasgow Theses Service 
http://theses.gla.ac.uk/ 
theses@gla.ac.uk 
  
  
  
  
  
  
  
Structural studies of the endotoxin 
sensing protein Factor C      
Karen McClymont  
  
Submitted in fulfilment of the requirements for the Degree  
of Doctor of Philosophy  
  
  
Institute of Molecular, Cell and Systems Biology  
College of Medical, Veterinary and Life Sciences  
University of Glasgow  
  
March, 2017  
  
  
2  
  
Abstract  
Human exposure to Gram-negative bacterial endotoxin can result in life-threatening 
conditions including sepsis and toxic shock syndrome. Given the importance of avoiding 
exposure to endotoxin, a sensitive test is required to ensure that medical devices and 
injectable medicines are not contaminated. Limulus amebocyte lysate (LAL), produced 
from the blood of horseshoe crabs, contains an endotoxin-sensing protein, Factor C, that 
initiates a coagulation cascade. This lysate is used to test for contamination of medical 
products, with formation of a clot indicating the presence of endotoxin in the sample.  
Alternative methods to the LAL test have been explored to overcome problems with the 
test. These include the detrimental effects that harvesting has on the wild population of 
horseshoe crabs. More recently, tests relying on the direct detection of enzymatically 
active Factor C have been introduced, some of which utilize Factor C produced 
recombinantly. Despite the importance of Factor C to the health industries, no detailed 
explanation of its mechanism of endotoxin recognition has been published. The aim of 
this project was therefore to develop a better understanding of how Factor C is activated 
by endotoxin binding and to identify conformational changes that take place as a result.  
Two main strategies were employed for structural characterisation and functional analysis 
of Factor C. First, fragments of Factor C protein were produced recombinantly in 
Escherichia coli to determine the structures of the individual domains and identify the 
endotoxin binding region more precisely. Second, expression of the whole Factor C 
protein in eukaryotic expression systems was attempted to produce material for 
experiments that would shed light on any overall conformational change that occurs.  
Factor C fragments were successfully expressed in E. coli and purified. Circular dichroism 
spectroscopy identified that the majority of these fragments were folded, and changes in 
the spectra of some fragments in the presence of lipopolysaccharide identified potential 
binding sites. A preliminary structure of the first pair of complement control domains has 
been determined by nuclear magnetic resonance spectroscopy. Comparison of this 
structure with other LPS binding proteins will pave the way for future work to 
characterise the endotoxin binding site of Factor C.  
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1 Introduction  
For over 40 years, horseshoe crabs have been important for the testing of all parenteral 
pharmaceuticals and medical devices for human use, for the detection of bacterial 
endotoxin. They have played a crucial role in preventing the spread of Gram-negative 
bacterial infections from drugs and other medical products, and the features that form the 
basis of this test have resulted in extensive research into the biological process behind this 
discovery.  
1.1 Bacterial Endotoxin  
Gram-negative bacteria are found in almost every life-supporting environment. Gram-
negative bacteria include the model organism Escherichia coli and several pathogenic 
bacteria strains, that are responsible for a number of infectious diseases. Bacterial 
endotoxin or lipopolysaccharide (LPS) is the main lipidic constituent of the outer leaflet 
of the outer cell membrane of Gram-negative bacteria. In humans/mammals, its presence 
is often the first sign of a Gram-negative bacterial infection which, if undetected or 
untreated, can result in ‘intravascular coagulation, amebocytopenia, incoagubility of the 
blood and death’ (Levin and Bang, 1968).  
Human exposure to endotoxin, not even necessarily from live bacteria can result in life 
threatening medical conditions, including toxic shock syndrome (TSS) and sepsis, which 
can lead to multiple organ failure and ultimately death. This is a result of an undamped 
stimulation of the host defence mechanisms, leading to the secretion of an excess amount 
of inflammatory cytokines from monocytes and macrophages, including tumour necrosis 
factor α (TNF-α), a number of interleukins (e.g. IL-1 and IL-8) and interferons (Ceramil 
and Beutler, 1988; Karima et al., 1999; Kreutz et al., 1997). Given the importance for 
humans of avoiding exposure to LPS, we need a sensitive test to ensure that medical 
devices and injectable medicines are not contaminated.   
LPS molecules are built of three structural components, each of which display distinctive 
genetic, biochemical and antigenic features. These are the variable O-antigen 
polysaccharide chain, the core-oligosaccharide and the highly conserved hydrophobic 
Lipid A (Figure 1-1). Lipid A is composed of two phosphorylated glucosamine sugars 
attached to a number of fatty acids. These fatty acids can vary in number and length, and 
while a number of them carry a hydroxyl group, others are not hydroxylated. The overall 
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structure of lipid A is conserved among different bacteria, but variation arises from 
differences in the acylation pattern, the length of the fatty acid residues and the number of 
fatty acids (Park and Lee, 2013). Lipid A is recognised as a pathogen-associated 
molecular pattern (PAMP) by immune cells and is accountable for the bioactivity of 
endotoxin (Wang and Quinn, 2010). Core oligosaccharides show more diversity and can 
be split into two regions that show structural differences to each other: the inner core 
covalently bonded to lipid A and the outer core that is attached to the O-antigen (Wang 
and Quinn, 2010). The inner core is made up of sugars found to be unique to bacteria: 2-
keto-3-deoxyoctonic acid (KDO) and heptose, whereas the outer core comprises common 
sugars (Van Amersfoort et al., 2003). LPS variability is determined by the O-antigen that 
is made up of a varying number of oligosaccharide units, attached to the outer core. The 
O-antigen is immunogenic and responsible for the numerous serotypes as a result of the 
varying composition and lengths. If undefended, upon lysis of the bacterial cells, LPS 
circulates into the blood stream resulting in systemic exposure. It was shown that removal 
of the O-antigen and core-oligosaccharide regions had a limited effect on LPS activity, 
indicating that these regions do not play a significant role in detection by the host immune 
receptor (Raetz and Whitfield, 2002; Trent et al., 2006).  
When horseshoe crabs become infected by LPS from Gram-negative bacteria, aggregation 
and degranulation occurs within the blood stream. This suggests that the coagulation 
cascade observed in horseshoe crabs plays a significant role for the defence of the species 
against Gram-negative bacteria invasions.   
In addition to the Factor C protein, there are a number of other proteins that recognise 
LPS. These include human receptors such as Toll-like receptor 4 (Chow et al., 1999), the 
ferric hydroxamate uptake receptor (FhuA) found on the surface of E. coli (Ferguson et 
al., 2000) and the anti-lipopolysaccharide factor (ALF-Pm3) from the black tiger shrimp 
Penaeus monodon (Yang et al., 2009). Structural studies to determine the binding site of 
LPS in FhuA and ALF-Pm3 indicated a highly-conserved region mainly consisting of 
positively charged and hydrophobic residues that are able to interact with the hydrophilic 
and phosphate groups of lipid A, through electrostatic and hydrophobic interactions.   
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Figure 1-1: Chemical structure of lipopolysaccharide (LPS) from E. Coli K-12. Lipid A 
glucosamines (GlcN) are linked to KDO sugars from the core oligosaccharide, which are linked to 
heptose sugars. The outer core is shown to consist of hexose moieties, including ᴅ-galactose (Gal) 
and ᴅ-glucose (Glc), and a disordered heptose group. The O-antigen is attached to Glc from the 
outer core (not shown).  Figure reproduced from Ferguson et al. (Ferguson et al., 2000).  
1.2 Horseshoe Crabs  
There are four species of horseshoe crab:  Carcinoscorpius rotundicauda, Limulus 
polyphemus, Tachypleus gigas and Tachypleus tridentatus. Limulus is the Atlantic species 
and is found off the East coast of North America. The other three species originate from 
Southeast Asia. Divergence studies have established that separation between the L. 
polyphemus and T. tridentatus species occurred around 135 million years ago, between 
the Asian species and T. gigas, 52.5 million years ago and between T. tridentatus and C. 
rotundicauda, 36.3 million years ago (Kawabata et al., 2003).   
The Atlantic horseshoe crab (Limulus polyphemus) has played an important role in several 
industries including the fishing industry, the agricultural industry and, most significantly, 
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the biomedical industry. In addition, they are preyed on by a variety of birds that attempt 
to feed on their eggs and also on stranded live, or deceased adult crabs (Botton and 
Loveland, 1989). In spite of the difficulties faced by horseshoe crab populations, they 
have survived for millions of years. However, as a result of the number of functions they 
serve, and thus the demand for them, the future of the horseshoe crab’s existence is under 
threat.  
For many years, a common use of horseshoe crabs was as soil fertiliser and livestock feed. 
However, as a result of a decline in numbers of the horseshoe crab population along with 
increased competition from alternative fertilisers, there is no longer a use for the 
horseshoe crabs in this industry (Berkson and Shuster, 1999). Subsequently, the 
commercial fishery industry identified the use of horseshoe crabs as bait to catch 
American eels, whelks (also known as conch) and, to a lesser extent, catfish. They have 
played a role in vision research, allowing for better understanding of the physiological 
properties of the visual system (Liu and Passaglia, 2009). Most notably, however, the 
horseshoe crab has played an important role in the medical industry, after the discovery by 
W.H. Howell in 1885 of the clotting ability of Limulus blood (Novitsky, 1984).  
 
Figure 1-2: Limulus polyphemus. Credit: Mark Thiessen/National Geographic Creative 
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Further studies into this unique characteristic resulted in the discovery by Frederik Bang 
that an extract of their blood cells, Limulus amebocyte lysate (LAL), was sufficient to 
recapitulate blood clotting in the horseshoe crabs, and further that the cause of this 
clotting was due to exposure to Gram-negative bacteria (Bang, 1956). This feature is still 
exploited, with horseshoe crabs being harvested to obtain samples of their blood for use in 
the biomedical industry (Figure 1-2). Up to 400 ml of blood is taken from each crab per 
bleed, depending on their size (Armstrong and Conrad, 2008). Although blood 
regeneration of surviving crabs is relatively quick (3 – 7 days), it can take up to 4 months 
for an individual’s amebocyte levels to be restored. Initial studies reported mortality levels 
as a result of this bleeding to be around 10% (Rudloe, 1983). However, this figure is 
believed to have risen to around 30% (Leschen and Correia, 2010).  
Attempts to breed Limulus polyphemus in captivity have proven difficult. This may be due 
in part to the fact that it can take them 9 - 11 years to reach sexual maturity, together with 
their moulting habits, which see them shedding their exoskeleton up to 16 or 17 times as 
they grow, each time becoming increasingly physically demanding and time consuming. 
They also appear to have a very specific mating ritual dependent on tidal and lunar 
patterns, with a need for particular temperatures, salinity levels and substrate type 
(Brockmann, 1990; Okun, 2012). As a result of this, along with the increasing negative 
impact on the species, habitat destruction, extensive fishing and pollution, the supply of 
blood from which to make LAL has come under threat and as such there is an urgent need 
to guarantee there is a sustainable supply of horseshoe crab amebocyte, or develop new 
assays to make use of the highly-sensitive endotoxin-sensing feature of the LAL test.  
The innate immune systems of vertebrates and invertebrates consist of multiple 
mechanisms by which Gram-negative bacterial infections, amongst others, can be 
recognised and eradicated from the whole organism. Three general qualities of these 
defence system are: the recognition of pathogen-associated molecular patterns (PAMPs) 
by pattern recognition receptors (PRRs); transcriptional activation by intracellular 
signalling cascades of primary response genes encoding, for example, cytokines, 
chemokines and effector molecules; and destruction of the infecting bacteria by 
phagocytosis and by antimicrobial peptides (Koshiba et al., 2007; Stuart and Ezekowitz, 
2005). Lacking an adaptive immune system, invertebrates rely solely on the innate 
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immune system for protection against pathogens and their incredibly efficient blood-
clotting systems are a central factor of this innate immunity.  
1.2.1 Amebocytes  
Horseshoe crabs are harvested to obtain samples of their blood (hemolymph), which 
contains hemocyanin (a copper containing protein) and an abundance of one cell type, the 
amebocyte. The multifunctional hemocyanin carries molecular oxygen and its presence is 
evident by the blue colour of the serum. Upon exposure to bacterial endotoxin, the 
horseshoe crab’s innate immunity serves to eradicate the infection by activating a clotting 
process as a result of interaction with a component in the blood. Experiments conducted 
by Bang determined hemocyanin did not play a role in the formation of the gel as a result 
of endotoxin contamination, and thus prompted further investigation into the role of the 
amebocyte (Bang, 1956).  
The amebocyte is a granular cell found in the hemolymph of horseshoe crabs and makes 
up over 99% of blood cells in this species. These circulating cells contain the Limulus 
coagulation system, which plays a key role in the crab’s defence against endotoxin 
infection. In 1968, Levin and Bang discovered that cell free plasma is incoagulable, even 
in the presence of LPS, establishing that the amebocytes, as the only supply of clottable 
protein in the blood of Limulus, play an important role in LPS-mediated coagulation 
(Levin and Bang, 1968). It was found that non-cellular components do not have any 
influence on the process.  
The secretory granules found within the amebocytes are exocytosed to release a number of 
proteins and proteases to work in the defence against the bacteria and upon exposure to 
endotoxin, the amebocyte degranulates. There are two types of granules: large (L) and 
small (S), that have been shown to contain a number of proteins and peptides that act as 
defence molecules against endotoxin infections (Toh et al., 1991). These are outlined in 
Table 1-1 and include coagulation factors, protease inhibitors, antimicrobial substances 
and lectins (Iwanaga, 2002; Iwanaga et al., 1998).  
The process of coagulation involves aggregation of amebocytes followed by shrinkage of 
the aggregated mass, before degranulation and appearance of a liquid phase that 
undergoes gelation upon exposure to bacterial endotoxin (Levin and Bang, 1968). The 
speed of gelation and concentration of endotoxin present are related implying that an 
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enzymatic reaction takes place. Factor C has been identified as being located in the large 
granules of the amebocyte and after degranulation, in addition to its role in LPS-binding, 
may contribute to several defence mechanisms including cell adhesion as a means by 
which clots and foreign material are removed.  
L-granules S-granules 
Coagulation 
Factors 
Factor C Antimicrobial 
Substances 
Tachyplesins 
Factor G Polyphemusins 
Proclotting enzyme Big defensin 
Coagulogen Tachycitin 
Protease Inhibitors LICI-1 Tachystatins 
LICI-2  
LICI-3 
LEBP-PI 
Limulus cystatin 
α2-Macroglobulin 
Antimicrobial 
substances 
Anti-LPS factor 
Big defensin 
Factor D 
Tachylectin-1 
Tachylectin-2 
Tachylectin-3 
Limunectin 
18K-LAF 
Others 8.6 kDa protein 
Pro-rich protein 
L1 
L4 
Table 1-1: Secretory granule components. 
The immobilisation of bacteria as a result of the disruption caused to amebocytes by 
bacterial endotoxin highlights the main way in which horseshoe crabs defend themselves 
against the constant exposure to gram-negative bacteria and the sensitivity of this method 
is emphasized by the fact that picograms of endotoxin is enough to elicit the gelation 
response.  
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1.2.2 Coagulation Cascade  
Further investigation of Limulus coagulation was motivated by the resemblance of this 
reaction to a number of previously established processes including the Schwartzman 
reaction in rabbits, intravascular coagulation in humans as a result of gram negative sepsis 
and the resemblance between amebocytes and mammalian platelets that function in 
mammalian coagulation. In particular, the similarities between amebocytes and 
mammalian platelets appear to be of significance and include the fact they both contain 
granules, aggregation of the cells followed by loss of granules occurs during their 
coagulation processes, they both aggregate at the site of injury and they also both display 
bactericidal activity (Levin and Bang, 1968). A difference of note however, between the 
horseshoe crab clotting system and that of mammalian coagulation, is that positive 
feedback activation does not appear to take place in the horseshoe crab system.  
The coagulation cascade comes about as a result of sequential enzymatic activation of 
serine protease zymogens after exposure of the amebocyte to bacterial endotoxins. 
Autocatalysis activates Factor C (Factor Ċ), which in turn activates Factor B (Factor Ḃ) 
and thus activates proclotting enzyme to give clotting enzyme, each by limited 
proteolysis. Clotting enzyme transforms coagulogen to coagulin gel resulting in a clot that 
acts to destroy the endotoxin infection. Tai et al. suggested the cleavage of a single 
peptide bond between an Arg and Lys gives rise to the production of this clot (Tai et al., 
1977). Figure 1-3 illustrates the coagulation cascade pathway. Due to the indisputable 
similarities, there are speculations surrounding the idea that the evolution of mammalian 
blood coagulation may have arisen from this primitive mechanism (Young et al., 1972).   
In 1981, Kakinuma et al. discovered that carboxymethylated (1→3)-β-ᴅ-glucan (CMPS), 
a polysaccharide with anti-tumour properties found on the surface of fungi, also activates 
the limulus coagulation system, similarly resulting in the formation of a clot (Figure 1-3) 
(Kakinuma et al., 1981). It was determined that CMPS did not have any effect on the 
previously discovered factors involved in the endotoxin-mediated pathway (Factor C, 
Factor B and proclotting enzyme), indicating a separate component, sensitive to CMPS, 
must be present to activate the proclotting enzyme. This factor, termed Factor G, was 
found to differ significantly from the others in that it gave no response in the presence of 
endotoxin. This confirmed the notion that two distinct pathways exist as a result of 
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PAMPs; one mediated by endotoxin and the other by (1→3)-β-ᴅ-glucan, both of which 
catalyse the production of coagulin gel.   
The coagulation cascade forms the basis of the Limulus amebocyte lysate (LAL) test, 
which was developed by Levin and Bang and is used for the detection of endotoxin (Levin 
and Bang, 1968).  
 
Figure 1-3: The coagulation cascade. Endotoxin and (1→3)-β-ᴅ-glucan-mediated pathways are 
shown to produce the same result of blood coagulation via activation of two different factors.  
1.2.3 Limulus Amebocyte Lysate Test  
Prior to the discovery of the LAL test, a number of methods existed for the detection of 
endotoxin that involved the use of whole or parts of living animals. The pyrogen test in 
rabbits was the most commonly used, where test solutions were injected into a rabbit’s 
bloodstream and its temperature was monitored over a specific time frame. If a high 
temperature was detected, the solutions were deemed to be contaminated with endotoxin 
and the pharmaceutical devices were discarded (Novitsky, 1984). The discovery of the 
endotoxin-sensing protein from horseshoe crab blood allowed for the development of a 
new endotoxin detection test meaning the rabbit pyrogen test was no longer necessary. 
This test, termed Limulus amebocyte lysate (LAL), was discovered by Levin and Bang 
when they established that Gram-negative bacteria resulted in rapid gelation of the lysate 
(Levin and Bang, 1968).  
 
Endotoxin (LPS) 
Factor C Factor  
Factor B Factor  Factor G Factor  
Proclotting enzyme Clotting enzyme 
Coagulogen Coagulin 
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The LAL test has been used for many years for the screening of pharmaceutical products 
including implants and vaccinations. It is simple and reliable and in high demand due to 
the lack of a more sensitive test. Horseshoe crabs are bled by cardiac puncture. 
Amebocytes are separated from hemocyanin by low speed centrifugation. Intact 
amebocytes are lysed by addition of pure distilled water and the clotting factors are found 
in the supernatant after high-speed centrifugation. This supernatant is the LAL, which can 
be activated by the addition of ions such as sodium, calcium or magnesium salts, that have 
been found to be necessary for the activation of proclotting enzyme (Tai and Liu, 1977). 
Sensitivity can be enhanced by performing solvent extraction. To perform the test, equal 
volumes of LAL and the test product are mixed in a glass test tube, and incubated at 37°C 
for one hour. The formation of a clot indicates endotoxin is present in the sample. There 
are a number of ways the test can be employed for the analysis of pharmaceutical products 
before their distribution, to detect trace amounts of LPS in solution (Novitsky, 1984).  
Alternative testing methods to the LAL test have been explored to overcome the 
drawbacks of this process, which include the possibility of fungal activation, fluctuations 
in the sensitivity between batches of LAL and the detrimental effects the process has on 
the horseshoe crab population. Fluctuations in pH or temperature, or the presence of 
substances such as divalent cations or chelating agents, may interfere with the LAL 
reagent, decreasing its capability to respond to endotoxin, thus giving rise to false 
negative and positive results. A number of biomedical companies have attempted to 
produce alternative tests based on purified or recombinant Factor C, with varying results, 
in an effort to bring an end to the bleeding process of horseshoe crabs. Examples of these 
tests include the LAL-based detection kits from Lonza (PYROGENT™ Gel Clot Assays) 
and Charles River (Endosafe® Endotoxin Testing Systems) and the recombinant Factor C 
test from Hyglos (EndoZyme® recombinant Factor C (rFC) Assay). However, false-
positives can arise from a substrate other than Factor C cleaving the chromogenic 
substrate and the tests are prone to false negative results due to sample conditions being 
inadequate for Factor C activation, such as a too high or too low pH. This supports the 
need for further investigation into the method behind LAL in order to develop highly 
sensitive and specific reagents for detection of endotoxin.  
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1.3 Factor C  
The glycoprotein Factor C was discovered by Nakamura et al. after further studies into 
Factor B were performed in the hope that a better understanding of the horseshoe crab 
clotting process would be achieved (Nakamura et al., 1985). They found that activation of 
Factor B required the action of another component (Factor C) to initiate the clotting 
cascade and therefore activate the proclotting enzyme. All three components were deemed 
necessary for coagulation. Factor C was originally purified from Tachypleus tridentatus in 
1986 by Nakamura et al. and since then, research has been undertaken to elucidate its 
structure, function and interactions within the coagulation cascade (Nakamura et al., 
1986).  
Factor C is a serine protease zymogen that works as a ‘biosensor’ in response to LPS. The 
pre-pro Factor C is synthesised as a single polypeptide, which has a molecular weight of 
123 kDa, is subsequently cleaved to form a two-chain glycoprotein consisting of two 
disulphide-linked polypeptide chains: an 80 kDa heavy chain and a 43 kDa light chain 
(Ariki et al., 2004; Muta et al., 1991; Nakamura et al., 1986). Investigations into the 
membrane anchored form believed to act as a sensor on the surface of amebocytes 
determined a 123 kDa Factor C antigen that corresponds to the single-chain zymogen 
(Ariki et al., 2004). It was revealed that binding to LPS results in the autocatalytic 
activation of two-chain Factor C (Factor Ċ) resulting in cleavage of the light chain into 
two fragments of molecular weight 7.9 kDa and 34 kDa, designated the A chain and B 
chain, respectively. The resulting Factor Ċ is composed of the three disulphide-linked 
chains: the heavy chain, A chain and B chain. Tokunaga et al. deduced that hydrolysis of 
a Phe-Ile bond in the light chain sequence -Pro-Phe-Ile-Trp-Asn-Gly- activates the Factor 
C zymogen, giving rise to the A and B chains, and initiating the sequential activation of 
the clotting factors (Tokunaga et al., 1987). It is thought that a conformational change 
takes place upon Factor C binding to LPS, which brings about this cleavage of the Phe-Ile 
bond and that this process is comparable to streptokinase-complexed plasminogen 
molecules’ activation of plasminogen (Reddy and Markus, 1972).  
The location of the LPS-binding region was first investigated by Nakamura et al. using 
Salkylation (Nakamura et al., 1988a). The two-chain intermediate form of ttFC was 
reduced by addition of dithiothreitol (DTT, 0.25 mM), then incubated with 4-
vinylpyridine to induce S-pyridylethylation (PE). After dialysis, the PE-FC was separated 
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by Reversed-Phase High Performance Liquid Chromatography (RP-HPLC), into the 
heavy and light chains. Incubation of Factor C with LPS and either the S-alkylated heavy 
chain or light chain determined whether inhibition of activation took place. The heavy 
chain, when S-alkylated, inhibited Factor C activation by LPS, however, the light chain 
when S-alkylated failed to inhibit the activation, indicating that the amino-terminal heavy 
chain of Factor C is likely to have the site of the LPS-binding. Consequently, it can be 
presumed that LPS recognition is affiliated with the heavy chain and catalytic activity can 
be attributed to the light chain.   
Nakamura et al. showed that the B chain of Factor C is a serine protease domain, while 
Tokunaga et al. determined the A chain had sequence similarity with the family of tandem 
repeats present in a number of factors, in particular, human complement factor B (Mole et 
al., 1984; Nakamura et al., 1988a; Nakamura et al., 1988b; Tokunaga et al., 1987). 
However, it was Muta et al. that determined the mosaic structure of Factor C domains and 
revealed its similarities to components of the mammalian complement cascade (Muta et 
al., 1991). They performed a search for proteins with sequence similarity to Factor C and 
identified that alongside the serine protease domain, Factor C comprises: five complement 
control proteins (CCPs) also known as ‘sushi’ domains or short consensus repeat domains 
– four in the H chain and one in the A chain; an epidermal growth factor (EGF)-like 
domain in the H chain; a lectin-like domain, which appears between CCP3 and CCP4; a 
Cys-rich domain found at the H chain’s amino terminus; a proline-rich region located at 
the carboxy-end of the H chain; and an LCCL module. A schematic representation of the 
domain organisation of Factor C can be seen in Figure 1-4.   
 
Figure 1-4: Schematic representation of the domain structure of Factor C. The positions of the 
heavy and light chains are indicated, along with the A and B chains. CCP = Complement Control 
Protein. LCCL = Limulus Factor C, Coch-5b2, LgII. CLECT = C-Type Lectin Domain.   
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Complement control proteins have been identified over 140 times in more than 20 human 
proteins that are most often associated with the mammalian complement system. Factor C 
was the first protein identified in invertebrates shown to exhibit these domains. They are 
said to have a ‘sushi’-like disulphide folding structure, which was discovered by Lozier et 
al. when studying the β2-glycoprotein 1 (Lozier et al., 1984). The domain has a compact 
hydrophobic core enclosed within six beta strands with four conserved cysteine residues 
forming disulphide bonds in the pattern Cys1 – Cys3 and Cys2 – Cys4. Four of the β-
strands appear to have a variable orientation, while β-strand 2 and β-strand 4 have a more 
conserved structural orientation. The variability tends to occur primarily at the interface 
between adjacent domains and Norman et al. speculated that interactions occur between 
these (Norman et al., 1991). CCPs have a number of additional highly conserved residues 
including a tryptophan and other mainly hydrophobic residues. Their role in other proteins 
is to facilitate protein-protein interactions, which suggests that the CCPs of Factor C could 
interact with other proteins during the clotting cascade, although it also likely that some 
CCPs play an entirely structural role (Day et al., 1987; Gaboriaud et al., 2000; Norman et 
al., 1991).  
The EGF-like domain comprises a sequence of around 30 – 40 amino acids from the 
epidermal growth factor (EGF). It is commonly found in proteins such as coagulation 
factors VII, IX, X and XII, decoagulants such as tissue plasminogen activator (tPA), and 
complement factors. It has a total of six cysteine residues that are shown to be involved in 
disulphide bond formation following the pattern Cys1 – Cys3, Cys2 – Cys4 and Cys5 – 
Cys6 (Savage et al., 1973). These disulphide bonds force the structure into three loops, 
with the main structure forming two antiparallel β-strands that occur between cysteine 3 
and 4 (Appella et al., 1988). Most EGF-like domains appear to have a conserved proline 
before Cys1 and a proline or a glycine before Cys2. EGF-like domains found in other 
proteins often play a role in ligand interactions.  
The Cys-rich region encompasses 11 out of a total of 56 cysteine residues present in the 
Factor C sequence. It is unknown whether this is a single domain, as typically, Cys-rich 
repeats are formed of around 40 amino acids with four or six conserved cysteine residues 
in each. Disulphide bonds are known to be conserved between Cys1 – Cys2, Cys3 – Cys5 
and Cys4 – Cys6, however, the Cys3 – Cys5 bond is at times missing, due to the absence 
of one of the Cys residues (Bazan, 1993; Mallett and Barclay, 1991). This could explain 
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the odd number of Cys residues found in the Factor C Cys-rich region as it is unknown 
whether the unpaired Cys residue forms an inter-chain disulphide bond. Folded single Cys 
repeats are thought to form loops defined by the Cys1 – Cys2 and Cys4 – Cys6 disulphide 
bonds, and a conserved Tyr or Phe residue enables correct packing of the loops.  
The identification of a lectin-like domain was surprising in that Factor C was the first 
protease where a domain of this type was discovered. The domain appears to be a member 
of the C-type lectin superfamily, that often function as calcium-dependent carbohydrate 
binding molecules (Drickamer, 1988). However, lectins are in fact diverse in terms of 
structure and function, with a number of C-type lectins being identified that fulfil different 
roles, including protein interactions with other proteins, lipids or nucleic acids (Kilpatrick, 
2002). The pattern of disulphide bond formation appears to match that of acorn barnacle 
lectins, where Cys1 – Cys2, Cys3 – Cys6 and Cys4 – Cys5 form disulphide linkages 
(Muramoto and Kamiya, 1986).  
The proline-rich region is a 48-residue domain where 13 of these residues are proline. 
This fragment shows homology with a region found in mammalian coagulation Factor XII 
but is of unknown significance in Factor C (Iwanaga et al., 1992; McMullen and 
Fujikawa, 1985).  
Another domain present in the Factor C protein is the LCCL module, named after the 
proteins found to contain it: Limulus Factor C, vertebrate cochlear protein cochlin 
(Coch5b2) and Lgl1 (Trexler et al., 2000). As shown for other domains in the protein, this 
domain is disulphide linked with bonds formed between the most highly conserved 
cysteine residues Cys1 – Cys4 and Cys5 – Cys6. It is also believed that, when present, 
disulphide bonds form between Cys2 – Cys3 and Cys7 – Cys8. Secondary structure 
prediction indicated the presence of two α-helices and six β-strands. The LCCL module is 
thought to be an autonomous folding domain that plays a role in construction of modular 
proteins. However, a specific function has not been elucidated for this domain (Robertson 
et al., 1998; Trexler et al., 2000).  
The B chain of Factor C is made up of a serine protease containing a His-Asp-Ser 
catalytic triad (Blow, 1997). There are over 20 families of serine proteases and Factor C is 
thought to be a novel serine protease zymogen receptive to α-chymotrypsin (Iwanaga et 
al., 1992; Rawlings and Barrett, 1994). A conserved Asp is the known site of substrate 
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binding but zymogen activation is a result of cleavage between a Phe-Ile bond (Tokunaga 
et al., 1987). Six out of seven cysteine residues form disulphide bonds: Cys1 – Cys2, 
Cys4 – Cys5 and Cys6 – Cys7. The 7th, Cys3, is thought to link with a Cys residue in 
chain A. The main structure of the serine protease is made up of two six-stranded β-
barrels, with the active site found between the two barrels (Hedstrom, 2002). The 
sequential activation of the serine protease zymogens results in blood coagulation.  
The domain composition and organisation of Factor C is particularly similar to three 
proteins known as ‘selectins’ that also play a role in defence systems (Muta et al., 1991). 
These proteins contain an EGF-like domain, a lectin-like domain and a number of CCP 
domains and are known as the endothelial leukocyte adhesion molecule (Bevilacqua et al., 
1989), the lymph node homing receptor (Siegelman et al., 1989) and the granule 
membrane protein 140 (Johnston et al., 1989).  
Tokunaga et al. endeavoured to establish whether there are any immunological or 
biochemical differences between the Limulus polyphemus Factor C and the Tachypleus 
tridentatus Factor C (Tokunaga et al., 1991). Comparisons revealed the two proteins were 
more or less identical and as purified ttFC was more readily available, it was used for 
further studies.  
Ding et al. carried out analysis on Factor C from the Carcinoscorpius rotundicauda 
species of horseshoe crab (crFC) (Ding et al., 1993). crFC was found to be larger than 
ttFC at 132 kDa and reduction of the chain resulted in two chains of 80 kDa and 52 kDa, 
representing the heavy and light chains, respectively. Upon activation by LPS, the light 
chain was shown to undergo similar cleavage to that apparent in ttFC upon exposure to 
endotoxin.  
1.4 Experimental Basis  
Characterisation of the key proteins involved in binding endotoxin and a better 
understanding of the molecular details surrounding LPS is necessary to develop new, 
highly sensitive biosensors to benefit pharmaceutical and medical device screening as the 
increase in demand for horseshoe crab blood may lead to an unsustainable burden on the 
wild population of horseshoe crabs. These new biosensors could be based on direct optical 
detection rather than relying on the enzymatic activity of the current LAL test. This could 
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be achieved by incorporating a FRET donor/acceptor pair whose separation is modulated 
by LPS binding to a Factor C derived conformational switch.  
Studies to understand the reason Factor C is so sensitive to minute quantities of LPS have 
been hindered by the difficulties faced with the production of biologically active 
recombinant Factor C, along with the fact LPS molecules separate from Factor C after 
activation. The recognition of the lipid A component of LPS by Factor C is very specific, 
and details surrounding this type of interaction are lacking. However, attempts have been 
made to determine the nature and exact site of LPS-binding to Factor C, which inspired 
the experimental approach taken in this project.  
Contradictory results as to the location of the LPS-binding site have been published by 
Tan et al. and Koshiba et al. after both groups carried out experiments on different 
fragments of Factor C (Koshiba et al., 2007; Tan et al., 2000). Tan et al. led investigations 
using the first three CCP domains located between the EGF-like and lectin-like domains. 
They expressed three fragments from Factor C of the Carcinoscorpius rotundicauda 
species as fusion proteins with enhanced green fluorescent protein (EGFP), using a novel 
secretory signal. The three fragments expressed were: Sushi123, Sushi1 and Sushi3. Two 
Factor C derived peptides comprising 34 amino acid regions of the CCPs were also 
synthesised and designated S1 and S3, alongside another two peptides containing two 
lysine mutations each: SΔ1 and SΔ3. These peptides each represented approximately half 
of a CCP module.  
The fusion proteins were expressed in Drosophila S2 cells with the selection vector 
pCoHygro, which was introduced to the cells by a calcium phosphate co-precipitation 
method (Sambrook et al., 1989). A Western blot was performed to confirm the presence 
of the fusion proteins, which were purified by anion exchange chromatography. Surface 
plasmon resonance (SPR) analysis was carried out to elicit protein/peptide interactions 
with lipid A. The binding constant of polymixin was established for use as a positive 
control.  
Results from the fusion proteins indicated there are multiple binding sites present within 
the first three CCP modules of Factor C. The peptides highlighted the disadvantages of 
producing truncated CCP domains and thus a lack of disulphide bonds, as a decreased 
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affinity for LPS was shown for S1 and S3 (10,000-fold and 100-fold, respectively). 
Despite this, further experiments were performed using the four peptides.  
Circular dichroism (CD) was used to estimate secondary structure contributions from each 
of the peptides. This revealed that all four peptides largely displayed a random coil 
structure. Upon addition of LPS, the structures of S1 and SΔ3 became largely α-helical, 
SΔ1 displayed mostly turns and SΔ3 displayed a high percentage of beta contributions. 
These findings, for the most part, contradict the previously observed structures of CCP 
modules, that mostly display β-strands (Norman et al., 1991).   
A chromogenic assay was performed on the four peptides. This assay involved using the 
first steps of the endotoxin reaction for activation of a synthetic substrate enzyme, which 
ultimately emitted a yellow colour that was monitored by absorbance at 405 nm. The 
potency of each individual peptide was determined in terms of its 50% endotoxin 
neutralising concentration (ENC50). A sigmoidal curve was observed for S1, suggesting 
this peptide binds to LPS and displays positive cooperativity, in comparison to the other 
three peptides that appear to bind independently. The introduction of lysine mutations into 
the peptides was based on computational analysis that suggested LPS binding would 
improve with the presence, at specific sites, of more lysine residues. However, the SΔ1 
peptide only displayed a 10-fold increase in LPS binding affinity, and there was no 
difference evident with SΔ3.  
Tan et al. suggested that endotoxin and Factor C interact in a “two-prong amplification 
activation pathway”, in which binding of a single LPS molecule to the “LPS-capturing” 
domain – sushi3 – would encourage positive cooperative binding of the “LPS epitope 
presenting” domain – sushi1, but also that binding to either one of the two domains would 
still activate Factor C (Tan et al., 2000).   
In conclusion, Tan et al. suggested the LPS-sensitivity of Factor C was due to multiple 
LPS binding sites and the high positive cooperativity of LPS binding. However, flaws of 
their experimental approach include the neglect of the N-terminal region that includes the 
EGF-like domain and the Cys-rich region, which could potentially be structurally 
important. Additionally, the use of truncated peptide sequences did not give a proper 
representation of the known domain structure of CCPs, and thus it does not seem plausible 
that accurate results can be drawn from use of these peptides. Experiments were also 
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lacking negative controls, which should have been used to confirm that it was specifically 
LPS binding to these domains, and not a different substrate, thus giving false positives.  
Koshiba et al. expressed Factor C fragments from the Tachypleus tridentatus species of 
horseshoe crab for their investigations into the N-terminal region of Factor C (Koshiba et 
al., 2007). Six constructs were sub-cloned into the pSecTag2A vector and expressed in 
HEK293 cells. The constructs each had three tandem copies of the Myc-tag inserted and 
they represented: the heavy chain (residues 1 – 723); CysEGFCCP123 (residues 1 – 296); 
LCCL/lectin (residues 300 – 543); CCP4 (residues 551 – 609); CCP5 (residues 669 – 
723); and the serine protease domain (residues 738 – 994). Myc-tagged anti-LPS factor 
(ALF), a known LPS recognising protein, was expressed for use as a positive control 
(Aketagawa et al., 1986). Purification was achieved by use of agarose beads coupled to 
the c-Myc polyclonal antibody and separation by SDS-PAGE.  
LPS binding was determined by immunoprecipitation experiments and flow cytometric 
analysis. Results showed binding of the heavy chain fragment and the CysEGFCCP123 
construct to LPS. On the other hand, the other four constructs (LCCL/lectin, CCP4, CCP5 
and the serine protease) failed to bind LPS. Structure function analysis was performed on 
a further two constructs that were produced in order to pinpoint a more exact location of 
LPS binding. These constructs were CysEGF (residues 1 – 116) and CCP123 (residues 
117 – 296). Binding tests revealed only the CysEGF construct formed a complex with 
LPS. The specificity of binding was highlighted by the fact cholesterol and acidic 
phospholipids could not disrupt the complex. By using a negative control of Gram-
positive bacteria, they were able to further confirm Factor C specificity to LPS as no 
binding took place in the presence of this bacteria.  
A feature of the Cys-rich region, which has been identified in a number of LPS-
recognising proteins, is a conserved tripeptide motif, consisting of an aromatic residue 
with a basic residue either side. Two copies of this motif were identified in the Cys-rich 
region of Factor C: Arg36-Trp37-Arg38 and Lys55-Tyr56-Lys57. When the Arg-Trp-Arg 
motif was mutated to Glu-Trp-Glu, the construct failed to bind to LPS. Furthermore, a 
substitution of the Trp residue with an Ala also left the construct incapable of binding to 
LPS. A mutation of Lys-Tyr-Lys had no effect on binding capabilities, therefore 
establishing that the conserved Arg-Trp-Arg motif plays an important role in LPS-
binding.  
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In conclusion, they proposed the first conserved tripeptide motif found at the N-terminal 
of Factor C plays a key role in LPS recognition, in the same way that predicted binding of 
ALF to LPS occurs, where the basic residues are involved with Lipid A’s glucosamine 
(GlcN) I1-phosphate and the aromatic residue associates with a hydrophobic portion 
(Pristovšek et al., 2005).   
Even though Koshiba et al. appeared to provide a more specific, detailed, alternative 
model for LPS binding and thus activation of Factor C, they failed to adequately describe 
the experiments performed in their structure-function analysis of LPS binding, thus 
questioning the credibility of the results. In both cases, protein constructs were not 
checked for correct folding, which could have a significant impact on the outcome of 
certain, if not all, experiments. Folding is especially important in heavily disulphide 
bonded proteins, as incorrectly bonded cysteines can result in mis-folding and 
aggregation, thus leading to improper results. In the experiments carried out by Koshiba et 
al., they failed to elucidate the extent of the role played, if any, by the second domain in 
the construct, the EGF-like domain. This domain could be important for proper folding or 
formation of disulphide bonds, thus playing a key role in LPS binding.  No indication was 
given that these experiments were repeated in any way, casting doubt on the reliability of 
the results being presented.  
Given the conflicts associated with the previous research and the questions that remain 
unanswered, further characterisation of LPS binding to Factor C is of paramount 
importance for the development of new endotoxin testing strategies.  
1.5 Project Aims  
The aims of this project were to identify and understand how Factor C binds LPS; to 
characterise the conformational changes induced by binding LPS at the molecular level; 
and to identify why Factor C binding to LPS is so specific to lipid A. To achieve these 
objectives, full-length synthetic Limulus polyphemus Factor C was to be produced in order 
to understand the overall conformational change that takes place upon LPS binding and 
fragments of Factor C were produced to reveal the precise location of LPS binding, 
through structural analysis.  
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Despite the fact that other Factor C based tests use protein from the Tachypleus 
tridentatus and Carcinoscorpius rotundicauda species, the commercial LAL test is made 
from Limulus Factor C. As there are known variances between different LPS binding 
sites, it is beneficial to study lpFC to identify any differences that may arise between the 
species in terms of sensitivity or specificity of binding. Additionally, Marine Biotech 
Limited, the industrial sponsor for this project, use Limulus polyphemus for their 
investigations, and so experiments were carried out using lpFC to coincide with their 
studies.  
As the heavy chain, and thus the N-terminal region of Factor C has been found to be the 
putative binding site of LPS, the first three CCP domains as well as the EGF-like and Cys-
rich fragments were investigated as potential sites of LPS binding. Thus, experimentation 
endeavoured to express and purify the CCPs as single domains and as multi-domain 
fragments, along with the Cys-rich domain and the EGF-like domain on their own and 
together.  
1.6 Experimental Approach  
The sequence of Limulus polyphemus Factor C is not publicly available. For this reason, it 
was necessary to assemble the lpFC gene from the raw data kindly provided from 
Washington University, St Louis, in order to synthesise full-length lpFC. Three different 
eukaryotic expressions systems were chosen to test synthetic production of the full-length 
protein, to establish which was the most suitable to produce lpFC to fulfil the aim of 
carrying out a combination of biophysical techniques including circular dichroism, 
analytical ultracentrifugation and small angle X-ray scattering, to elicit its ligand-free and 
LPS-bound conformations in solution.  
In order to determine the exact location of LPS binding, fragments of the Factor C protein 
were expressed recombinantly in E. coli to allow for their ligand-free and LPS-bound 
conformations to be determined by high resolution techniques such as nuclear magnetic 
resonance spectroscopy (NMR) or X-ray crystallography. Lipid binding analyses were 
performed using circular dichroism and NMR spectroscopy. 
NMR is a powerful analytical spectroscopic technique that is used for the study of 
molecules in solution to obtain structural and dynamic information. Active nuclei are 
observed as a result of nuclear magnetic spin and transfer of magnetisation allows for the 
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detection of signals. From this, interactions between nuclei that are near each other can be 
detected and assignment of the resonances can be made, to piece together the overall 
structure of the protein under investigation. 
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2 Limulus polyphemus Gene  
2.1 Overview  
In order to identify and understand how Factor C binds lipopolysaccharide (LPS) and to 
characterise the conformational changes induced by binding LPS at a molecular level, it 
was expected that it would be necessary to study the whole, intact protein. This could give 
insights into why Factor C binding to endotoxin is so specific to lipid A and how Factor C 
binding to endotoxin changes the structure of the protein, thereby activating it. Ideally, 
purified native Factor C from amebocytes would be studied in order to determine the 
ligand free and LPS-bound conformations in solution to see the structural change that 
occurs from the inactive to the active forms. However, the Factor C protein is not at all 
abundant in the amebocyte and large quantities of Limulus blood would be required in 
order to purify enough for structural analysis. Additionally, blood and amebocyte lysate is 
a difficult source to deal with as it clots so easily, therefore additional measures to prevent 
these risks are required. Eukaryotic expression systems were selected to test synthetic 
production of the intact protein; yeast (Pichia pastoris), insect (Baculovirus system) and 
mammalian (Flp-In™ TREx™ system). Each system comes with its own advantages and 
limitations and so to determine the most suitable one for expression of lpFC, it was 
intended to test all three (see Chapter 4).  
2.2 Choice of Factor C Sequence  
The most widely used amebocyte lysate tests are produced from Limulus polyphemus (lp) 
blood, while the commercially available recombinant Factor C tests use proteins based on 
the previously determined Tachypleus tridentatus (tt) and Carcinoscorpius rotundicauda 
(cr) sequences. Given published differences in LPS binding sites, in order to assess 
whether differences in sensitivity of current synthetic Factor C based endotoxin reagents 
exist due to variations in the sequences, it was considered desirable to obtain the Limulus 
polyphemus Factor C sequence. This would allow for a direct comparison of the Factor C 
genes between the three species.   
2.3 Assembly of the Limulus polyphemus Factor C Coding Sequence  
Neither the amino acid, nor the genomic DNA or cDNA sequences for Factor C from 
Limulus polyphemus were available in any public databases. However, the McDonnell 
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Genome Institute at Washington University, St Louis (WUSTL) granted pre-release 
access to their Limulus polyphemus genome data (project funded by the National Human 
Genome Research Institute (NHGRI)). This was mined in an attempt to assemble the 
Limulus polyphemus Factor C coding sequence and gene.  
2.3.1 Identification of Limulus polyphemus Genomic Sequences 
Encoding Factor C  
Data was received as ‘contigs’, which are contiguous (or adjacent) sequences of DNA 
assembled by overlapping fragments of sequence reads from a chromosome, and 
‘supercontigs’, longer stretches of sequence, assembled from correctly oriented contigs 
joined together systematically to build up the genomes, but separated by gaps. The 
genomic sequence was built using Roche 454 sequencing technology with 15X coverage, 
where each nucleotide was ‘read’ 15 times during the process (Margulies et al., 2005). 
This technique uses pyrosequencing technology (sequencing by synthesis), and produces 
several hundred thousand reads up to 1 Kb in length (Mardis, 2008). The McDonnell 
Genome Institute, WUSTL, also proposed to generate a Bacterial Artificial Chromosome 
(BAC) library and to use 6X BAC end sequencing, where DNA is cloned into a bacterial 
cell where it is stable and can be manipulated easily in order to construct the DNA library 
(Shizuya et al., 1992).   
Eukaryotic genes consist of coding regions known as exons that are disrupted by parts of 
genes that do not code directly for the protein, known as introns. Pre-mRNA is formed 
during transcription and comprises both exons and introns, however, the introns must be 
removed to create the mature mRNA. This is achieved by RNA splicing, where small 
nuclear ribonucleoproteins (snRNPs) attach to the 3’ and 5’ ends of introns to form a loop. 
After removal, the exons can then join together. It is important that introns are removed 
accurately, as remaining intron nucleotides or removal of exon nucleotides can result in a 
frameshift of the genetic code (Clancy, 2008).  
In order to identify which of the numerous contigs and assembled supercontigs were 
required to build up the full Factor C gene sequence, searchable databases were produced 
in order to identify regions of similarity between sequences. These were achieved by 
processing the sequence data in FASTA format using CLC genomics workbench software 
version 6.0.1 to generate two Basic Local Alignment Search Tool (BLAST) databases. 
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The supercontigs database comprised 683 sequences ranging from 374,669 bp to 
5,251,686 bp and totalling 572,829,000 bp. In comparison, the contigs database consisted 
of 526,922 sequences ranging from 200 bp to 133,477 bp and totalling 1,685,998,000 bp. 
The Limulus polyphemus genome is estimated to be 270 Mb. However, the information 
produced from this did not allow for the supercontigs or contigs to be used simply to 
elucidate the sequence.  
Consequently, a tblastn search was carried out using CLC genomics, where the translated 
nucleotide databases were searched using a known protein query; pre-Tachypleus 
tridentatus factor C (pre-ttFC). This was achieved using the BLAST program tblastn: 
Protein sequence and translated DNA database, and the following parameters: Standard 
database genetic code; Matrix: BLOSUM62; Gap cost: Existence 11, Extension 1; Max 
number of hit sequences: 250. Firstly, the supercontig database was searched against the 
pre-ttFC amino acid sequence. 139 sequences provided a hit but all had a percentage 
similarity of less than 30% (Figure 2-1). The likely reason for this lack of hits from the 
supercontigs database is probably due to not enough supercontigs being pieced together 
correctly. If this search had identified the Factor C gene, the hits would have been in 
sequence at adjacent sites on one supercontig representing the exons of the gene and 
interspersed with intron sequences. The fact that they were scattered across supercontigs 
and appeared significantly overlapped implies they were unlikely to represent Factor C.   
Since no gene candidate could be clearly identified in the supercontig database, the next 
step was to perform a search of the contig database against the pre-ttFC amino acid 
sequence. This resulted in 485 hits, with contig size ranging from 51 bp up to 939 bp with 
varying degrees of similarity, up to 100% similarity in some regions (Figure 2-2). 
Including overlapping segments, there was a total coverage of 97,134 bp, over 30X the 
length of the Factor C cDNA. Contigs that were correctly assembled to the ttFC sequence 
should correspond to fragments of the lp genome and those that were long enough to 
overlap could be used to find the exons and assemble the entire Factor C gene. The hits 
were examined manually to select the most closely matching contigs for each region of 
the protein.   
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Figure 2-1: Supercontigs BLAST hits against pre-ttFC sequence. A small subset of supercontig 
hits are represented by each bar and are colour coded according to the quality of the hit. The pre-
ttFC sequence is shown by the black bar across the top. Multiple hits for the same region of ttFC 
were often found within the same supercontig and hits at low similarity scores were found 
between ttFC and many different supercontigs. A full list of the supercontigs unique identifiers 
are outlined in Appendix A. 
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Figure 2-2: Contigs BLAST hits against pre-ttFC sequence. The black bar along the top represents 
the pre-ttFC sequence, with contig hits shown as bars of varying colour depending on sequence 
similarity. Each line represents a hit within a specific contig and in this case, there are a number of 
hits of more than 60% sequence identity. There are often multiple hits to different regions of 
Factor C in any one contig meaning a contig may appear in more than one line. A full list of the 
contigs unique identifiers are outlined in Appendix A. 
For the assembly of the lpFC cDNA, pairs of the selected contigs encoding adjacent 
regions of the protein coding sequence presumed to represent exons were compared in an 
attempt to identify common sequences that would allow the intervening intron sequences 
to be identified. However, this approach was unsuccessful in assembling the gene.  
As a result of failing to produce a sensible construct the contigs identified in the tblastn 
search were assembled using the ttFC cDNA sequence as a guide in the CLC “assemble 
sequences to template” tool. The resulting assembly was examined and the regions of each 
contig contributing to the consensus coding sequence were adjusted by hand to likely 
splice sites following the consensus splicing rules where the intron sequence typically 
starts before the GT at the 5’ end and after the AG at the 3’ end (Figure 2-3).   
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As highlighted in Figure 2-3 there are a few cases where the contigs only go part way 
through a module. However, this was to be expected as the right arrangement of the 
contigs was dependent on the correctness of the assembly, which was likely to contain 
errors, but also, some modules have internal introns. Furthermore, in some instances, 
more than one contig covered a domain, which could be due to differences between 
chromosomes. 
  
Figure 2-3: Selected contigs for sequence determination. The contigs are shown for each domain 
of the protein. The vertical black lines give an indication of the contig coverage.  
As shown in Figure 2-4, the contigs show a good coverage of the pre-ttFC sequence. 
However, as to be expected between different species, there are several base pair 
mismatches. In one instance, two contigs were found with the same sequence that 
matched the reference sequence and around 20bp either side of the corresponding 
fragment before diverging. Limulus polyphemus is diploid, with a count of 52 
chromosomes, and so both chromosomes may have been showing, however, it is more 
likely that the contigs were assembled wrong thus giving inconsistent results. At a gap in 
the sequence, the sequence was manually altered to include an extra codon, in line with 
the ttFC sequence. Additionally, the very N-terminal did not produce any matches and so 
a targeted search was carried out in order to find this part of the cDNA sequence. The 
differences that arose could be put down to the sequence data not being good enough, the 
data being incorrectly assembled or that big differences exist between the species.   
After identifying the contigs from the Limulus raw data that best matched the ttFC 
sequence, the sequences were combined in the correct order to obtain the lpFC cDNA 
sequence. This was then translated using the CLC genomics software to obtain the pre-
lpFC protein sequence.  
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Figure 2-4: pre-ttFC guided lpFC contig assembly. The pre-ttFC open reading frame is shown by 
the yellow arrow. Coverage is indicated by the pink graph revealing at least one lpFC contig 
sequence matched the pre-ttFC sequence over the whole sequence. The different colours shown at 
each contig represent a different base pair mismatch on the lpFC contig (Red = A, Green = T, 
Blue = C and Yellow = G). 
2.3.2 Factor C Sequence Alignment  
Having obtained the predicted cDNA sequence for pre-lpFC, and translating this to protein, 
a protein sequence alignment was created to compare pre-lpFC, pre-ttFC and pre-crFC 
sequences to identify regions of similarity between the species (Figure 2-5). Identical 
amino acid sequences would suggest the domains are highly conserved between species 
and that use of the Tachypleus sequence would be sufficient for structural analysis of the 
protein fragments. It would also suggest a strong likelihood that the LPS binding site may 
be found in this region as it is thought to be conserved between species. If significant 
differences were seen between the three species, then the Limulus sequence would be 
required for obtaining accurate data with regards to the native Limulus protein.   
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Figure 2-5: Sequence alignment of lpFC, ttFC and crFC N-terminal region. This alignment 
allows comparison of the Cys-rich, EGF-like and CCP1-3 domains between the three horseshoe 
crab species. The Cys-rich sequence is shown by the purple bar, the EGF-like by the green bar 
and the CCPs by the yellow bar. The pink bars indicate the conservation of each residue between 
the species.  
There is a high level of similarity between the N-terminal region of the Factor C gene in all 
three species of horseshoe crab with the sequence identities for each domain as follows: 
Cys-rich = 88%; EGF-like = 97%; and CCPs = 86%. However, a few differences do exist 
between the three species. The majority of these differences are conservative substitutions, 
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where changes have resulted in amino acids with similar biochemical properties for 
example, charge, hydrophobicity or size, occupying a particular site. There are also a few 
non-conservative substitutions, but if we assume that all three proteins bind lipid A in the 
same way, the non-conservative substitutions suggest that residues at positions 71, 140, 
159, 160, 201, 216, 255, 256, 270 and 304 are less likely to be involved in electrostatic 
interactions with the ligand.  
2.4 Design and Assembly of the Synthetic Gene Construct  
In order to avoid the production of glycosylated protein in the target eukaryotic expression 
systems, asparagine (N)-linked glycosylation sites were to be avoided in the final protein 
sequence. These sites play a role in determining protein structure and shape by post-
translationally adding oligosaccharides to asparagine residues, which could potentially lead 
to structural complications. These sites are not homogenous across any expression system, 
which can cause conformational or chemical heterogeneity, resulting in considerable 
differences between each of the samples (Schwarz and Aebi, 2011). Glycosylation is 
known to strongly influence the folding process, and can also play a role in localisation and 
binding (Imperiali and O’Connor, 1999). Asn-Xaa-Ser/Thr is the consensus sequence for N-
linked glycosylation where Xaa is not Pro and Thr occurs more often than Ser (Marshall, 
1972). Typical practice for removing N-linked glycosylation sites from recombinantly 
expressed proteins use chemical or enzymatic methods. Release of oligosaccharides can be 
achieved with the use of mild alkali or mild hydrolysis, however, this often results in 
protein degradation (Ogata and Lloyd, 1982). Enzymatic methods using the glycosidases 
PNGase or Endo H are much better for the protein, providing complete removal of 
oligosaccharides with no protein degradation (Maley et al., 1989). However, the change 
may have adverse consequences for the stability of the structure.  
To identify N-linked glycosylation sites in order to exclude them from the final sequence, 
the proposed protein sequence for lpFC was entered into the ‘Glycosylation site predictor’ 
GlycoEP (www.imtech.res.in/raghava/glycoep/). Both the ‘Standard predictor’ and 
‘Advanced predictor’ were used, which gave rise to the same results. Five sites were 
identified at positions 522 and 535 in the CLECT domain, 625 in the CCP4 module, and 
768 and 913 in the serine protease domain. Asparagines are likely to be on the surface of 
proteins, exposed to the aqueous environment. The identified Asparagines (N) were 
changed to Serine (S). The altered amino acid sequence was again tested using the 
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glycosylation site predictor, and a further two potential glycosylation sites were identified 
at positions 766 and 911, also found in the serine protease domain. These were also 
changed to serine and the resulting sequence now contained no potential N-linked 
glycosylation sites.  
Using the information from the assembled amino acid sequence of Limulus polyphemus 
Factor C, a DNA sequence was generated to allow easy construction of genes for Factor C 
expression in three different eukaryotic expressions systems; mammalian, yeast and 
insect.  
The predicted horseshoe crab Factor C signal sequence was omitted, and alternative signal 
sequences were added at the N-terminus for secretion from each system: Ig κ-chain from 
pSecTag for mammalian expression; Saccharomyces cerevisiae α-mating factor pre-
sequence for the yeast, Pichia pastoris; and gp67 from Baculovirus vector pAcGP67 for 
insect cell expression. Restriction sites were engineered into the construct to allow for 
signal sequences to be cut out and to enable re-ligation of the sequence with the 
appropriate starting sequences. Additional features were added at the N-terminus: a 
6xHis-tag was incorporated to allow for purification by nickel affinity chromatography; 
phiLOV2.1 (Christie et al., 2012) was added as a fluorescent tag; a biotinylation site 
(Hofmann et al., 1980) was added to be used for detection or purification methods; and a 
very specific protease cleavage site, human rhinovirus 3C (HRV 3C) (Cordingley et al., 
1989), was added to enable separation of the expressed Factor C from the tags during 
purification. A restriction site, XmaI, was incorporated 3’ of the 3C site to facilitate 
subsequent reuse of the vectors to express other proteins, such as the individual domains 
of Factor C. The designed DNA sequence’s total length was 3,943 bp (Figure 2-6).  
The predicted lpFC amino acid sequence was run through DNAworks for Drosophila 
melanogaster codon optimisation (http://helixweb.nih.gov/dnaworks). This also allowed 
for the exclusion of specific restriction sites that would disrupt the subsequent cloning 
process, namely; AseI, BglI, BamHI, EcoRI, EcoRV, HindIII, KpnI, NcoI, NdeI, NotI, 
PstI, SphI, SwaI, XhoI and XmaI. Subsequently, the signal sequences and tags were added 
to the N-terminal end of the sequence. The full amino acid and DNA sequences for 
Limulus polyphemus Factor C are shown in Appendix B.  
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The designed DNA sequence was ordered from Genewiz Inc. It was found that the most 
time and cost effective way to do this was to order two fragments each of less than 3 Kb 
and so an additional restriction site was required, ideally between domains and roughly in 
the middle of the sequence. To achieve this, the ‘Silent’ program from the European 
Molecular Biology Open Software Suite (EMBOSS) was used. The sequence was 
analysed in a ‘fuzzy’ way to recognise all restriction sites up to and including 6 bp in 
length using the ‘silent’ function, which identifies cryptic restrictions sites where a single 
nucleotide change will generate a new site without changing the amino acid sequence of 
the protein produced. The best solution was to introduce an SpeI site between CCP2 and 
CCP3, allowing the construct to be ordered as two fragments of size 1631 bp and 2318 bp.  
 
Figure 2-6: Limulus polyphemus Factor C synthetic gene design. Highlighted in blue are the 
positions of the three signal sequences for the different expression systems: Ig κ-chain; α-factor; 
and gp67. The various tags for purification and detection are shown at the N-terminal end: His-tag 
(orange); phiLOV2.1 (green); BAP (purple); and 3C (grey). The restriction sites and positions for 
use during the molecular cloning process are indicated. 
Assembling the lpFC coding sequence and gene from the raw lp genome data allowed a 
synthetic gene construct to be designed. The resulting construct was to be used to test 
production of full-length Factor C protein in three eukaryotic expression systems to 
determine which was the most suitable for protein expression. Determining the sequence 
for lpFC also allowed comparisons to be made between the different species to identify 
any differences that may exist between the LPS binding sites. The high-level of similarity 
between the three N-terminal regions supports the assumption that all three proteins are 
likely to bind lipid A in the same way. 
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3 Recombinant Expression in E. coli  
3.1 Overview  
Purification of protein from its natural source, for example animal or plant tissue, is 
problematic and time-consuming, often resulting in very low yields and protein that is 
heterogeneously glycosylated. The typical yield of Factor C from horseshoe crab blood is 
approximately 1.15 mg/ml (Levin and Bang, 1968). In order to overcome the difficulties 
faced, recombinant protein expression systems have been developed and are now the 
favoured option for the production of protein to serve a variety of purposes including, but 
not limited to: structural characterisation, the development of drugs and vaccines, and in 
industrial processes such as diagnostics. Escherichia coli (E. coli) is a popular choice for 
the host organism as it can not only produce high density cell cultures, but molecular 
biology is quick and easy, and media components are readily available and inexpensive 
(Rosano and Ceccarelli, 2014). When faced with preparation of samples for nuclear 
magnetic resonance (NMR) spectroscopy, these features of protein expression are crucial.   
Samples produced for analysis by NMR need to be of sufficient concentration (50 – 500 
nmoles at 0.1 – 1 mM) and are required to have NMR-active nuclei that interact with the 
static magnetic field. However, due to the relatively low abundance of naturally active 
isotopes for specific nuclei, there is a need to incorporate these into the sample through 
‘labelling’. Active isotopes commonly used for the study of proteins and nucleic acids by 
NMR include 13C and 15N, but these can be expensive. So, in order to ensure production is 
economically viable, an adequate yield of recombinantly expressed protein must be 
attained.  
As described in Chapter 1, it has been determined that the N-terminal region of the Factor 
C protein is the site of lipopolysaccharide (LPS) binding, but with conflicting claims as to 
the exact location of the binding site (Koshiba et al., 2007; Tan et al., 2000). This chapter 
describes how individual domain fragments along with combinations of the domains were 
produced recombinantly in E. coli in order to build a detailed picture of the 
structure/function relationship of this multi-modular protein and determine the site of LPS 
binding correctly. The correct conformation for LPS binding may only arise in fragments 
containing more than one domain.  
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It was appreciated that protein produced in E. coli was likely to have endogenous LPS 
bound, in which case extra purification steps could be carried out to strip the LPS from the 
protein, to allow studies of the apo-protein and of complexes with defined LPS-derived 
ligands such as Lipid A. Extracellular expression would be unfavourable as it would 
guarantee contact with LPS and could be toxic to the E. coli. In addition, it is widely 
known that intracellular expression of correctly folded disulphide-linked protein can be 
challenging in E. coli (Berkmen, 2012) and so for this reason, an expression vector and an 
E. coli expression strain were chosen to maximise the chance of success, more details of 
which can be found in section 3.3.1.   
3.2 Protein Production  
There are three main stages required for recombinant protein production: vector 
construction; protein expression and protein purification. For the most part, the same 
procedures were used for all recombinant Factor C fragments expressed. Any differences 
are described below.  
3.3 Vector Construction  
DNA encoding proteins can be transferred to different organisms in order to produce 
recombinant DNA that can then be used for efficient gene expression in the new host.  
3.3.1 Expression Plasmid  
There are a vast number of expression vectors available for use in protein expression, with 
various features that must be considered in order to determine the most suitable plasmid 
for the research being undertaken. pNH-TrxT (Figure 3-1) from the pET expression 
system produced by the Structural Genomics Consortium (SGC) (Genbank ID: 
GU269914) for bacterial expression, with a pET28-a backbone, was selected for a variety 
of reasons (Savitsky et al., 2010). These include the presence of a hexa-histidine (6xHis) 
tag allowing for simple purification by Ni2+ affinity chromatography (Bornhorst and 
Falke, 2000); a thioredoxin (Trx) fusion partner used to encourage correct protein folding 
(Kern et al., 2003) and high-level production of soluble protein (LaVallie et al., 1993); a 
TEV-cleavage site to enable cleavage of the tags from the protein of interest (Carrington 
and Dougherty, 1987a, b); and primers that can be used for cloning via a ligation 
independent cloning (LIC) technique (Aslanidis and de Jong, 1990). pNH-TrxT carries a 
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kanamycin resistance gene for selection. Features of the pET system also present include a 
strong T7 promoter, lac repressor control and induction of both the chromosomal copy of 
the T7 polymerase in the host genome and of the promoter in the vector by isopropyl β-
thiogalactopyranoside (IPTG) (Studier and Moffatt, 1986). T7 RNA polymerase 
promoters do not appear in the E. coli genome meaning it is extremely selective for its 
specific promoters (Studier and Moffatt, 1986). This, along with having a transcription 
rate five times faster than E. coli polymerase, makes T7 RNA polymerase a highly 
effective tool for high-level expression of protein in E. coli (Studier et al., 1990).  
  
Figure 3-1: pNH-TrxT Vector Map. Created with SnapGene® using the full sequence obtained 
from Addgene. The two BsaI restriction sites used to linearise the vector are shown at positions 
423 and 2354. Other features shown include the E. coli thioredoxin (TrxA), the TEV cleavage site 
and the 6xHis site.  
3.3.2 Ligation Independent Cloning  
Developed by Aslanidis and de Jong, ligation independent cloning (LIC) makes use of the 
T4 DNA polymerase 3’ → 5’ exonuclease activity to create cohesive ends, 12 nucleotides 
long, on the vector and insert fragments, allowing for circularisation without the need for 
ligase, alkaline phosphatase or restriction enzyme treatment of the insert (Aslanidis and de 
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Jong, 1990). Using this method, constructs from the N-terminal region of Factor C, based 
on the Tachypleus tridentatus sequence, were made for the Cys-rich domain, EGF-like 
domain and CysEGF domains together, as information on the Limulus polyphemus 
sequence was not yet available. The ttFC protein used was a codon optimised TBIO 
product, previously produced in the Smith lab. CLC genomics software was used to 
identify the sequences of the three fragments, which were used to design primers 
incorporating the LIC overhangs to be used to produce the fragments by the LIC method.  
Originally there was a need for primers to be designed for both amplification of the vector 
and the insert, the former lacking dGMP at their 5’ ends and the latter lacking dCMP at 
their 3’ ends. However, the SGC designed their vectors in such a way that simply 
linearizing the vector and treating the resulting linearized DNA with T4 DNA polymerase 
and dGTP would be sufficient preparation for the vector for use in the LIC method, and so 
primers were designed only for the desired inserts (Savitsky et al., 2010). The vector will 
have noncomplementary tails at each end, which will prevent the formation of circular 
forms containing only vector.  
3.3.2.1 Linearisation of the LIC Vector 
pNH-TrxT in DH5α was plated on kanamycin lysogeny broth (LB) agar from a glycerol 
stock, for selective growth of pNH-TrxT. Individual colonies were picked and used to 
inoculate 10 ml of LB plus kanamycin in 30 ml universals. Samples were grown 
overnight at 37°C in the shaking incubator. Plasmid DNA was purified using the 
Wizard® Plus SV Minipreps DNA purification system (Promega). Initial culture was 
pelleted at 5,000 × g (Sigma Laboratory Centrifuge 4K15 SciQuip, Rotor 11150) and all 
Eppendorf centrifugation was carried out at 13,000 × g (Heraeus™ Biofuge Fresco 
Sorvall benchtop centrifuge). BsaI-HF (NEB) was used for the linearization in a mixture 
containing 1X NEB Buffer 4, 1X BSA (100 µg/ml), linearized pNH-TrxT vector and 
BsaI-HF (10 U/µg of DNA). The mixture was incubated for 1 hour at 37°C before heat 
inactivation for 20 minutes at 65°C. Digested vector was separated from undigested 
vector using a 0.8% agarose gel (Figure 3-2) made by melting agarose electrophoresis 
grade in 1X TAE buffer (40 mM Tris-base, 20 mM acetic acid, 1 mM EDTA, pH 8.0) and 
adding GelGreen™ Nucleic Acid Gel stain (Biotium). Bands were excised on a blue light 
box (Dark Reader™, Clare Chemical Research) and DNA extraction was carried out 
using Macherey-Nagel’s NucleoSpin® Gel and PCR Clean-up kit.   
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Figure 3-2: Agarose gel analysis of linearised pNH-TrxT vector. Digestion with BsaI resulted in 
two fragments corresponding to the predicted sizes, 5671 bp and 1931 bp. The larger fragment 
was excised for treatment with T4 DNA polymerase. 1. Quickload® 1 Kb DNA ladder (NEB), 2. 
Uncut pNH-TrxT, 3. pNH-TrxT linearised with BsaI-HF.  
3.3.2.2 T4 DNA Polymerase Treatment of the Linearised LIC Vector  
To generate the long single stranded overhangs required for LIC, 600 ng of BsaI-digested 
pNH-TrxT vector was treated with 0.06 Units (U) T4 DNA polymerase (NEB) in a 
reaction containing 1X NEB Buffer 2, 2.5 mM dGTP, 5 mM DTT and 1X BSA (100 
µg/ml). The reaction was incubated for 30 minutes at room temperature before addition of 
EDTA to a final concentration of 10 mM and further incubation for 20 minutes at 75°C to 
inactivate the polymerase. Due to the competing 3’ → 5’ exonuclease activity, the 
polymerase activity and the presence of dGTP, the bases are removed from the 3’ ends 
until the first guanine (G) residue is reached.  
3.3.2.3 Polymerase Chain Reaction Amplification of the Inserts  
The primers for amplification of the insert fragments included the sequences: 
TACTTCCAATCC added to the 5’ end of the upstream primer and 
TATCCACCTTTACTG added to the 5’ end of the downstream primer (full primer 
sequences are shown in Appendix C). PCR reactions were set up containing: 1X Pfu 
polymerase buffer, 0.5 µM Forward primer, 0.5 µM Reverse primer, dNTPs (2.5 mM of 
each dATP, dCTP, dGTP and dTTP), 1.25 U PfuTurbo DNA polymerase (Agilent 
Technologies) and 20 ng DNA. The PCR program used for amplification involved 30 
cycles of denaturation at 95°C for 30 seconds, annealing at 54°C for 30 seconds, 
elongation at 72°C for 30 seconds and a final extension of 72°C for 10 minutes.  
3.3.2.4 T4 DNA Polymerase Treatment of the PCR Product  
The resulting PCR products were analysed using a 2% agarose gel (Figure 3-3) and gel 
extracted (Macherey-Nagel), then treated with T4 DNA polymerase in the presence of 
dCTP to create single-stranded ends complementary to those of the vector. 0.2 pmol of 
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PCR product (calculated using the DNA concentration determined from A260 using the 
assumed e = 50 ng μl-1 cm-1, where e = wavelength) was treated with 0.06 U of T4 DNA 
polymerase in a reaction containing 1X NEB buffer 2, 2.5 mM dCTP, 5 mM DTT and 1X 
BSA (100 µg/ml).  
    
Figure 3-3: Agarose gel analysis of PCR insert products. Cys-rich-, EGF-like- and CysEGF-
coding regions amplified in preparation for insertion into linearised pNH-TrxT vector. 1. 1 Kb 
Plus DNA Ladder (Invitrogen™), 2. Cys-rich PCR product (252 bp), 3. EGF-like PCR product 
(102 bp), 4. Quickload® 1 Kb DNA ladder (NEB), 5. CysEGF PCR product (348 bp).  
3.3.2.5 Annealing of the insert and LIC vector  
The complementary ends allowed for non-covalent, intermolecular associations during 
annealing where vector DNA and insert DNA were incubated in a ratio of 1:5 for 10 
minutes at room temperature (RT) before 10 mM EDTA was added and the samples were 
heated to 75°C before being cooled slowly to room temperature.   
3.3.2.6 Transformation into DH5α  
The annealed DNA was transformed into Subcloning Efficiency™ DH5α™ Competent 
Cells (Invitrogen™), a strain providing a transformation efficiency of > 1 x 106 cfu/µg 
plasmid DNA and useful for routine subcloning procedures. Cells were thawed on ice 
before 1 μl of the annealing mixture was transferred to 20 μl of cells and then placed on 
ice for 30 minutes. The cells were heat shocked at 42°C for 30 seconds and placed on ice 
for a further 2 minutes. S.O.C. media (Novagen) was added to the cells and the mixture 
was incubated at 37°C with shaking for 1 hour. A sample was spread on kanamycin-
containing agar and incubated overnight at 37°C. Correctly assembled constructs were 
determined by sequencing (refer to section 3.3.5).  
3.3.3 Thermodynamically  Balanced  Inside-Out  PCR-Based Gene 
Synthesis  
The TBIO method of primer design was developed by Gao et al. in order to assemble gene 
sequences by using smaller fragments to build up the sequence using PCR (Gao et al., 
0.1   
0.2   
     
0.3   
  
0.5   
    
Kb 
55  
  
2003). TBIO works to efficiently generate double stranded DNA (dsDNA) from 
overlapping synthetic single stranded DNA (ssDNA) fragments that cover the entire 
sequence more efficiently than synthesizing completely complementary dsDNA. The 
main points are to design the ss fragments so that the overlaps are such that they prime 
from dsDNA generated in each round of a PCR reaction so that all stages are efficient 
with the same PCR temperature cycle, and to have the ssDNAs present in relative 
concentrations such that the inner ds fragment is generated in early cycles and extended in 
subsequent ones as primers further and further "out" can anneal. An initial fragment of 
around 0.4 – 0.5 Kb, the ‘inside’, is produced and gel purified, to be used for bidirectional 
elongation of the ‘outside’, using corresponding fragments of 0.4 – 0.5 Kb each time.  
DNAworks is a software tool developed by Hoover and Lubkowski to enable automated 
and optimized design of overlapping oligonucleotides, with a low chance of hairpin 
formations (Hoover and Lubkowski, 2002). Primer pairs are also constrained to have 
matching melting temperatures. Overlapping sense strand primers correspond to the N-
terminal sequence, whereas the overlapping anti-sense strand primers correspond to the C-
terminal sequence.  
TBIO was used in an attempt to synthesise a codon optimized fragment for the first three 
complement control protein domains (CCPs), which lie 3’ of the EGF-like domain, with 
the sequence corresponding to the Tachypleus tridentatus protein sequence. The amino 
acid sequence was submitted to the DNAworks web service using the parameters outlined 
in Table 3-1. DNAworks was also constrained to exclude the following, frequently used 
restriction sites from the protein coding region: BamHI, BsaI, EcoRI, HindIII, KpnI, 
NcoI, NdeI, NotI, PstI, SacI and XhoI. In the highest scoring solution, DNAworks 
suggested sixteen oligonucleotides with melting temperatures in the range 57-58°C. These 
sequences were ordered as synthetic oligonucleotides with the addition of restriction sites 
NcoI and XhoI added at the 5’ and 3’ oligos in the appropriate frame, respectively, to 
allow for easy cloning. Correct assembly of the designed oligos was checked using CLC 
genomics software’s ‘Assemble sequences’ tool. The synthetic oligonucleotides were 
ordered from Eurogentec.  
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Parameter  Condition  
Standard organism  E. coli  
Oligo size  55 nucleotides  
Annealing temperature  58°C ± 1°C  
Oligo concentration  1 x 10-7  
Sodium concentration  5 x 10-2 M  
Magnesium concentration  2 x 10-3 M  
Codon frequency threshold  10%  
Table 3-1: DNAworks parameters for oligonucleotide synthesis. The codon frequency threshold 
sets a minimum cut-off for the codons to be used for reverse translation of protein sequences into 
DNA. The codon frequencies are based on the number of times each codon appears in protein 
regions of the organism’s genome.  
3.3.3.1 TBIO Experimental Procedure  
In order to determine the best conditions for TBIO of the CCPs, PCR reactions were set 
up for a range of temperatures and with and without additional Mg2+. The combination of 
oligos used and their concentrations are listed in Table 3-2. The PCR program used for the 
reactions containing 1X HotStarTaq DNA polymerase buffer, dNTPs (2.5 mM of each), 
HotStarTaq DNA polymerase (3.75 U, Qiagen), oligos (see Table 3-2) and MgCl2 (if 
required) included a hot start at 95°C for 15 minutes followed by 30 cycles of 
denaturation at 94°C for 15 seconds, annealing for 30 seconds and extension at 72°C for 1 
minute. The five annealing temperatures tested were: 57°C, 58.1°C, 59.3°C, 59.9°C and 
61°C.  
Reaction Oligo combinations and concentrations (nM)  
A    8 200 nM 
9 
200 nM    
B   7 200 nM 
8 
120 nM 
9 
120 nM 
10 
200 nM   
C  6 200 nM 
7 
120 nM 
8 
60 nM 
9 
60 nM 
10 
120 nM 
11 
200 nM  
D 5 200 nM 
6 
120 nM 
7 
60 nM 
8 
40 nM 
9 
40 nM 
10 
60 nM 
11 
120 nM 
12 
200 nM 
Table 3-2: Inner TBIO oligo combinations and concentrations. The CCP coding region of ttFC 
was built up from combinations of between two oligos and four oligos to determine the optimal 
reaction conditions and concentrations, and to identify any problematic oligo pairs.  
Following PCR using the TBIO oligos, the products were analysed by agarose gel 
electrophoresis to determine whether the correct constructs had been achieved. The gel 
revealed an increase in fragments ranging in size from 94 bp for reaction A up to 323 bp 
for reaction D (results not shown). This suggested that the TBIO reaction had been 
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successful and therefore, the addition of the next set of ‘outside’ oligo pairs could take 
place (Table 3-3). The ‘inside’ template was cleaned up using the Macherey-Nagel 
NucleoSpin® Gel and PCR Clean-up kit and used as a template at a concentration of 40 
nM for the addition of the next four oligo pairs. It was determined that extra Mg2+ was not 
necessary as agarose gel electrophoresis analysis showed equivalent bands in the presence 
and absence of the additional Mg2+.  
Reaction   Oligo combinations and concentrations (nM)  
E    4 200 nM 
Inside 
Template 
13 
200 nM    
F   3 200 nM 
4 
120 nM 
Inside 
Template 
13 
120 nM 
14 
200 nM 
 
  
G  2 200 nM 
3 
120 nM 
4 
60 nM 
Inside 
Template 
13 
60 nM 
14 
120 nM 
15 
200 nM  
H 1 200 nM 
2 
120 nM 
3 
60 nM 
4 
40 nM 
Inside 
Template 
13 
40 nM 
14 
60 nM 
15 
120 nM 
16 
200 nM 
Table 3-3: Outer TBIO oligo combinations and concentrations. The CCP coding region of ttFC 
was built up from combinations of between two oligos and four oligos added to the “inside” 
template to determine the optimal reaction conditions and concentrations, and to identify any 
problematic oligo pairs.  
TBIO fragments containing the ‘outside’ oligo pairs were analysed by agarose gel 
electrophoresis, which revealed fragments of increasing size in reactions E to H (results 
not shown). These results were very promising. However, clearer, more conclusive results 
with sharper bands were desired and so conditions were judged to require further 
optimization.  
The repeated “outer” PCR reactions did not produce the same results, so various changes 
were made to the experimental procedure, including further annealing temperature tests 
and varying the concentration of inside template used (in the range 2.5 – 20 nM). To 
check the sequences of the products obtained after the addition of the inner 
oligonucleotides, the products produced from up to four oligo pairs were TA cloned 
(3.3.3.2) using the TOPO TA Cloning® kit (Invitrogen™), and transformed into One 
Shot® TOP10 chemically competent cells (Invitrogen™). Plasmid from selected colonies 
was prepared for sequencing, which revealed that there were too many errors in the 
recovered sequences including base pair deletions, missense mutations and frameshift 
mutations. In order to try to resolve these problems, the assembly was repeated from the 
start using the proof-reading polymerase KOD Hot Start DNA polymerase (Novagen®) 
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along with the KOD Hot Start Master Mix in an attempt to minimise the chance of mis-
priming events when assembling the construct.  
Sequencing results from these additional attempts revealed that base pair deletions were 
frequently observed in oligo 10. Secondary structure predictions identified oligo 10 as 
prone to a hairpin loop formation and so the inner PCR reactions were repeated with the 
addition of dimethyl sulfoxide (DMSO) at concentrations of 5% or 10% to inhibit the 
formation of intramolecular secondary structures. Oligo 10 was also redesigned 
maintaining its complementary ends, but with an altered nucleotide sequence, coding for 
an unchanged polypeptide sequence in between. The CLC genomics software was used to 
generate suggestions of alternative E. coli optimised coding sequences. Several 
possibilities were generated and the oligo with the lowest secondary structure score was 
chosen and obtained (see Appendix C for new oligo sequence).  
  
Figure 3-4: ttFC CCPs TBIO PCR products. The upper image shows the products of TBIO PCR 
reactions including either 5% DMSO (1-4) or 10% DMSO (5-8) for the “inner” set of primers 
tested at three different temperatures: 54.3°C, 54.9°C and 56.0°C using the original oligo 10. The 
bottom image shows the products of reactions using the redesigned oligo 10, each tested at five 
different temperatures: 52.0°C, 53.1°C, 54.3°C, 54.9°C and 56.0°C. L = 1 Kb DNA ladder 
(Invitrogen™). Reactions labelled: 1, 5 & 9 = 1 primer pair (expected size 94 bp, Table 3-2 
reaction A); 2, 6 & 10 = 2 primer pairs (expected size 170 bp, Table 3-2 reaction B); 3, 7 & 11 = 3 
primer pairs (expected size 246 bp, Table 3-2reaction C); 4, 8 & 12 = 4 primer pairs (expected 
size 323 bp, Table 3-2 reaction D).  
TBIO synthesis with the redesigned oligo 10 appeared to be more successful than 
synthesis with the old oligo 10 plus DMSO (Figure 3-4), as judged by agarose gel 
electrophoresis, since less variability was seen between results. TA cloned plasmids from 
selected colonies were prepared and sent for sequencing. However, the sequencing results 
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revealed little success in generating the correct sequence by TBIO, with sequences 
showing the same errors as before, and so a change in experimental procedure was 
needed. At this stage, the Limulus cDNA sequence had been determined and so the focus 
switched to producing the CCP fragments from the commercially produced synthetic 
cDNA using the LIC strategy.   
3.3.3.2 TA Cloning  
TA cloning relies on the tendency of Taq polymerase to add 3’ A-overhangs to dsDNA, 
and the ability of a fragment of one of the topoisomerases, which is previously attached to 
the linearised TOPO vector that contains a 3' T overhang at each end, to recombine 
annealed DNA fragments in a ligase-independent fashion. Thus, PCR amplification 
products can be treated with Taq and dATP before ligation into a pre-prepared TOPO 
vector. 2 mM dATP along with 1 X GoTaq® Buffer, 5 U GoTaq® DNA polymerase 
(Promega) and the PCR product were mixed together and incubated at 72°C for 15 
minutes, before being mixed with the pCR™4-TOPO® vector (Thermo Fisher Scientific) 
in a reaction containing 1 µl vector (10 ng), 0.5-4 µl insert DNA and 1 µl salt solution (1.2 
M NaCl, 0.06 M MgCl2). The mixture was incubated at room temperature for 5 minutes 
before transformation into the TOP10 cells (according to the manufacturer’s instructions, 
Thermo Fisher Scientific), after which the mixture was plated on to kanamycin-containing 
agar.  
3.3.4 lpFC Complement Control Protein Domains  
3.3.4.1 Primer design for LIC of CCPs  
In order to use LIC to produce the CCP fragments, primers were designed for each 
construct based on the synthetic Limulus polyphemus sequence designed to produce the 
amino acid sequence determined in Chapter 0. The CCP fragments to be produced were: 
CCP1, CCP2, CCP3, CCP12, CCP23 and CCP123. For the 5’ primers, ~18 bp starting 
from the 5’ end of the desired coding sequence was chosen and synthetic primers designed 
with this sequence immediately preceded by the vector’s LIC sequence in the appropriate 
frame. For the 3’ primers, ~18 bp complementary to the 3’ end of the sequence was 
chosen and synthetic primers designed with this sequence immediately preceded by the 
vector’s LIC sequence in the appropriate frame (3.3.2.3). See Appendix C for full primer 
sequences.  
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PCR reactions were set up containing 1 X Pfu DNA polymerase buffer, 0.5 µM LIC 
forward primer, 0.5 µM LIC reverse primer, dNTPs (2.5 mM of each dATP, dCTP, dGTP 
and dTTP), 1.25 U PfuTurbo DNA polymerase and Factor C cloned into the mammalian 
expression vector pcDNA5 as the template (section 4.2.1). The PCR program involved 30 
cycles of 94°C for 30 seconds, an annealing temperature of 52°C for 30 seconds and an 
extension at 72°C for 30 seconds, with a final extension at 72°C for 10 minutes.  
The PCR reactions successfully amplified all the desired fragments except for CCP3 
alone. Secondary structure prediction for the CCP3 5’ primer revealed the probability that 
it would form a large hairpin. The primer was redesigned such that the final glutamine 
codon (CAG) was omitted, which reduced the stability of the predicted hairpin, leaving 
only a weak AT-rich hairpin. The redesigned primer sequence is highlighted in Appendix 
C. PCR reactions performed with the new primer resulted in amplification of a fragment 
of the correct size. For all constructs, PCR products of the correct size were generated as 
judged by agarose gel electrophoresis analysis (Figure 3-5).   
The CCP coding fragments were inserted into the pNH-TrxT vector by LIC, following the 
protocol outlined in section 3.3.2 and their DNA sequences were subsequently checked by 
DNA sequencing (3.3.5). However, T4 polymerase based LIC was initially unsuccessful, 
and so a more streamlined version, In-Fusion® cloning (Takara/Clontech), was used 
instead.  
 
Figure 3-5: Agarose gel electrophoresis analysis of PCR amplified CCP domains. 1. 1 Kb Plus 
DNA Ladder (Invitrogen™) 2. CCP1 (186 bp), 3. CCP2 (183 bp), 4. CCP3 (221 bp), 5. CCP12 
(360 bp), 6. CCP23 (399 bp), 7. CCP123 (576 bp).  
3.3.4.2 In-Fusion® HD EcoDry™ Cloning  
The In-Fusion® HD EcoDry™ cloning kit (Clontech) relies on an In-Fusion enzyme to 
efficiently ligate linearised DNA fragments that have at least 15 bp of homologous 
sequence at their respective ends. This In-Fusion enzyme is believed to be a poxvirus 
DNA polymerase from vaccinia virus that uses its 3′–5′ exonuclease activity to remove 
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nucleotides from the 3’ end and exposes complementary regions to allow for base pair 
annealing (Hamilton et al., 2007; Zhu et al., 2007). Solutions containing 20 ng of insert 
DNA and 50 ng linearised vector DNA were added to an In-Fusion HD EcoDry pellet and 
mixed well by pipetting. The mixture was incubated for 15 minutes at 37°C, followed by 
15 minutes at 50°C before being placed on ice and then transformed into Stellar™ 
competent cells (according to the manufacturer’s instructions, Clontech). Colony PCR 
(3.3.4.3) was carried out to confirm the presence of the inserts and DNA sequencing 
(3.3.5) confirmed that the correct sequences had been achieved for all the desired CCP 
fragments in the pNH-TrxT vector.  
3.3.4.3 Colony PCR  
Colony PCR allows for colony screening without the need for DNA purification. A dab of 
colony is transferred to 100 μl of sterile water and boiled for 10 minutes, before PCR is 
carried out using the appropriate primers for amplification of the DNA the colony is being 
checked for. Standard PCR reactions and programs can be used and agarose gel 
electrophoresis is used to analyse the PCR products.  
3.3.5 DNA Sequencing  
Plasmid DNA was purified using Wizard® Plus SV Minipreps DNA Purification Systems 
Kit (Promega) and DNA sequencing was performed by DNA Sequencing & Services 
(MRC PPU, College of Life Sciences, University of Dundee, Scotland, 
www.dnaseq.co.uk) using Applied Biosystems Big-Dye Ver 3.1 chemistry on an Applied 
Biosystems model 3730 automated capillary DNA sequencer or Sanger Sequencing 
Services, Source Bioscience (www.lifesciences.sourcebioscience.com). Sequencing 
results were analysed using CLC genomics software and compared against the expected 
sequence to confirm whether the samples contained the correct sequence.   
3.4 Protein Expression  
E. coli is unable to perform post-translational modifications often necessary for the correct 
folding and functional properties of proteins (Yin et al., 2007). As disulphide bond 
formation is an important post-translational modification to achieve the correct structure 
of the Factor C fragments, SHuffle®, an E. coli expression strain designed to produce 
correctly folded disulphide bonded active proteins was used (Lobstein et al., 2012). This 
strain is based on the trxB gor suppressor strain, SMG96, that allows cytoplasmic 
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disulphide bond formation, and incorporates disulphide bond isomerase (DsbC), that 
proofreads formed bonds and acts as a chaperone for native disulphide bond formation. 
The cells, SHuffle® T7 Express lysY Competent E. coli (New England Biolabs), express 
a chromosomal copy of T7 RNA polymerase that is under the control of the lacUV5 
promoter and induced by IPTG, which initiates transcription of the target gene (Sørensen 
and Mortensen, 2005). LysY is a variant of T7 lysozyme that lacks amidase activity and 
therefore this feature makes cells less prone to lysis during induction.  
3.4.1 Protein Test Expressions  
To investigate protein solubility and establish optimal growth conditions, small scale test 
expressions were carried out, in which fresh LB cultures were inoculated 1:40 with 
overnight cultures and 50 μg/ml of kanamycin and grown at 37°C until an optical density 
at 600 nm (OD600nm) of 0.6-0.8 was reached. At this point, growth temperature and 
concentration of IPTG were varied to determine the ideal growing conditions for each 
construct, detailed in 3.7.  
3.4.2 Large Scale Protein Expression  
Expression conditions were scaled up to produce a larger volume of protein, firstly by 
expression in two litres (L) of LB to test for solubility and concentration of protein 
produced before testing unlabelled M9 minimal media (recipe in Appendix D) for the 
same parameters. In order to produce sufficient isotopically labelled protein for NMR 
studies, a high-density growth protocol was followed (3.4.2.1).  
3.4.2.1 High Density Growth  
In order to produce suitable levels of protein to carry out NMR spectroscopy, Marley et al. 
developed a time-efficient and cost-effective method to produce large quantities of 
isotopically labelled protein (Marley et al., 2001). Initially, high cell numbers are grown 
in unlabelled rich media, the cells are then recovered and resuspended in isotopically 
labelled minimal medium, at higher cell densities than they would normally achieve, 
before protein expression is induced. Thus, isotopically labelled media components are 
not wasted on producing biomass. For the Factor C fragments, initial growth in 2 x YT 
media (recipe in Appendix D) was used, which contains double the concentration of yeast 
extract in comparison with LB medium, at 37°C until an OD600nm = 1.5 – 2. According to 
Lobstein et al., using glycerol as a carbon source results in poor growth in T7 SHuffle 
cells and therefore it was important not to use a medium that contained glycerol such as 
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terrific broth (TB) (Lobstein et al., 2012). The cells were then pelleted (Beckman® Model 
J2-21 Centrifuge, Rotor JA-10, 9,056 × g) and washed with 1 X M9 media lacking 
Thiamine, ammonium salts and D-glucose before being pelleted again. This time, the 
pellets were resuspended into half the original culture volume using M9 minimal medium 
containing 15N-ammonium chloride (15NH4Cl) for nitrogen labelling or 15NH4Cl and 13C6-
glucose for carbon labelling to produce a double-labelled sample. The cells were then 
cultured at 15°C for 1 – 1.5 hours before induction with IPTG (0.1 mM – 0.4 mM 
depending on construct) and growth overnight at the lowered temperature 
(Sivashanmugam et al., 2009).  
3.5 Protein Purification  
In order to isolate the protein of interest from the resulting protein mixture, the cells were 
first pelleted by centrifugation (Beckman® Model J2-21 Centrifuge, Rotor JA-10, 9,000 
rpm), and then resuspended in water and COmplete™, EDTA-free Protease Inhibitor 
Cocktail (Sigma-Aldrich®), Lysozyme (0.1 mg/ml, Sigma-Aldrich®) and Benzonase® 
Nuclease-HC (25 U, Novagen®) were added. The protease inhibitor cocktail inhibits the 
proteolytic activity of a wide range of proteases, lysozyme is used to help with protein 
extraction by breaking down the bacterial cell wall, and Benzonase® Nuclease-HC 
degrades nucleic acids.  
3.5.1 Cell Lysis  
Cell lysis was achieved by sonication (MSE Soniprep 150, Sanyo), where cells are 
disrupted by high-frequency pressure waves applied via a vibrating probe. A constant low 
temperature is crucial to prevent the protein from denaturing, and this is maintained by 
keeping the sample on ice and applying short, 15 second pulses, followed by 15 second 
pauses (Palmer and Wingfield, 2004).  
3.5.2 Centrifugation  
High speed centrifugation (40,000 g, Sigma Laboratory centrifuges 3K30 SciQuip, Rotor 
12150-H) was used to pellet insoluble cell debris, which was in some cases retained for 
inclusion bodies protein purification (IBPP, section 3.5.4). The cell lysate containing the 
protein of interest and other soluble compounds was further purified by Ni2+ affinity 
chromatography (section 3.5.3).   
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3.5.3 Ni2+ Affinity Chromatography  
Immobilized metal ion affinity chromatography (IMAC) was first described in 1975 by 
Porath et al., who recognised the ability of matrix bound metal ions, for example Zn2+ and 
Cu2+, to interact with protein imidazole and thiol groups (Porath et al., 1975). This 
allowed the development of peptide affinity tags that can be expressed as fusion proteins 
of the protein of interest in order to purify recombinant proteins (Uhlén et al., 1983). 
Poly-histidine tags are the most commonly used affinity tags as a strong complex is 
formed between the histidine imidazole rings and appropriately immobilized Zn2+ ions. 
The cell lysate is passed through the column containing the metal ions and the 6xHis-
tagged protein is captured on the matrix. After washing with buffer to remove non-
specifically bound proteins, His-tagged protein can be eluted using a buffer containing 
free imidazole (Bornhorst and Falke, 2000).  
For the Factor C protein fragments, soluble cell lysate was filtered (0.8 µm, Minisart® 
Sartorius stedim biotech) before application onto the pre-charged Ni2+-affinity matrix (Ni-
Superflow Resin, Generon). The column was washed with buffers containing 20 mM 
TrisHCl, 150 mM NaCl and 0.01% NaN3, pH 7.9 and increasing concentrations of 
imidazole (binding buffer 5 mM; wash buffer 20 mM; and elution buffer 250 mM). 
Hydrochloric acid (HCl) was used to lower the pH to 7.9. Sodium azide (NaN3) was 
added as an antimicrobial and all buffers were filter sterilised. Flow through from each 
column wash was collected and analysed by SDS-PAGE (see section 3.7)  
3.5.4 Inclusion Bodies Protein Purification  
Inclusion bodies formed by E. coli contain aggregates usually of inactive, insoluble 
protein and are often formed during recombinant protein expression (Rudolph and Lilie, 
1996). This protein has to be solubilized and refolded correctly in order to produce active 
protein (Palmer and Wingfield, 2004).  
For each of the Factor C constructs that produced inclusion bodies, the inclusion body 
pellet was resuspended and washed thoroughly three times with a solution of a few grams 
of methionine per litre of water and 1 mM EDTA. The cell debris was sonicated and 
centrifuged at 40,000 × g between each wash. Then, 5 volumes of aqueous organic solvent 
(50:50 acetonitrile-water with 0.2% TFA and some methionine) were added to the pellet 
and the solution was stirred overnight at room temperature. The soluble and insoluble 
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fractions from this final stage were separated by centrifugation at 40,000 × g and both the 
pellet and supernatant were retained for analysis by SDS-PAGE.  
3.5.5 Buffer Exchange and Sample Concentration  
Protein samples were exchanged into the desired buffer using a 20 ml capacity Vivaspin 
with a 5,000 kDa molecular weight cut-off (Sartorius Stedim Biotech). This allowed for 
removal of undesired buffer components, for example imidazole, and concentration of the 
sample to the required volume for further purification by gel filtration (see section 3.5.7) 
or analysis by NMR spectroscopy (see section 3.6.2).  
3.5.6 TEV-Cleavage  
The presence of a TEV-cleavage site within the expression vector allowed for the simple 
cleavage of the histidine and Trx tags from the protein of interest by TEV-protease. TEV 
protease is the 27 kDa catalytic domain of Nuclear Inclusion a (NIa) protein, which is 
encoded by the Tobacco Etch Virus (TEV) and recognises a sequence of the general form 
E – Xaa – Xaa – Y – Xaa – Q – (G/S) with cleavage occurring between Q and G or Q and S 
(Carrington and Dougherty, 1987b). The TEV-protease used was expressed in the lab and 
was His-tagged.  
Cleavage was carried out at room temperature overnight in either Tris or Phosphate based 
buffer at a concentration of 83 µg of TEV-protease per mg of protein. Separation of the 
protein of interest from the tags and TEV-protease was achieved by Ni2+ affinity 
chromatography (section 3.5.3), gel filtration chromatography (section 3.5.7) or Reversed  
Phase High-Performance Liquid Chromatography (RP-HPLC, section 3.5.8)  
3.5.7 Gel Filtration Chromatography  
Gel filtration chromatography was introduced by Lathe and Ruthven and further 
developed by Porath and Flodin, to be used for the size dependent separation of protein 
molecules (Lathe and Ruthven, 1956; Porath and Flodin, 1959). This method involves 
passing a protein sample through a pre-packed Superdex 75 10/300 GL (GE Healthcare 
Lifesciences) column containing cross-linked agarose and dextran, with a bed volume of 
24 ml. The column was attached to an ÄKTA chromatography system controlled with 
UNICORN™ software version 5.01 (GE Healthcare Lifesciences). This allowed a semi-
automated method for sample collection to be run, which, in this case, consisted of a 30 
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ml equilibration with the appropriate buffer before injection of 0.5 ml of concentrated 
sample via the injection valve and elution with 1.5 column volumes of buffer. The 
program was run at 0.5 ml/min to ensure the column’s pressure limit (1.8 MPa) was not 
exceeded and 0.5 ml protein fractions were collected. The UV absorbance at 220 nm and 
at 280 nm were recorded to identify the volume at which the desired protein was eluted.  
3.5.8 Reversed Phase High-Performance Liquid Chromatography  
The Reversed Phase High-Performance Liquid Chromatography (RP-HPLC) method 
typically involves the use of an n-alkyl-silica-based column for elution of proteins in an 
aqueous mobile phase from immobilized hydrophobic ligands in the stationary phase. 
This can be achieved by increasing the concentration of a buffer containing an organic 
solvent, for example the nonpolar solvent acetonitrile (ACN) and an ionic modifier, for 
example trifluoroacetic acid (TFA) (Aguilar and Hearn, 1996; Aguilar, 2004; Mant and 
Hodges, 1996). 
Samples were prepared by filtering them through a Minisart® 0.2 µm syringe filter 
(Sartorius Stedim Biotech) and making to 10% ACN, before injection onto the Supelco 
analytical Discovery® BIO wide pore C8 column (Sigma-Aldrich®), with dimensions 25 
cm x 10 mm, a particle size of 10 µm, pore size of 300 Å and base column volume (CV) 
of 19.635 ml, via the ÄKTA explorer (Amersham Pharmacia Biotech). UNICORN™ 
software version 5.31 (GE Healthcare Lifesciences) was used to control the method for 
RP-HPLC, which followed the following protocol: 0.5 CV equilibration with 10% ACN; 
up to three sample injections of 3 ml each; 0.5 CV column wash with 10% ACN to wash 
out unbound sample; first gradient step (target 50% ACN in 0.5 CV); second gradient step 
(target 60% ACN in 2 CV); third gradient step (target 100% ACN in 0.5 CV); 100% ACN 
for 0.5 CV before returning to 10% ACN for 0.5 CV for re-equilibration. The program 
parameters included flow rate – 4 ml/min; wavelengths recorded – 280 nm and 220 nm; 
and the collection of 2 ml fractions by the fraction collector Frac-920 (GE Healthcare 
Lifesciences), which were analysed by SDS-PAGE (section 3.7).  
3.5.9 Lyophilisation  
Lyophilisation or freeze-drying, invented in 1906 by Arsène d'Arsonval and Frèdèric 
Bordasis, is a dehydration process used to remove solvents by sublimation. Samples are 
completely frozen before being subjected to low pressures. RP-HPLC fractions containing 
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the protein of interest were divided between 1.5 ml Eppendorf tubes with needle point 
holes in the lid, deep frozen by submerging them in liquid nitrogen and placed within the 
chamber of the Heto PowerDry LL1500 freeze dryer (Thermo Scientific), pre-cooled to -
110°C, connected to an Edwards XDS5 Pump. Samples were lyophilised overnight and 
the resulting powdered protein was dissolved in water before addition of stock solutions 
of appropriate buffer components, in preparation for further analysis by circular dichroism 
spectroscopy (CD), nuclear magnetic resonance spectroscopy (NMR) or X-ray 
crystallography.  
3.6 Protein Analysis  
3.6.1 Circular Dichroism Spectroscopy  
Circular dichroism was used to obtain information regarding the structure and stability of 
the Factor C fragments. Samples were made up in 10 mM Tris, pH 8.0 before being 
examined by near UV and far UV, more details of which can be found in Chapter 5.  
3.6.2 Nuclear Magnetic Resonance Spectroscopy  
NMR was carried out to analyse protein folding, ligand binding and to determine the 
three-dimensional structure of the Factor C fragments. Samples were prepared in NMR 
Buffer (20 mM Na2HPO4, 50 mM NaCl, 0.01% NaN3, adjusted to pH 7.0 using 
phosphoric acid) and D2O was added to make a 5% solution. Details of the NMR 
experiments used can be found in Chapter 5.  
3.6.3 X-Ray Crystallography  
Another method that was explored for structure determination of the Factor C fragments 
was X-ray crystallography. X-ray crystallography requires the production of protein 
crystals from a protein sample at high concentration. The crystals are then exposed to an 
X-ray beam to generate diffraction patterns and the diffraction patterns can be analysed to 
gain information about distribution of electrons within the crystal, and thus the protein’s 
conformation.  
Unlabelled samples of the Factor C Cys-rich, EGF-like, CCP1 and CCP2 individual 
domains were expressed as Trx-fusion proteins and purified to be used for crystallisation 
trials. Purified samples were buffer exchanged into 10 mM Tris, 100 mM NaCl (made to 
pH 7.9 using HCl), resulting in concentrations of ~10 mg/ml each. Preliminary screens for 
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crystallisation conditions were carried out with the help of Dr Alastair Gardiner, in which 
two 96-well plates were set up for each sample using the JCSG-plus™ and PACT 
premier™ kits dispensed by a Cartesian robot (Newman et al., 2005; Page et al., 2003). 
JCSG-plus™ is a sparse matrix screen that tests standard PEG (polyethylene glycol) and 
salt conditions, in a wide pH range (4.0 – 10.0). The PACT premier™ is a PEG/ion screen 
exploring pH, cations and anions in varying PEG conditions. Used together, these two 
screens give a comprehensive investigation of crystallisation conditions.  
A total drop size of 1 μl was used, containing 0.5 μl of protein sample and 0.5 μl of 
reservoir condition. Each plate contained two wells for each condition, one of which a 
high concentration sample was added, and the other a sample containing half the 
concentration, after being diluted with Tris buffer. Once trays had been set up, they were 
stored at 16°C. At the time of setting up crystal trials, it was unknown how the protein 
would react in low salt concentrations and so the concentration of NaCl was kept at 100 
mM. In terms of sample preparation, it would have been optimal for there to be no salt 
present. This is due to the fact that lots of the conditions being screened included salt, 
which may have been masked by a high concentration of salt in the sample.   
After a few days, liquid-liquid phase separation and/or precipitation was apparent in some 
of the wells. These features are both regarded as positive as phase separation indicates a 
metastable transition and precipitation indicates the protein is in a state of supersaturation, 
both of which can result in crystal growth. After almost four months, crystals appeared in 
a few of the wells, with the most promising crystals found in the JCSG+ well containing 
0.2 M lithium sulphate, 0.1 M sodium acetate, pH 4.5, conc. 50% w/v and precipitant 
PEG 400. Two types of crystals had been produced, globular and rod-like, with the largest 
around 100 μm. These crystals were exposed to the X-ray beam on the mardtb “desktop 
beamline” fitted with the mar345 image plate detector (marXperts) by Dr Aleksander 
Roszak. The presence of PEG in the buffer means the crystal is cryo-protected and will 
not freeze in the liquid nitrogen. Unfortunately, the diffraction pattern revealed the 
presence of salt alone. Further endeavours to produce high enough concentrations of 
unlabelled samples proved unsuccessful and a decision was made to focus on structural 
elucidation by NMR.  
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3.7 Factor C Protein Constructs  
3.7.1 Tachypleus tridentatus Recombinant Factor C LPS Binding 
Fragments  
The following sections provide details and results regarding the three Factor C fragments 
that were produced from the Tachypleus tridentatus sequence information.  
3.7.1.1 Cys-rich  
Produced by LIC and expressed at 37°C with 0.1 mM IPTG induction, soluble protein was 
produced in either unlabelled or 15N-labelled M9 minimal media and purified by Ni2+ 
affinity chromatography (Figure 3-6). Fractions containing soluble protein were combined 
and the Trx tag was cleaved by overnight cleavage with TEV-protease. Cleaved Cys-rich 
was separated from the fusion tag by RP-HPLC.  
RP-HPLC fractions containing the cleaved protein were lyophilised and the dehydrated 
samples were re-dissolved in either NMR buffer or Tris buffer in preparation for NMR 
spectroscopy analysis, CD (results shown in Chapter 5) or X-ray crystallography.  
 
Figure 3-6: pNH-TrxT Cys-rich. SDS-PAGE analysis of Ni2+ affinity chromatography fractions 
showing purified protein. 1-2. Flow through 3-4. Binding buffer 5-7. Wash buffer 8-11. Elution 
buffer 12. Elution buffer with 1 M imidazole. Marker = Precision Plus Protein™ Dual Xtra 
Standards (Bio-rad). The strong bands around 23.7 kDa in fractions 8-10 show protein of the 
correct MW for pNH-TrxT Cys-rich.  
Analysis by NMR was carried out on the fusion protein, which showed mainly Trx peaks. 
Less than 10 peaks were associated with Cys-rich, significantly less than the 80 to be 
expected. This suggested that the Cys-rich fragment was only partially folded or it was 
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sampling multiple conformations. To get a clearer picture, the fusion protein was cleaved 
using TEV-protease and the unseparated mixture was examined by NMR. This showed 
clearer Trx peaks, which is consistent with the idea that Cys-rich is aggregated, bound to 
LPS or even interacting with Trx directly. Gel filtration was used to separate the Cys-rich 
fragment from the Trx. Fractions containing the protein of interest were combined, 
concentrated and looked at by NMR, but again, only around 10 peaks that could account 
for the Cys-rich domain were visible, implying the Cys-rich was tumbling slowly and 
could not be seen.  
Reversed-phase HPLC (RP-HPLC) was used to strip the protein sample of any 
endogenous LPS and to fully separate the protein from the Trx. Fractions containing Cys-
rich were lyophilised to remove the solvent, resuspended in H2O and their NMR spectra 
acquired. Again, the majority of expected peaks were not observed for this sample, with 
only around 16 visible. Most of these appeared close to the random coil chemical shift, 
which suggests these are from a flexible terminus or a loop. Only around 5 were thought 
to be in more structured parts of the protein. It is likely the protein is in a state of multiple 
conformations and so experiments were carried out over a range of temperatures from 283 
K to 313 K to investigate whether temperature changes would help to stabilise a particular 
conformation. Slight changes occurred in that sharp peaks got broader, broad peaks got 
sharper, some peaks appeared and some peaks disappeared, but these were not significant 
enough to warrant further investigation into effects of temperature differences. Further 
investigations could look into the effects of varying other conditions such as altering the 
pH or the addition of LPS to determine any structural changes that may occur.  
3.7.1.2 EGF-like  
The EGF-like domain was also expressed as a Trx-fusion protein in unlabelled and 15N-
labelled M9 media at 37°C with induction by 0.1 mM IPTG. Purification by Ni2+ affinity 
chromatography resulted in a large concentration of the EGF-like fusion protein (Figure 
3-7), which allowed for structural investigation by NMR and X-ray crystallography to 
take place with labelled and unlabelled samples, respectively.  
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Figure 3-7: pNH-TrxT EGF-like. SDS-PAGE analysis of Ni2+ affinity chromatography fractions 
showing purified protein. 1. Flow through 2-3. Binding buffer 4-6. Wash buffer 7-10. Elution 
buffer 11. Elution buffer with 1 M imidazole. Marker = Precision Plus Protein™ Dual Xtra 
Standards (Bio-rad). The large band around 17.8 kDa indicates the presence of pNH-TrxT EGF-
like, with the lower band around 14 kDa indicating possible proteolytic cleavage of the Trx.  
A two dimensional (2D) 15N-HSQC was recorded before and after TEV-cleavage (Figure 
3-8). Each peak in the spectrum represents an amide-proton nitrogen pair from one amino 
acid on the protein backbone. The position of the peaks is affected by the chemical 
environment around the amino acids and therefore NMR spectra is very informative when 
the sample is subject to local conformational or chemical changes (for more information 
see Chapter 6). In Figure 3-8A, the sample has not been cleaved from the Trx. There is a 
good dispersion of peaks, which suggests the protein is correctly folded. However, upon 
cleavage (Figure 3-8B), the peaks become disordered, which indicates the protein without 
the fusion protein is not folded. It is likely that this sample exists in multiple 
conformations as there were around 40 peaks when there should only be around 30. To try 
to refold the protein correctly, the pH was lowered by increments of 0.5 from pH 7 to pH 
3 using HCl. This did not result in any differences and so the pH was raised back to pH 7 
using NaOH and the protein sample was run on gel filtration to ensure complete 
separation of the EGF-like domain from the cleaved tag.  
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Figure 3-8: 15N-HSQC of the EGF-like domain. A: A spectrum for the EGF-like Trx-fusion 
protein. B: A spectrum for EGF-like cleaved and separated from the Trx-fusion protein. Proton is 
along the x-axis and Nitrogen is along the y-axis.  
The sample was again examined by NMR where the temperature was lowered in 
increments from 298 K to 278 K to observe any changes to the structure. Slight 
differences were observed, including the appearance of peaks at lower temperatures, but 
these were considered insignificant and so RP-HPLC was used to strip the protein of any 
endogenous LPS. However, again the NMR did not show very clear peaks and due to time 
constraints, the focus was changed to a different construct.   
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3.7.1.3 CysEGF  
15N-labelled protein was expressed in minimal media overnight at 15°C, following 
induction by 0.1 mM IPTG, and purified by Ni2+ affinity chromatography (Figure 3-9). 
The majority of the protein produced was found to be insoluble and so inclusion bodies 
protein purification was carried out. Soluble protein was buffer exchanged into NMR 
buffer, concentrated and examined by NMR at 298 K. The spectra of uncleaved protein 
showed broad peaks, there were no peaks for the Cys or EGF tryptophans and only about 
10 peaks of the 100 expected for CysEGF were visible. This suggests the protein may be 
unfolded, mis-folded, sampling multiple conformations or aggregated. Experiments were 
run at the lower temperature of 283 K, which resolved a few of the peaks but did not make 
a significant difference. If this protein was in a monomeric state, either the whole of the 
protein was not well structured or it was flexible and required other conditions or factors 
to stabilise its structure.   
Gel filtration was carried out using a sample diluted 10-fold, followed by a sample that 
was undiluted. This was performed to investigate whether correct folding was 
concentration dependent. It was expected that if the protein was susceptible to 
concentration dependent aggregation or oligomerisation, the protein would elute at 
different volumes. However, there was no apparent difference between the two samples. 
Fractions thought to contain the desired protein, eluted around 10 ml, were combined, 
concentrated and again looked at by NMR. The 1D-1H experiments revealed protein in the 
sample, but no peaks were seen in the 15N-HSQC. This suggests that either the sample 
was not the protein expected or, if it was 15N-labelled, indicates that the protein was 
misfolded and tumbling slowly. This may be due to it aggregating, it might be bound to 
LPS micelles or some sort of oligomerisation has taken place. The gel filtration data 
supported these possibilities as the protein sample is eluted at a volume corresponding to a 
higher MW protein than expected for CysEGF.   
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Figure 3-9: pNH-TrxT CysEGF. SDS-PAGE analysis of Ni2+ affinity chromatography fractions 
showing purified protein. 1. Flow through. 2-3. Binding buffer. 4-6. Wash buffer. 7-10. Elution 
buffer. 11. Elution buffer with 1 M imidazole. Marker = Precision Plus Protein™ Dual Xtra 
Standards (Bio-rad). The strong band in the first elution buffer wash contains protein of the 
correct MW for CysEGF – 27.2 kDa  
SDS-PAGE analysis (data not shown) revealed a laddering of bands, which may be 
artefacts of gel sample preparation or might actually reflect inter-molecular disulphide 
bonded forms that are resistant to reduction in the SDS-PAGE sample buffer, revealing 
that the protein was misfolding in multiple different ways. Additionally, the bands may be 
a result of proteolytic cleavage. This could be tested by making the samples more 
reducing for example by adding 10 mM TCEP. If the protein was indeed a misfolded 
inter-molecular disulphide bonded aggregate, then an alternative route to producing 
correctly folded protein that could be attempted is treatment with a redox shuffle (e.g. 
GSH & GSSG) and/or a protein disulphide bond isomerase such as protein disulphide 
isomerase (PDI) that should catalyse the formation and breakage of disulphide bonds as 
the protein folds. However, time did not allow to take this construct any further.  
3.7.2 Limulus polyphemus recombinant Factor C LPS binding fragments  
The following sections provide details and results for the complement control proteins 
(CCPs) that were produced using the Limulus polyphemus Factor C sequence described in 
Chapter 2.  
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3.7.2.1 CCP1  
15N-labelled protein was expressed in minimal media after overnight induction at 15°C 
with 0.4 mM IPTG, and purified by Ni2+ affinity chromatography (Figure 3-10). Soluble 
protein was buffer exchanged into NMR buffer, concentrated and examined by 15N-
HSQC. The data obtained were encouraging with the observation of clearly defined peaks 
for both the Trx and the CCP1 protein. The presence of a tryptophan not associated with 
the Trx suggested there was a favourable chance that the protein was properly folded. A 
T2 relaxation experiment was set up before cleavage from the Trx. This experiment 
indicates how the molecules are tumbling in solution. As the Trx and CCP1 are different 
sizes, they should tumble independently and their 15N signals should relax with different 
T2 rates. From the NMR spectra, it was possible to determine which peaks belonged to 
CCP1 and which belonged to the Trx tag. TEV-cleavage was carried out and a 15N-HSQC 
was recorded before the CCP1 protein was separated from the Trx tag (Figure 3-11). This 
showed good chemical shift dispersion indicating that both the Trx and the CCP fragment 
were folded. The close correspondence between the peak positions indicated that the 
fusion partners were not interacting, as there is no evidence that a structural change 
occurred. Clear differences between the two samples are seen in the expanded region of 
the figure, likely reflecting changes in conformation of linker residues on cleavage.   
  
Figure 3-10: pNH-TrxT CCP1. SDS-PAGE analysis of Ni2+ affinity chromatography fractions 
showing purified protein. 1. Flow through 2-3. Binding buffer 4-6. Wash buffer 7-10. Elution 
buffer 11. Elution buffer with 1 M imidazole. Marker = Precision Plus Protein™ Dual Xtra 
Standards (Bio-rad). The clear band in fraction 7 indicates protein of the correct size (21.1 kDa) 
for CCP1. 
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Figure 3-11: 15N-HSQC spectrum of CCP1. The spectrum shows pNH-TrxT CCP1 (blue) and a 
TEV-cleaved sample of pNH-TrxT CCP1 before gel filtration (red) superimposed. A new peak 
(indicated in the expanded region) appears in the cleaved sample at chemical shift coordinates 
expected for a C-terminal residue and a few peaks have shifted likely reflecting slight changes in 
conformation of linker residues on cleavage.  
Gel filtration was carried out to separate the CCP1 from the Trx, however, SDS-PAGE 
analysis revealed the two proteins were eluted in the same fraction. As Ni2+ affinity 
chromatography also failed to separate the proteins, RP-HPLC was attempted to 
effectively separate the two from each other in order to perform further experiments for 
structure determination. This resulted in a severe decrease in protein concentration and 
further experiments were ineffective and so efforts were directed to a different construct.  
3.7.2.2 CCP2  
Soluble 15N-labelled protein was expressed in minimal media overnight at 15°C after 
IPTG induction (0.4 mM), and purified by Ni2+ affinity chromatography (Figure 3-12). As 
with the CCP1 fragment, CCP2 was examined by NMR as a Trx fusion protein and 
cleaved from the fusion protein but not separated (Figure 3-13). Again, clearly defined 
peaks were observed for both the Trx and the CCP2 protein and the presence of a 
tryptophan not related to the Trx suggested folded protein was present in the sample, 
further indicated by good chemical shift dispersion of the peaks. Slight differences 
between the samples before and after TEV treatment were observed that likely reflect 
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changes to the conformation of the linker residues upon cleavage, but cleavage does not 
appear to affect the overall structure.  
 
Figure 3-12: pNH-TrxT CCP2. SDS-PAGE analysis of Ni2+ affinity chromatography fractions 
showing purified protein. 1. Flow through 2-3. Binding buffer 4-6. Wash buffer 7-10. Elution 
buffer 11. Elution buffer with 1 M imidazole. Marker = Precision Plus Protein™ Dual Xtra 
Standards (Bio-rad).  The strong band at the start of the elution’s reveals protein of the correct 
MW for CCP2 (20.9 kDa).  
 
Figure 3-13: 15N-HSQC spectrum of CCP2. The spectrum shows an uncleaved sample of pNH-
TrxT CCP2 (teal) and a cleaved sample of pNH-TrxT CCP2 before gel filtration (orange) 
superimposed. The expanded region reveals that some peaks have shifted positions (indicated) 
revealing differences between the two samples, suggesting slight conformational changes upon 
cleavage. A new peak (circled) is evident in the cleaved sample at chemical shift coordinates 
expected for a C-terminal residue. 
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Gel filtration, Ni2+ affinity chromatography and RP-HPLC were used in an attempt to 
separate the Trx and CCP2 protein. SDS-PAGE analysis revealed that separation did not 
occur and that there was a reduction in the protein concentration, meaning further 
structural determination of this fragment was not feasible. Due to the difficulties faced 
when separating the cleaved fragments, analysis of this construct was not taken any 
further. 
3.7.2.3 CCP3  
15N-labelled protein was expressed in minimal media at 15°C overnight after induction 
with  
0.4 mM IPTG, and purified by Ni2+ affinity chromatography (Figure 3-14).   
 
Figure 3-14: pNH-TrxT CCP3. SDS-PAGE analysis of Ni2+ affinity chromatography fractions 
showing purified protein. 1. Flow through 2-3. Binding buffer 4-6. Wash buffer 7-10. Elution 
buffer 11. Elution buffer with 1 M imidazole. Marker = Precision Plus Protein™ Dual Xtra 
Standards (Bio-rad). The band at 22.2 kDa in fractions 7 and 8 reveal the presence of CCP3 in the 
samples, with what appears to be truncated Trx at the lower MW.  
The soluble protein was buffer exchanged into NMR buffer, concentrated and looked at 
by NMR. The data from this revealed the peaks were predominantly from the Trx. A few 
peaks most likely from CCP3 were present but the signals were weak.  The sample was 
cleaved from the fusion protein by TEV-protease and run on gel filtration to separate the 
proteins from each other. However, SDS-PAGE revealed no separation and so 
optimisation is required in order to obtain a suitable sample for further analysis.   
3.7.2.4 CCP12  
15N-labelled protein was expressed overnight at 15°C in minimal media after induction 
with 0.4 mM IPTG, and purified by Ni2+ affinity chromatography (Figure 3-15).  Soluble 
protein was buffer exchanged into NMR buffer, concentrated and examined by NMR. The 
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spectra showed peaks that were well dispersed, indicating folded protein, but also 
contained broad peaks at random coil chemical shifts suggestive of unfolded protein. 
TEV-protease was used to successfully cleave CCP12 from the fusion protein. CCP12 and 
Trx were separated by Ni2+ affinity chromatography. The CCP12 sample was 
concentrated and examined by NMR, which showed there was correctly folded protein in 
the sample and no Trx (Figure 3-16). The unfolded protein was also separated from the 
folded sample. The presence of two tryptophans confirmed the presence of both CCP1 
and CCP2. 110 peaks were counted, which corresponded to the correct number expected 
and so a T2 relaxation experiment was performed. In this case, the T2 experiment was 
important as it gave an indication of how the two domains act in relation to each other. 
Following this a 3D TOCSY experiment with a mixing time close to 60 ms was carried 
out. This experiment is a key one in the determination of protein structures and resonance 
assignment for 15N-only labelled samples. A {15N, 13C} double labelled sample was 
produced and more information concerning the NMR experiments carried out can be 
found in Chapter 0.   
 
Figure 3-15: pNH-TrxT CCP12. SDS-PAGE analysis of Ni2+ affinity chromatography fractions 
showing purified protein. 1. Flow through 2-3. Binding buffer 4-6. Wash buffer 7-10. Elution 
buffer 11. Elution buffer with 1 M imidazole. Marker = Precision Plus Protein™ Dual Xtra 
Standards (Bio-rad). Indication of protein at 27.5 kDa confirms the presence of CCP12 in the 
elution’s.  
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Figure 3-16: 15N-HSQC spectrum of CCP12. The well dispersed peaks indicate folded protein. 
Proton is along the x-axis and nitrogen is along the y-axis.  
To test whether CCP12 contains an LPS binding site, LPS was added to the sample and 
after incubation at room temperature, NMR experiments were performed. The absence of 
marked differences suggested that perhaps LPS was already bound and so the sample was 
run through the RP-HPLC to ‘strip’ any bound LPS. This resulted in clear chemical shift 
differences in proton and nitrogen, which suggests a ligand may have been stripped off. 
However, there are a few other possibilities as to why this may have occurred, for 
example, oxidation of methionine, and further experimentation is required to confirm any 
assumptions that can be made.  
3.7.2.5 CCP23  
15N-labelled protein was expressed at 15°C overnight in minimal media, with the addition 
of 0.4 mM IPTG for induction. The majority of the fusion protein was found to be 
insoluble and so was purified from inclusion bodies by RP-HPLC, with soluble protein 
being purified by Ni2+ affinity chromatography (Figure 3-17). Difficulties faced when 
attempting to express and purify a high enough concentration for structural analysis of 
this protein resulted in focus being given to other protein constructs that gave better initial 
results. 
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Figure 3-17: pNH-TrxT CCP23. SDS-PAGE analysis of Ni2+ affinity chromatography fractions 
showing purified protein. 1. Flow through 2-3. Binding buffer 4-6. Wash buffer 7-10. Elution 
buffer 11. Elution buffer with 1 M imidazole. Marker = Precision Plus Protein™ Dual Xtra 
Standards (Bio-rad). CCP23 has a MW of 28.8 kDa, which is shown in fractions 7 and 8 of the 
purification.  
3.7.2.6 CCP123  
15N-labelled protein was expressed in minimal media at 15°C overnight after induction 
with 0.4 mM IPTG, and purified by Ni2+ affinity chromatography (Figure 3-18).  
  
Figure 3-18: pNH-TrxT CCP123. SDS-PAGE analysis of Ni2+ affinity chromatography fractions 
showing purified protein. 1. Flow through 2-3. Binding buffer 4-6. Wash buffer 7-10. Elution 
buffer 11. Elution buffer with 1 M imidazole. Marker = Precision Plus Protein™ Dual Xtra 
Standards (Bio-rad). A protein band around 35 kDa in the first two elution’s indicates the 
presence of CCP123 in these fractions.  
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The fractions containing soluble protein were buffer exchanged, concentrated and 
examined by NMR, which revealed mainly Trx peaks and evidence of disordered protein. 
Gel filtration was carried out on the protein sample, which revealed the presence of 
molecules of several different sizes, confirmed with analysis by SDS-PAGE (Figure 
3-19). Some fractions contained high molecular weight species; a strong band appeared 
around 70 kDa, which could be the chaperone DnaK from E. coli. Some of the purer 
fractions containing protein of the correct molecular weight for CCP123 were combined 
and examined by NMR. The 15N-HSQC spectra revealed peaks for Trx but only around 
10 peaks out of the 170 expected for CCP123. These were at the random coil chemical 
shift and were broad. This suggests the protein may be quite rigid and that this is why data 
cannot be produced for the whole protein. Further NMR experiments may provide useful 
information regarding this sample, for example, running a TROSY experiment, which can 
pick up signals from things tumbling slower due to their large size. The protein may be 
aggregated or LPS micelles may be bound and so given more time, RP-HPLC could be 
used in an attempt to strip this from the protein. 
 
 
Figure 3-19: CCP123 gel filtration fractions. SDS-PAGE analysis of cleaved CCP123 gel 
filtration fractions reveals multiple bands for each sample, suggesting the presence of several 
different molecules. The fractions from lanes 4-6, containing protein of 35 kDa were combined 
for NMR experiments. Marker = Precision Plus Protein™ Dual Xtra Standards (Bio-rad). 
3.8 Summary 
In an effort to determine the exact location of LPS binding, nine N-terminal Factor C 
fragments were successfully cloned into the pNH-TrxT vector using either a ligation 
independent cloning method or an InFusion® cloning technique. Soluble fusion protein 
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was produced in E. coli and purified for all nine fragments and varying degrees of 
structural analysis was carried out.  
The Cys-rich, EGF-like and CysEGF fragments appeared to be misfolded or sampling 
multiple conformations. Further experiments are needed to determine the optimal 
conditions for the analysis of these proteins in order to determine their structures. CCP1 
and CCP2 samples produced good spectra indicating folded protein when cleaved from 
the fusion protein. However, there is a need to optimise separation from the Trx in order 
to retain a suitable concentration of CCP1 and CCP2 for further structural analysis of the 
individual fragments by NMR. The overall quality of CCP3 was poor, meaning the 
sample was not suitable for further analysis. An improvement in expression and 
purification of this construct is necessary for further studies. 
CCP12 produced the best NMR data, which allowed for preliminary structure calculations 
to be carried out, as detailed in Chapters 0 and 7. For CCP23 and CCP123, it was difficult 
to express enough protein for structural analysis and further experimentation is required 
for these constructs. 
Although X-ray crystallography was initially unsuccessful, improving the quality and 
concentration of protein samples may improve its success in future. 
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4 Recombinant Expression in Alternative Expression 
Systems  
4.1 Overview  
For the majority of recombinant protein expression, E. coli is the expression system of 
choice for convenience. This is due, in the most part, to its rapid rate of growth, 
inexpensiveness and ability to produce large quantities of the target protein (Yin et al., 
2007). However, E. coli has its limitations and so alternative expression systems including 
other prokaryotic as well as mammalian, insect and yeast cell systems have been 
developed for the production of folded proteins that proved unsuccessful in E. coli (Tanio 
et al., 2008). In the case of Factor C, it was anticipated that protein production would be 
difficult in E. coli, especially the expression of full-length protein, and so alternative 
expression systems were explored: mammalian, insect and yeast.  
4.2 Vector Selection  
4.2.1 pcDNA™5/FRT/TO for Mammalian Expression  
The vector chosen for mammalian expression was pcDNA™5/FRT/TO (Invitrogen™, 
Figure 4-1). This vector is an attractive choice as it is designed to produce stable 
transformants as a result of co-transfection into a Flp-In™ T-REx™ host cell with the 
expression plasmid, pOG44 Flp. This integration allows for the creation of a cell line that 
can be easily propagated. Unlike many other mammalian expression systems, expression 
is regulated by the tet operator, and so the level of expression is determined by the amount 
of tetracycline added.   
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Figure 4-1: pcDNA5/FRT/TO vector map. The HindIII and NotI restriction sites to be used during 
molecular cloning are shown at positions 978 and 1046, respectively. The tet operator is marked 
along with other key features of the vector. Created with SnapGene®.  
 
4.2.2 pVL1392 for insect cell expression  
The vector of choice for insect expression was pVL1392 (Baculovirus transfer vector, BD 
Biosciences, Figure 4-2), which contains the complete polyhedrin enhancer-promoter 
sequences for high expression of recombinant protein. The advantages of using an insect 
expression system include the fact that it is able to carry out complex post-translational 
modifications and it can produce properly folded proteins. High yields of protein can be 
produced, and, specifically with regards to Factor C, insect cells have previously been 
used to produce Carcinoscorpius rotundicauda (cr) complement control protein (CCP) 
fragments, suggesting that protein production is likely to succeed in this system (Tan et 
al., 2000).  
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Figure 4-2: pvL1392 vector map. The polyhedron promoter is indicated, as well as the PstI site 
and BamHI site at locations 4142 and 4174, respectively. Created with SnapGene®. 
4.2.3 Pichia Pink™-HC for Yeast Expression  
Pichia Pink™-HC (Invitrogen™, Figure 4-3) was chosen for expression in yeast. There is 
a limited selection of Pichia vectors, but Pichia pastoris is known for high-level, large 
scale expression and secretion of recombinant proteins and has previously been 
successfully used for many secreted proteins studied by NMR. pPink™-HC was the 
preferred plasmid for its use of the AOX inducible promoter to drive expression encoding 
the desired heterologous protein and also for its colour based selection as a result of the 
presence of the ADE2 gene that catalyses a biosynthesis step of purine nucleotides. The 
colony colour is determined by the integrant copy number. White colonies contain more 
copies of the integrated construct and are more desirable than the pink colonies that 
express very little gene product. This expression system is faster, easier and more cost-
effective than other eukaryotic systems and can produce grams per litre under certain 
circumstances (Clare et al., 1991; Cregg et al., 1987; Sreekrishna et al., 1989).  
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Figure 4-3: Pichia Pink™-HC vector map. The AOX1 promoter is highlighted along with other 
features of the plasmid including the ADE2 gene promoter. The SphI and SwaI restriction sites for 
use in molecular cloning are indicated at positions 958 and 987, respectively. Created with 
SnapGene®.  
4.3 Construct Assembly  
The lpFC fragments ordered from Genewiz Inc. (Chapter 2), one containing the signal 
sequences, tags and N-terminal region of lpFC and one containing the C-terminal region 
of lpFC, were received in powdered form at a concentration of 4 µg each. They were 
made to a final concentration of 10 µg/ml by reconstituting with TE buffer (10 mM Tris, 1 
mM EDTA, pH8), which was used to solubilise the DNA whilst protecting it from 
degradation. The fragments – lpFC N-terminal plus signal sequences and lpFC C-terminal 
– were transformed into Subcloning Efficiency™ DH5α™ Competent Cells 
(Invitrogen™) and overnight cultures were set up in order to purify plasmid DNA using 
Wizard® Plus SV Minipreps DNA Purification Systems Kit (Promega). The overnight 
cultures were also used to prepare glycerol stocks for long term storage of the constructs.  
4.3.1 Vector Preparation  
pcDNA™5/FRT/TO (Invitrogen™) was transformed into Subcloning Efficiency™ 
DH5α™ Competent Cells and plasmid DNA was purified using the Wizard® Plus SV 
Minipreps DNA purification system (Promega). DNA was linearised for insertion of the 
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lpFC gene by a restriction digest using HindIII (2.5 U/µg, NEB) and NotI-HF (5 U/µg, 
NEB) in a mixture containing 1 X NEB Buffer 2 and 1 X BSA (100 µg/ml) alongside the 
restriction enzymes and DNA. The digestion was incubated at 37°C for 1 hour before 
vector dephosphorylation by adding 0.5 U/µg Alkaline Phosphatase, Calf Intestinal (CIP) 
(NEB), which prevents self-ligation by catalysing the removal of 5’ phosphate groups. 
Linearised DNA fragments were separated by agarose gel electrophoresis (Figure 4-4) and 
the vector band (5063 bp) was cut out for gel extraction (Macherey-Nagel). 
 
Figure 4-4: Agarose gel electrophoresis of linearised pcDNA5™/FRT/TO. The gel reveals 
digestion by HindIII and NotI has been successful in linearising the pcDNA5 vector. 1. 1 Kb 
ladder (Invitrogen), 2. Uncut pcDNA5™/FRT/TO, 3. HindIII single digest, 4. NotI-HF single 
digest, 5. HindIII and NotI-HF double digest.  
4.3.2 Insert Preparation  
In order to prepare the two fragments of Factor C to enable them to be ligated together to 
obtain the full-length sequence, both fragments had to be cut out of the vector they were 
supplied in (pUC57-kanamycin). The 5’ fragment encoding the N-terminal part of the 
protein including the tags (lpFC-N) was digested using HindIII (5 U/µg, NEB) and SpeI 
(5 U/µg, NEB) in a mixture containing 1 X NEB Buffer 2 and 1 X BSA (100 µg/ml). The 
digestion was incubated at 37°C before being analysed by gel electrophoresis to separate 
the lpFC-N fragment from the pUC57 vector (results not shown). The correct insert band 
(1630 bp) was cut out for gel extraction (Macherey-Nagel).   
The 3’ fragment encoding the C-terminal part of the protein (lpFC-C) was cut out from 
pUC57-kanamycin using SpeI (5 U/µg, NEB) and NotI-HF (5 U/µg, NEB) with NEB 
CutSmart™ buffer. The mixture was incubated at 37°C for 1 hour before fragments were 
separated by agarose gel electrophoresis (results not shown) and the insert band (2316 bp) 
was cut out for gel extraction (Macherey-Nagel).  
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4.3.3 Vector and Insert Ligation  
After successful isolation of the fragments and vector backbone, a three-way ligation was 
carried out using a 1:3:3 molar ratio (0.025 pmol vector: 0.076 pmol lpFC-N insert: 0.076 
pmol lpFC-C insert) in a reaction containing 1 X T4 DNA ligase buffer and T4 DNA 
ligase (400 U, NEB). The mixture was incubated at room temperature for 10 minutes 
before being transformed into Subcloning Efficiency™ DH5α™ Competent Cells and 
plated onto amp-agar plates. Colonies were checked for the correct clones by digestion 
using HindIII (2.5 U/µg) and NotI-HF (5 U/µg), 1 X NEB buffer 2 and 1 x BSA (100 
µg/ml), incubated at 37°C for 1 hour and the correct sequence was confirmed by 
sequencing using the CMV forward primer and BGH reverse primer (Chapter 3). This 
construct was the starting point for introduction of lpFC into the vectors for the other 
expression systems.  
4.4 Mammalian  
As described above, the lpFC gene was successfully cloned into the pcDNA™5/FRT/TO 
vector, but with both the insect and the pichia signal sequences still present. It had been 
intended that the insect and pichia signal sequences would be cut out from the pcDNA5 
lpFC construct using restriction enzymes AseI and NdeI. This would allow for religation 
of the pcDNA5 lpFC construct, with just the mammalian signal sequence present. 
However, it was discovered that five AseI and four NdeI sites exist in the pcDNA5 vector, 
which resulted in the presence of several bands as shown by agarose gel electrophoresis, 
indicating the construct was being digested into lots of smaller fragments. In an effort to 
resolve these issues, an alternative cloning strategy was attempted, which involved the use 
of the pCR2.1 vector. lpFC with all three signal sequences was to be cloned into pCR2.1 
and subsequent cloning steps would be taken to isolate the individual signal sequences for 
ligation with the lpFC into the correct expression vectors.  
However, ligation of lpFC into pcR2.1 failed, with sequencing results showing empty 
vector or sequencing errors. A new strategy was developed to produce a linear version of 
the plasmid with homologous ends that could be re-joined using InFusion® cloning to 
produce pcDNA5 lpFC with only the mammalian sequence. The experimental design is 
illustrated in Figure 4-5 and the primers used f or the amplification are shown in Table 
4-1.  
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Figure 4-5: Schematic representation of experimental design for pcDNA5 lpFC production. 
Signal sequences are indicated by the coloured boxes: Ig κ-chain (purple), Saccharomyces 
cerevisiae α-mating factor pre-sequence (red) and gp67 (green). The coloured arrows represent 
the part of the primer sequence shown in Table 4-1.   
5’ → 3’  TGGTGACATGCACCATCATC  
3’ → 5’  GGTGCATGTCACCAGTGGAA  
Table 4-1: Primers for the amplification of lpFC with the mammalian signal sequence. The 
primers are colour coded in line with Figure 4-5 indicating the part of the sequence that 
corresponds to the primer indicated by the arrows on the figure.  
The PCR program used to amplify pcDNA5 with the lpFC gene and no other signal 
sequences is outlined in Table 4-2. The mixture contained 1 X Pfu DNA polymerase 
buffer, dNTPs (20 mM), forward primer (10 µM), reverse primer (10 µM), DMSO, DNA 
(25 ng pcDNA5 lpFC) and Pfu DNA polymerase (2.5 U) after a hot start at 94°C for 5 
minutes.  
Number of Cycles  Temperature  Length  Step  
1  95°C  2 minutes    
30  
95°C  
53°C  
72°C  
30 seconds  
30 seconds  
7 minutes  
Denaturation  
Annealing  
Extension  
1 72°C 4°C 10 minutes Hold  
Table 4-2: PCR program for amplification of pcDNA5/FRT/TO, lpFC and mammalian signal 
sequence.  
DpnI digestion was carried out at 37°C for 1 hour before PCR-clean up using Macherey 
Nagel’s NucleoSpin® Gel and PCR Clean-up kit. InFusion® cloning was used to religate 
the construct, which was transformed into Stellar™ competent cells and mini-prepped to 
get purified DNA. DNA sequencing was used to confirm the correct sequence. However, 
time did not allow this construct to be taken further.  
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4.5 Insect  
4.5.1 Vector preparation  
After transformation into Subcloning Efficiency™ DH5α™ Competent Cells and 
purification of plasmid DNA using Wizard® Plus SV Minipreps DNA purification system 
(Promega), pVL1392 was linearised with PstI (10 U/µg, NEB) and BamHI-HF (5 U/µg, 
NEB) for 1 hour at 37°C in a mixture containing the enzymes, vector DNA, 1 X NEB 
Buffer 4 and 1 X BSA (100 µg/ml). The linearised vector was dephosphorylated as 
described previously (section 4.3.1). The bands were separated by agarose gel (results not 
shown) and the linearised vector (9598 bp) was cut out and gel extracted (Macherey-
Nagel).  
4.5.2 Insert Preparation  
The pcDNA™5/FRT/TO lpFC construct described in section 4.3.1 was used to cut out the 
lpFC synthetic cDNA containing only the insect signal sequence (gp67). Digestion was 
carried out with Pst-I (5 U/µg) and BamHI-HF (5 U/µg) and samples were analysed by 
agarose gel electrophoresis (Figure 4-6), which revealed three distinct bands. The correct 
band (3575 bp) was cut out for gel extraction (Macherey-Nagel), and used for ligation into 
linearised pVL1392 in a reaction containing 0.076 pmol insert DNA, 0.025 pmol vector 
DNA, 1 X T4 DNA ligase buffer and 400 U T4 DNA ligase. The ligation mixture was 
incubated overnight at 16°C before being transformed into Subcloning Efficiency™ 
DH5α™  
Competent Cells and plated onto amp-containing agar. The correct sequence was 
determined by DNA sequencing.    
 
Figure 4-6: Agarose gel electrophoresis of digested lpFC with gp67. In the double digest, the 
band second from the top (3575 bp) was the correct size for the lpFC with gp67. 1. 1 Kb DNA 
ladder (Invitrogen), 2. Uncut pcDNA5 lpFC, 3. 5 U PstI single digest, 4. 10 U PstI single digest, 
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5. 5 U BamHI-HF single digest, 6. 10 U BamHI-HF single digest, 7. 5 U PstI and BamHI-HF 
double digest, 8. 10 U PstI and BamHI-HF double digest.  
4.5.3 Insect Cell Expression  
For insect cell expression, the BacMagic™ DNA Kit (Novagen) was used to perform 
positive selection for recombinant baculovirus. The lpFC gene was cloned into the 
PVL1392 compatible transfer plasmid and co-transfected into insect cells with the 
BacMagic™ DNA. Homologous recombination within the cells generates recombinant 
virus DNA and the target gene sequence. Virus is produced from replicating recombinant 
DNA.  
According to the manufacturer’s instructions, small scale cell cultures were prepared for 
transfection, co-transfection was carried out and recombinant virus was amplified for 4 – 
5 days. The insect cell culture was analysed by Bradford Assay, SDS-PAGE and Western 
Blot, following standard procedures for each. A band indicating likely expression of lpFC 
protein was shown and cells were infected for a larger scale expression. Dr Jan Petersen 
infected Sf9 cells to express protein. Cells were harvested and again analysed by SDS-
PAGE and Western Blot for the presence of protein. Ni2+ affinity chromatography 
(Chapter 3) was used for purification of the protein sample, however this gave rise to 
uncertainty as to whether or not the protein of interest was being expressed and so a 
change in medium to BacVector™ insect cell medium (serum-free) occurred. Analysis 
revealed that the band shown in SDSPAGE and Western Blot was not lpFC, but likely to 
be a chaperone from the medium, and further experiments with insect cell expression were 
not taken any further, due to time constraints.  
4.6 Yeast  
4.6.1 Vector Preparation  
pPink™-HC was transformed into Subcloning Efficiency™ DH5α™ Competent Cells and 
the Wizard® Plus SV Minipreps DNA purification system (Promega) was used to purify 
plasmid DNA. Linearisation was achieved by sequential restriction digests, first using 
SwaI (2.5 U/µg, NEB) in a reaction mixture containing 1 X NEB buffer 3.1 and 1 X BSA 
(100 µg/ml) along with the enzyme and DNA, at 25°C for 1 hour before heat inactivation 
at 65°C  
for 20 minutes and DNA clean-up using Macherey-Nagel’s NucleoSpin® Gel and PCR 
Clean-up kit. The vector was then digested with SphI-HF (5 U/µg, NEB) in a reaction 
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containing 1 X NEB Buffer 4, 1 X BSA (100 µg/ml), the enzyme and DNA at 37°C for 1 
hour before vector dephosphorylation (see section 4.3.1). Linearised DNA was analysed 
by agarose gel electrophoresis (results not shown), and the resulting band (7638 bp) was 
extracted for purification by the NucleoSpin® Gel and PCR Clean-up kit (Macherey-
Nagel).  
4.6.2 Insert Preparation  
As with the mammalian insert preparation, design flaws required a PCR based strategy to 
be adopted to amplify the pichia signal sequence and the lpFC gene as fragments with 
homologous ends that would allow for the InFusion® cloning of the two fragments into 
the linearised pPink-HC vector. The design is set out in Figure 4-7 and the primers are 
listed in Table 4-3.   
 
 
Figure 4-7: Schematic representation of the experimental design for amplification of pPink signal 
sequence and lpFC. Primers indicated by the broken arrows are numbered and colour coded to 
relate to the primer sequence highlighted in Table 4-3.  
Number  Amplification section  Primer sequence  
1  5’ → 3’ vector and signal sequence  TCCGGACCGGCATGCATGAGATTTCCTTCA  
2  5’ → 3’ signal sequence and lpFC  GAAAAGGCATATGCACCATCAT  
3  3’ → 5’ lpFC and signal sequence  GTGCATATGCCTTTTCTCGAGAGA  
4  3’ → 5’ vector and lpFC  AAAAGGGGCCTGTATTTAAATGGATCCCTAGAT  
Table 4-3: Primer sequences for pPink lpFC preparation. The primers are designed to amplify the 
signal sequence and lpFC independently of each other with homologous ends to each other and to 
the pPink-HC vector, for 3-way ligation by InFusion® cloning. Primer sequences are colour 
coded to match the position they relate to on the schematic in Figure 4-7.  
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4.6.2.1 Signal Sequence  
Saccharomyces cerevisiae α-mating factor pre-sequence was amplified from 
pcDNA5/FRT/TO lpFC in a reaction containing 1 X Pfu DNA polymerase buffer, dNTPs 
(25 mM each NTP), primer 1 (0.2 µM), primer 3 (0.2 µM) and Pfu DNA polymerase (2.5 
U). The PCR program used to amplify the sequence was similar to that outlined in Table 
4-2 but with 30 cycles at 95°C for 30 seconds, followed by 53°C for 30 seconds and then 
72°C for 30 seconds.  
4.6.2.2 lpFC  
LpFC was amplified for insertion into the pPink™-HC vector from the pcDNA5/FRT/TO 
lpFC construct in a reaction containing 1 X Pfu DNA polymerase buffer, dNTPs (25 mM 
each NTP), primer 2 (0.2 µM), primer 4 (0.2 µM) and Pfu DNA polymerase (2.5 U). The 
PCR program used to amplify the sequence lpFC fragment followed that shown in Table 
4-2 except there was 30 cycles at 95°C for 30 seconds, 50°C for 30 seconds and an 
extension at 72°C for 3.5 minutes. The amplified fragments were analysed by agarose gel 
electrophoresis as shown in Figure 4-8.  
 
Figure 4-8: pPink PCR products. The bands indicate successful amplification of the α-mating 
factor pre-sequence and lpFC for cloning into the pPink vector. 1. P. pastoris signal sequence (307 
bp), 2. Amplified lpFC (3546 bp), 3. 1 Kb DNA Plus ladder (Invitrogen).  
4.6.3 In-Fusion® HD EcoDry™ Cloning  
In-Fusion® HD EcoDry™ cloning was used as described in Chapter 3 to clone the α-
mating factor pre-sequence (20 ng) and lpFC (20 ng), amplified with the specific primers, 
into the pPink™-HC vector digested with SwaI and SphI-HF (50 ng). After incubating at 
37°C for 15 minutes followed by 50°C for 15 minutes, the mixture was transformed into 
Stellar competent cells (Clontech) and plated onto amp-containing agar.  
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Colonies were mini-prepped and the sequence was determined using the AOXI 5’ 
sequencing primer and the CycI 3’ sequencing primer. It became clear that during the 
design and preparation of the sequence for yeast expression, the ‘Kozak’ sequence 
(AGATTTCCTTCA), which plays a major role in the initiation of translation, had been 
omitted. Primers were designed in order to introduce this into the final sequence by 
InFusion® HD EcoDry™ cloning. The experimental procedure involved linearising the 
pPink lpFC construct using SphI-HF before In-Fusion® cloning with the two primers 
(kindly performed by Donald Campbell). DNA sequencing confirmed that the correct 
sequence including the Kozak sequence had been produced, however, time did not allow 
for this to be taken any further.  
4.7 Brevibacillus choshinensis  
Brevibacillus choshinensis is a non-pathogenic Gram positive bacterium with low natural 
levels of secreted proteases, which can be used for heterologous protein expression 
(D’Urzo et al., 2013). Being Gram-positive, it produces no lipopolysaccharide, which 
would be a distinct advantage for the production and purification of Factor C fragments 
(Udaka and Yamagata, 1993). Secretion of proteins into the extracellular medium is 
efficient and thus the organism is well suited to the production of disulphide bonded 
proteins such as Factor C (Tanio et al., 2008). Brevibacillus choshinensis can be grown on 
defined growth media and has previously been used to produce isotopically labelled 
protein for NMR analysis (Tanio et al., 2008). The BIC (Brevibacillus in vivo cloning) 
system provides an efficient method by which secreted proteins can be produced.  
Primers were designed for the production of lpFC CysEGF, lpFC CCP12, lpFC CCP23 
and lpFC CCP123 in the BIC system. These primers include 15 bp of sequence that is 
homologous to the ends of the linear vector. The pBIC vectors are provided in linear form 
and allow for the amplified insert DNA to be inserted straight into the vector of choice, 
without the need for restriction digests. The full primer sequences are shown in Table 4-4. 
The fragments were successfully cloned into pBIC-4 and initial test expressions showed 
promising expression of soluble protein (experiments kindly performed by Donald 
Campbell). 
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Amplification 
section  Primer sequence  
5’ lpCysEGF  GATGACGATGACAAACAGCAGATGCACCCAGTGC  
3’ lpCysEGF  CATCCTGTTAAGCTTTCAGCCTTCATATCGGTCA  
5’ CCP1  GATGACGATGACAAAGAGATACTCCAGGGCTGC  
3’ CCP2  CATCCTGTTAAGCTTTTACTGTTTCTGGCATTGGGGAATTTG  
5’ CCP2  GATGACGATGACAAAATCAGGGAATGCAGCATG  
3’ CCP3  CATCCTGTTAAGCTTTTACTGCTCCCGGTCAGCTAC  
Table 4-4: Primer sequences for insertion into the pBic vector. The underlined sequences indicate 
the 15 bp needed for the 5’ primers. The sequences in bold indicate the 15 bp required for the 3’ 
primers.  
4.8 Summary 
Full-length lpFC was successfully cloned into the selected mammalian, insect and yeast 
expression vectors. Although initial expression tests were performed for insect cell 
expression, experimental optimisation is needed to ensure the protein being produced is 
lpFC. Expression of protein in all three eukaryotic expression systems will determine the 
most suitable system for production of full-length lpFC. For the BIC expression system, 
the next stage would be to perform a large-scale expression of the constructs that have 
been produced to determine whether this expression system has advantages over other 
recombinant expression systems. 
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5 Structural and Functional Analysis – Circular Dichroism  
5.1 Overview  
Circular dichroism (CD) is a technique that can be used for the study of proteins to elicit 
information about structure, stability and interactions with other molecules. CD is the 
differential absorption of left and right circularly polarised light (CPL) by chiral 
molecules. CD spectropolarimeters measure the difference between right-handed, 
clockwise rotations and left-handed, anticlockwise rotations. CD signals are observed in 
proteins due to the chirality of the peptide bond and contributions from aromatic amino 
acids or other chiral cofactors present in the protein. The CD effect is most commonly 
measured by modulation (used for the experiments described below) where signals are 
received from switching between the L and R components. This occurs from passing the 
light through a modulator, exposed to an alternating electric field at 50 kHz, that is made 
up of a piezoelectric quartz crystal and a thin plate of isotropic material, in this case, 
quartz silica. When measured as a function of wavelength, a CD spectrum is generated 
and from this several observations can be made (Kelly et al., 2005).  
CD signals at specific wavelengths can be used to identify different structural 
characteristics of the protein being studied. In the far UV region (260 – 190 nm), spectral 
features give an indication of the types of secondary structures, such as alpha helices, beta 
sheets and extended coil (or random coil) present within the protein. It is also possible to 
observe contributions from aromatic amino acids in the far UV region, however, these 
contributions are often very weak and can be cancelled out by the large contributions 
associated with alpha helical content. Absorption in the range 260 – 320 nm can report on 
contributions from aromatic amino acid side chains if they are held rigidly within the 
protein. Broad signals around 260 nm have been associated with disulphide bond 
contributions. Specifically, for aromatics, a peak near 290 nm, as well as data between 
290 and 305 nm, is usually indicative of contributions from Tryptophan residue(s). 
Tyrosine is shown by the presence of a peak between 275 and 282 nm and also a shoulder 
if this hasn’t been concealed by the Tryptophan. Phenylalanine reveals sharp but weak 
bands between 255 and 270 nm. A near UV (320 – 250 nm) CD spectrum depends on the 
number and type of any aromatic amino acids present and other features of these including 
their mobility and location within the protein.  
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Due to the nature of the experiments carried out and results gained from CD, 
conformational changes as a result of, for example, ligand binding, can be easily detected. 
Therefore, CD is an appropriate technique to use in determining structural changes as a 
result of molecular interactions and therefore binding of LPS to Factor C protein 
fragments.  
As a low-resolution technique, CD is a more straightforward method for obtaining 
structural information about proteins in comparison to high-resolution techniques such as 
NMR spectroscopy and X-ray crystallography. The results garnered from CD can give 
invaluable information about the sample.  
5.2 CD Experimentation  
CD was carried out for this project primarily as a structural comparison between the 
recombinant fragments produced. It was also used as a means to determine whether 
protein domains were correctly folded, to identify the secondary structure contributions 
from each of the samples and to detect putative conformational changes after the addition 
of lipopolysaccharide (LPS). All experiments were kindly carried out by Dr Sharon Kelly, 
using the Jasco J-810 spectropolarimeter and samples were measured in quartz cuvettes of 
varying path length, as indicated below for each construct along with the experimental 
parameters used (Table 5-1). For the most accurate data collection, it is imperative that the 
spectropolarimeter is correctly calibrated and operated and it is also important that the 
protein concentration has been calculated properly.  
Samples must be free from contaminants and any components that give strong signals, 
including imidazole, that would mask protein signals. There should be no aggregates, 
which would interfere with light scattering and absorption, affecting the shape and size of 
the spectrum. Buffer blanks are measured in order to check for any contributions that will 
need to be subtracted from the resulting spectra and also to ensure the buffer does not give 
a high absorbance.  
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Instrument Experimental Parameters  
Data array type  Linear data array * 3  
Near UV Start  320 nm  
Near UV End  250 nm  
Far UV Start  260 nm  
Far UV End  190 nm  
Data pitch  0.2 nm  
Data points  351  
Band width  1 nm  
Response  2 seconds  
Sensitivity  Standard  
Scanning speed  10 nm/min  
Accumulation  3  
Cell length Near UV  0.2 or 0.5 cm  
Cell length Far UV  0.1 or .02 cm  
Solvent  10 mM Tris, pH 8.0  
Temperature  Room temperature  
Table 5-1: CD parameters for data acquisition by near and far UV.  
5.3 CD Data Analysis  
DICHROWEB (Lobley et al., 2002; Whitmore and Wallace, 2004; Whitmore and 
Wallace, 2008), hosted by Birkbeck College, University of London, provides online 
analysis for protein spectra from CD experiments. The percentage contribution of several 
types of secondary structure is calculated including for α-helices, β-sheets and β-turns. 
Numerous algorithms and reference databases made up of CD spectra from a number of 
proteins of various structures determined by X-ray crystallography and/or NMR, are used 
to gain sufficient information to calculate the NRMSD (normalised root mean square 
deviation), which represents a standard ‘goodness-of-fit’ parameter. This allows for 
accurate comparisons to be made between experimental data and previously calculated 
spectra that have been stored in the reference databases. A perfect fit is indicated by a 
score of 0, whereas no fit whatsoever gives a score of 1. Several algorithms are available 
for use, but for the experiments described, analysis was carried out using the CONTIN-LL 
database and algorithms, which is a variant of Provencher and Glöckner’s CONTIN 
method (Provencher and Glöckner, 1981; Sreerama and Woody, 2000).  
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5.4 Experimental results for Factor C constructs  
For most of the constructs produced, far UV and near UV CD spectra were measured to 
obtain an estimate of secondary and tertiary structural content using the parameters 
outlined in Table 5-1. For near UV and far UV CD measurements, protein concentrations 
of between 0.5 – 1 mg/ml were used. All samples were prepared to 10 mM Tris, pH 8.0. 
Cells of path length 0.01 cm and 0.02 cm were used for far UV CD spectral 
measurements. For near UV CD measurements, cells of path length 0.2 – 0.5 cm were 
used. All spectra were corrected for buffer contribution, protein concentration and cell 
path length. Contributions from unbound LPS were removed by subtracting spectra for 
buffer and LPS in isolation from the spectra of protein and LPS together. CCP1 and CCP2 
preparations were found to be cloudy following purification, which precluded CD 
measurement due to excessive light scattering. An overview of the estimates of secondary 
structure for each Factor C construct is shown in Table 5-2. 
Construct % alpha helix 
% beta 
sheet 
% 
Turns 
% 
Unordered NRMSD 
Cys-rich  24.2  25.2  12.4  38.2  0.051  
Cys-rich LPS  25.6  23.4  12.7  38.3  0.042  
EGF-like  10.5  33.6  13.5  42.4  0.055  
EGF-like LPS  9.2  34.1  13.4  43.3  0.06  
Cys-EGF  24.2  25.1  20.9  29.8  0.06  
CCP3  18.9  29.7  12.5  38.9  0.107*  
CCP3 LPS  18.5  29.8  12.4  39.3  0.114*  
CCP12  5.0  41.5  12  41.5  0.057  
CCP12 +LPS  5.0  39.0  13  43.0  0.06  
CCP23  8.1  35.6  13.4  42.9  0.120*  
CCP23 + LPS  8.0  35.6  13.4  43.0  0.123*  
CCP123  12.2  28.6  14.9  44.3  0.067  
CCP123 + LPS  12.7  28.5  15.7  47.1  0.063  
Table 5-2: Secondary structure estimates of Factor C constructs (* denotes poor fit as judged by 
normalised root mean squared (NRMSD) value).  
5.4.1 Cys-rich  
The far UV CD spectra of the Cys-rich region in the absence and presence of LPS is 
shown in Figure 5-1. The spectra were predominantly superimposable indicating that no 
marked changes in the secondary structural contents in the presence of LPS took place. 
The spectral data of each were submitted to DICHROWEB, as described above.  
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Figure 5-1: Far UV CD spectra of Cys-rich in the absence (solid line) and presence (dotted line) 
of 1 mg/ml LPS.  
The secondary structure of the Cys-rich construct was estimated to contain 24.2% α-helix 
and 25.1% beta sheet content. A large proportion of the construct (38.2%) was estimated 
to be unordered (Table 5-2). Overall, the NRMSD value indicates that the goodness of fit 
was considered to be reliable. The secondary structural estimates obtained for Cys-rich in 
the presence of LPS were comparable. Slight differences were observed in the spectral 
data around 192 nm, which may be due to the slightly higher instrument voltage values 
required to maintain a constant current in the presence of LPS.  
The near UV CD data obtained for the Cys-rich construct in the absence and presence of 
LPS were of poor quality in terms of their signal to noise ratios and did not exhibit any of 
the characteristic peaks expected from aromatic residues that are held in a rigid position 
with the 3D structure of a protein (Figure 5-2). This suggests that any aromatic residues in 
this construct are probably contained within a flexible region of the structure.  
102  
  
  
Figure 5-2: Near UV CD spectra of Cys-rich in the absence (solid line) and presence (dotted line) 
of 1 mg/ml LPS.   
5.4.2 EGF-like  
The far and near UV CD spectra of the EGF-like construct in the absence and presence of 
LPS are shown in Figure 5-3 and Figure 5-4, respectively. LPS did not appear to influence 
the spectral intensity or shape over the ranges measured, which indicates that there were 
no significant effects on the secondary or tertiary structure of this construct. The far UV 
CD spectrum gave a small positive peak around 230 nm, which most likely reflects the 
contribution from a tryptophan residue. Aromatic contributions in the far UV region are 
usually masked by the larger contributions from alpha helical structure. The overall shape 
of the spectrum from the EGF-like construct indicates that there is probably only a small 
amount of alpha helical structure present in this construct. The large negative minimum 
around 202 nm suggests a high proportion of unordered structure. The presence of 
aromatic contributions in the far UV and the presence of characteristic aromatic peaks in 
the near UV (centred between 280 – 290 nm) indicate that the construct must contain a 
region with a rigid structure. The secondary structure estimates shown in Table 5-2 
indicate that this construct contains around 10% alpha helix, 33.6% beta sheet and 42.4% 
unordered structure.  
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Figure 5-3: Far UV CD spectra of EGF-like in the absence (solid line) and presence (dotted line) 
of 1 mg/ml LPS.  
  
Figure 5-4: Near UV CD spectra of EGF-like in the absence (solid line) and presence (dotted line) 
of 1 mg/ml LPS.  
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5.4.3 CysEGF  
Figure 5-5 shows the far UV CD spectra of CysEGF. The far UV CD spectra were 
recorded in the absence and presence of LPS. The spectra obtained and the secondary 
structural analysis of the data suggest that the construct undergoes a conformational 
change upon binding of LPS. From Table 5-2 it can be seen that the construct contains 
around 22.2% alpha helical structure, 24.4% beta sheet and 31.7% unordered structure. 
The addition of LPS appears to result in a slight increase in helical content of ~ 2% and a 
concomitant slight decrease in unordered structure.   
There were no significant aromatic contributions evident in the near UV CD region, which 
indicates that either the tertiary structure surrounding the tryptophan residue is probably 
flexible or that there was insufficient protein concentration to observe these aromatic 
contributions. Due to insufficient volume and concentration of this construct it was not 
possible to measure the effect of the addition of LPS in the near UV CD region.  
 
Figure 5-5: Far UV CD spectra of CysEGF in the absence (solid line) and presence (dashed line) 
of 1 mg/ml LPS  
5.4.4 CCP3  
It can be seen from Table 5-2 that the CCP3 construct is estimated to contain around 
18.9% alpha helical structure, 29.7% beta sheet and 38.9% unordered structure. The 
presence of LPS did not alter these estimates significantly although the spectral intensities 
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exhibited a slight reduction between 205 nm and 228 nm (Figure 5-6). Since the amount 
of sample available for this measurement was limited, it was not possible to obtain the 
necessary replication to ensure reproducibility in the far UV region. In addition, there was 
insufficient sample available to obtain a near UV CD spectrum. Given the superimposable 
spectral shapes obtained between 200 – 205 nm and 230 – 260 nm it is possible that the 
addition of LPS may have contributed to the minor spectral changes observed in the 
region associated with alpha helical and beta sheet contributions.  
  
Figure 5-6: Far UV CD spectra of CCP3 in the absence (solid line) and presence (dotted line) of 1 
mg/ml LPS.  
5.4.5 CCP12  
The far and near UV CD spectra of the CCP12 construct in the absence and presence of 
LPS are shown in Figure 5-7 and Figure 5-8. The far UV CD spectrum exhibits a small 
positive peak around 235 nm and a large minimum around 195 nm. The lack of minima at 
220 nm and 208 nm suggest that there is very little alpha helical content in this construct. 
The positive peak at 230 nm is indicative of the contribution from the tryptophan residue, 
which together with the spectral features centred around 285 – 295 nm suggest the 
tryptophan is held rigidly within the structure of CCP12. Secondary structure estimates 
were found to give very low helical content (~5%) with the predominant spectral 
contributions attributed to beta sheet (41%) and unordered structure (41%). When CCP12 
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was incubated with LPS differences were evident in both the far and near UV CD spectra 
indicating some secondary and tertiary conformational changes.  
  
Figure 5-7: Far UV CD spectra of CCP12 in the absence (solid line) and presence (dotted line) of 
1 mg/ml LPS.  
  
Figure 5-8: Near UV CD spectra of CCP12 in the absence (solid line) and presence (dotted line) 
of 1 mg/ml LPS.  
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5.4.6 CCP23  
The far and near UV spectra of CCP23 are shown in Figure 5-9 and Figure 5-10. The 
addition of LPS to the construct did not result in any observable changes in the spectra 
obtained in the far or near UV regions. The far UV CD spectrum of CCP23 exhibited a 
minor positive peak centred around 235 nm indicative of aromatic contributions. The 
shape of the spectrum below 230 nm is unusual with a negative slope down to 210 nm, a 
small positive shoulder around 205 nm followed by a large minimum centred around 190 
nm. The absence of strong negative ellipticities around 220 nm and 208 nm and a large 
positive peak around 190 nm suggest that the construct contains very little alpha helical 
structure.  
The lack of helical content would account for the observed far UV spectral contributions 
from aromatic residues held in a rigid asymmetric environment. Spectral features around 
235 nm and 205 nm have previously been associated with tryptophan contributions in the 
enzyme carbonic anhydrase following systematic mutagenesis of the individual 
tryptophan residues (Freskgard et al., 1994). These results together with the presence of 
characteristic tryptophan peaks in near UV CD region indicate that the region of the 
protein that contains the tryptophan residue is rigid and the aromatic residue is held in an 
asymmetric environment.  
The secondary structure estimates obtained for CCP23 had poor NRMSD values, which is 
probably due to the fact that the observed spectral features do not match well with 
proteins in the Database. It is clear from the estimates obtained that the construct contains 
very little alpha helix and that it is composed of mainly beta sheet (35.6%) and unordered 
structure (42.9%).  
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Figure 5-9: Far UV CD spectra of CCP23 in the absence (solid line) and presence (dotted line) of 
1 mg/ml LPS.  
  
Figure 5-10: Near UV CD spectra of CCP23 in the absence (solid line) and presence (dotted line) 
of 1 mg/ml LPS.  
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5.4.7 CCP123  
Figure 5-11 and Figure 5-12 show the spectra obtained for the CCP123 construct in the 
absence and presence of LPS. There were no observable changes in the far UV CD 
spectrum upon addition of LPS. Secondary structure estimates suggest that the construct 
contains a low amount of alpha helical structure (~12.2%) and that it predominantly 
consists of beta sheet and unordered structure (28.6% and 44.3% respectively). Data 
obtained in the near UV CD region suggest that LPS affects the environment of the 
aromatic residues. An increase in the intensity of the spectral peaks between 290 – 260 nm 
can be observed, which could be representative of changes in the local environment of 
phenylalanine, tyrosine, and/or tryptophan residues.  
  
Figure 5-11: Far UV CD spectra of CCP123 in the absence (solid line) and presence (dotted line) 
of 1 mg/ml LPS.  
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Figure 5-12: Near UV CD spectra of CCP123 in the absence (solid line) and presence (dotted 
line) of 1 mg/ml LPS.  
5.5 Summary 
The CD results indicated structural changes in a few of the domains upon exposure to 
LPS, as set out in Table 5-3. Changes were observed in the CysEGF, CCP3, CCP12 and 
CCP123 constructs. For the latter three constructs, these findings potentially corroborate 
the results from Tan et al., who concluded that CCP1 and CCP3 both contain sites for 
LPS binding (Tan et al., 2000). However, further repeats of these experiments, to ensure 
the reliability of these results, would be needed before any firm conclusions could be 
drawn. Alternative LPS and lipid binding assays would also need to be used to obtain 
quantitative data.  
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Construct Far UV Near UV 
Cys-rich No No 
EGF-like No No 
CysEGF Yes -  
CCP3 * - 
CCP12 Yes Yes 
CCP23 No No 
CCP123 No Yes 
Table 5-3: Structural changes observed upon addition of LPS. * indicates inconclusive results due 
to limited sample available that precluded the performance of replicate experiments to ensure 
reproducibility. – indicates no data available. 
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6 NMR  
6.1 Overview  
Nuclear magnetic resonance spectroscopy (NMR) is an analytical spectroscopic technique 
that can be used for the study of molecules in solution to obtain structural and dynamic 
information. NMR depends on nuclear magnetic spin and NMR active nuclei are those 
that have a non-zero spin quantum number. Those with the spin quantum number of ½ are 
used most often for NMR studies of organic molecules, in particular 1H, 13C, 31P and 15N. 
Of these, the proton, 1H and 31P are the most naturally abundant isotopes at close to 100%. 
In contrast to this, 13C and 15N have natural abundances of only 1.11% and 0.36%, 
respectively. Since the sensitivity of NMR measurements depends on the abundance of 
the NMR active nuclei, and sensitivity is usually a limiting factor for protein NMR, 
enrichment of protein samples for heteronuclear NMR studies is typically required 
(Cavanagh et al., 1996). Detection of 13C and 15N is less sensitive than detection of 1H as 
the magnitude of the gyromagnetic ratio (γ), which is a constant property of the nucleus, is 
smaller in both cases. This can be overcome by the use of NMR experiments that start 
with the magnetisation originating on 1H, which is then transferred to 13C and/or 15N, 
before ultimately detecting the signal on 1H.   
Interactions between nuclei that are near each other can be detected via either through-
space or through-bond effects. Through-bond interactions can be exploited to transfer 
coherence from one nucleus to another through the bonded network in experiments such 
as the TOCSY (total correlation spectroscopy) and INEPT (insensitive nuclei enhanced by 
polarisation transfer) style transfers used in heteronuclear NMR experiments (Figure 6-1). 
Through-space or dipolar coupling is the direct effect on a nucleus as a result of the 
magnetic field produced by a different nucleus. Dipolar coupling allows NOE transfer to 
take place, which can be used to determine intra- or inter-molecular distances. NMR 
experiments can be one dimensional or multidimensional and the experiments used in this 
study are described below. The theory of NMR has been well documented in a number of 
publications (Keeler, 2005; Levitt, 2001).  
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Figure 6-1: 1J - 2J coupling constants. Indicates the size of the coupling constants for the 
magnetisation transfer in {13C, 15N}- labelled proteins. These give an indication as to how long 
delays in INEPT style transfers need to be. Figure reproduced from Sattler et al. (Sattler et al., 
1999).  
6.2 NMR Experiments  
NMR experiments were carried out on a Bruker AVANCE IIIHD 600 MHz spectrometer 
equipped with an Ultrashield™ Plus magnet and a TCI triple resonance cryoprobe. 
Experiments were run using Bruker’s Topspin™ v3.2 software using standard Bruker 
pulse programs, except where noted below.  
Experiments described below were carried out using either a 15N-labelled sample or a 
{15N,13C}-labelled sample of CCP12, produced in M9 media as described in Chapter 3, in 
an attempt to characterise the structure of this di-domain fragment. All experiments were 
run at 305 K, unless stated otherwise. Samples were prepared by adding 30 µl deuterium 
oxide (D2O) to 570 µl of concentrated protein sample in NMR buffer (20 mM Na2PO4, 50 
mM NaCl, 0.01% NaN3, adjusted to pH 7.0 using phosphoric acid). The presence of D2O 
in the sample allows for field-frequency locking. Each sample was centrifuged at 13,000 
rpm in a microfuge for 5 minutes to remove any particulates before pipetting into a 5 mm 
NMR tube (Wilmad 535-PP-7).  
6.2.1 1H 1D with solvent suppression  
One dimensional (1D) 1H experiments of a low concentration sample in H2O requires 
suppression of the signal from the solvent (Hwang and Shaka, 1995). 1D 1H experiments 
allow signals from non-exchanging hydrogen atoms from the protein to be seen, and helps 
judge if the sample is in a good condition, free from contamination by small molecules 
such as imidazole or glycerol. Peaks at specific chemical shifts reveal information as to 
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the nature of the sample including the presence of aromatic sidechains and backbone 
NH’s, and the dispersion of chemical shifts, in particular amide and methyl signals, gives 
an indication as to whether the protein sample is folded. One dimensional NMR 
experiments are sometimes sufficient for the study of small molecules, but fail to provide 
sufficient information for resonance assignments for larger, more complex biomolecules 
such as proteins, as the peaks are too poorly resolved and the spectra lack the information 
required to assign the signals to specific atoms.  
6.2.2 Multidimensional Experiments  
Multidimensional experiments are crucial for structure determination of small molecules, 
proteins and nucleic acids. They produce spectra in which the NMR signals are separated 
into second, third, fourth or more frequency dimensions. These additional dimensions 
help both by reducing signal overlap, and increasing the information content of each 
cross-peak observed.   
In homonuclear-coupled experiments, both axes of the spectrum display the chemical shift 
for the same type of nucleus. A cross peak is seen when transfer of magnetisation takes 
place between two nuclei whose signals have different frequencies. Homonuclear 
experiments also typically contain diagonal peaks, for which the shifts are identical in 
both dimensions. Diagonal peaks arise from either magnetisation that has not been 
transferred, or from transfer between two nuclei with the same chemical shift. In 
heteronuclear-coupled experiments, transfer of magnetisation occurs between different 
types of nuclei. The chemical shift for the different nuclei are displayed on different axes. 
A signal will appear at the intersection of the frequencies, but only if a transfer takes 
place, and diagonal peaks are not seen.  
NMR data acquisition can be lengthy due to the requirements for signal averaging, as 
addition of scans is needed to improve the signal to noise, and incrementation of time 
delays that give rise to the indirectly detected frequency dimensions requires multiple 
repeats of the pulse sequence. In general, it is advantageous to optimise data acquisition.  
In some experiments, it is desirable to minimise the spectral width (SW). Choosing a 
narrower SW allows better digital resolution from fewer increments, since the size of the 
time increments goes as 1/SW. For lpFC CCP12, this was achieved by choosing 15N and 
13C sweep widths and offsets that caused aliasing of peaks thus folding signals up field of 
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the spectral region downfield and vice versa so they appear within the reduced spectral 
width without overlapping with non-aliased peaks.  
6.2.2.1 Heteronuclear Single Quantum Coherence (HSQC)  
The HSQC is a very commonly used 2D NMR experiment and reveals all 1-bond 
correlations between H and N or H and C, depending on the nuclei being used. In a 15N 
HSQC, magnetisation is transferred by exploiting J-coupling between the 15N nuclei and 
their covalently attached hydrogen. 13C HSQC experiments obtain a chemical shift 
correlation map between the directly-bonded 1H and 13C. There is more equilibrium 
magnetisation on H than C or N, and so the magnetisation starts on H, transfers to C/N 
and then back to H for detection. The chemical shift evolves before being transferred back 
for detection on the hydrogen. High sensitivity is achieved due to the detection on proton.  
The 15N HSQC experiment mostly gives information about backbone amide groups. 
However, some side chain groups can also be seen, which can include the Trp side chain 
NεHε and Asn and Gln side chain groups. Figure 6-2 shows a 15N-HSQC for CCP12.   
     
116  
  
 
Figure 6-2: CCP12 15N-HSQC. A. Full spectral width spectra displaying all assigned CCP12 
cross-peaks, labelled with their residue number and type. B. Zoomed in region of the middle of 
the spectra for better clarity of the labelled peaks in this area.  
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6.2.2.2 Triple Resonance Experiments  
Triple resonance experiments were used to identify linked sets of the atomic nuclei, in 
order to obtain backbone 1H, 13C and 15N resonance assignments of the protein. They 
depend upon heteronuclear 1J/2J couplings for magnetisation transfer (Figure 6-1). Each 
experiment is named after the nuclei involved, organised in the order in which the 
magnetisation transfer occurs. Examples include: HNCA, CBCA(CO)NH and 
HN(CA)CO. Nuclei in parentheses are in the magnetisation transfer pathway but their 
chemical shifts are not detected. Spins that are frequency labelled during acquisition, or 
indirect dimensions, 1HN, amide 15N, 1Hα, 13Cα, 13CO, 1Hβ and 13Cβ, are represented by 
HN, N, HA, CA, CO, HB and CB, respectively (Ikura et al., 1990; Kay et al., 1990). 
Magnetisation transfer pathways for the majority of experiments used in this study are 
shown in Figure 6-3. In so called “out-and-back” experiments, magnetisation starts on a 
proton and is then transferred back to this proton for detection. In comparison, in “out-
and-stay” experiments, magnetisation is transferred to a different spin where it stays for 
acquisition. A full list of all the experiments carried out and their acquisition parameters 
can be found in Table 6-1.  
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Figure 6-3: Magnetisation transfer pathways. Arrows indicate the transfer of magnetisation 
between nuclei. Nuclei in red are in the magnetisation transfer pathway but their chemical shifts 
are not detected. 
 Experiment F1 (indirect)  
 F2 (direct)    F3 (indirect)   NUS NS Temp (K) Pulse Program Reference NC SW AQ NC SW AQ QD NC SW AQ QD 
15N-HSQC  15N  22.5  0.047  1H  16.025  106.496  ST  -  -  -  -  -  8  305  (Mori et al., 1995)  
13C-HSQC  1H  14.029  0.059  13C  32.999  12.854  E- Anti  
1H  16.025  106.496  ST  -  32  305  (Davis et al., 1992) 
HNCA  13C  32  13.256  15N  22.5  24.121  ST  1H  16.025  106.496  ST  37.879  64  305  (Grzesiek and Bax, 1992; Kay et al., 1994; Schleucher et al., 1993)  
HNCACB  13C  75  6.716  15N  22.5  24.852  ST  1H  16.025  106.496  ST  20.433  64  305  (Muhandiram and Kay, 1994; Wittekind and Mueller, 1993)  
CBCACONH  13C  75  6.716  15N  22.5  24.852  ST  1H  16.025  106.496  ST  20.433  64  305  (Grzesiek and Bax, 1993a; Muhandiram and Kay, 1994)  
HNCO  13C  22  24.098  15N  22.5  24.121  ST  1H  16.025  103.496  ST  32.727  16  305  (Grzesiek and Bax, 1992; Kay et al., 1994; Schleucher et al., 1993)  
HNCACO  13C  22  24.098  15N  22.5  24.121  ST  1H  16.025  106.496  ST  26.061  72  305  (Clubb et al., 1992; Kay et al., 1994)  
HBHACONH  1H  16.025  6.656  15N  22.5  24.121  ST  1H  16.025  106.496  ST  35.606  64  305  (Grzesiek and Bax, 1993a; Muhandiram and Kay, 1994)  
HBHANH  1H  16.025  6.656  15N  22.5  24.121  ST  1H  16.025  106.496  ST  35.606  64  305  (Wang et al., 1994)  
15N-NOESY-HSQC  1H  13.333  16  15N  22.5  43.125  ST  1H  16.025  106.496  ST  -  8  305  (Sklenar et al., 1993) 
13C-NOESY-HSQC  1H  13.333  13.75  13C  32.999  8.034  E- Anti  
1H  16.025  106.496  ST  -  16  305  (Davis et al., 1992)  
hCCHTOCSY  1H  75  11.312  13C  33  12.854  ST  13C  16.025  106.496  ST  19.922  64  305  (Kay et al., 1993)  
HCcHTOCSY  1H  8.333  20  13C  33  6.226  ST  1H  16.025  106.496  ST  25  16  305  (Kay et al., 1993)  
T1 relaxation  1H  26.999  643.21  15N  16.666  102.4  ST  -  -  -  -  -  32  298  (Kay et al., 1992)  
  
  
 Experiment 
F1 (indirect)  F2 (direct)   F3 (indirect)  
NUS NS Temp (K) Pulse Program Reference 
NC SW AQ NC SW AQ QD NC SW AQ QD 
T2 relaxation  1H  27  548.79  15N  16.666  102.4  ST  -  -  -  -  -  48  298  (Kay et al., 1992)  
HDEx  15N  39.999  13.157  1H  16.025  106.496  ST  -  -  -  -  -  16  298  (Mori et al., 1995)  
15N-NOEref  15N  26.999  107.202  1H  16.666  102.4  ST  -  -  -  -  -  40  298  (Grzesiek and Bax, 1993b)  
15N-NOEsat  15N  26.999  107.202  1H  16.666  102.4  ST  -  -  -  -  -  40  298  (Grzesiek and Bax, 1993b)  
aroNOESY  1H  13.336  16  13C  74.994  0.044  E- Anti  
1H  16.029  106.496  ST  -  1536  305  (Davis et al., 1992)  
HBCBCGCDHD  1H  16.025  106.496  13C  40  5.302  ST  -  -  -  -  -  736  305  (Yamazaki et al., 1993) 
HBCBCGCDCEHE  1H  16.025  106.496  13C  40  5.302  ST  -  -  -  -  -  736  305  (Yamazaki et al., 1993) 
Table 6-1: NMR experiments and their acquisition parameters. NC = Nucleus, SW = Spectral Width (ppm), AQ = Acquisition Time (ms), NUS = Non-
Uniform Sampling Amount (%), QD = Quadrature detection mode: ST = States-TPPI, E-Anti = Echo-Antiecho, NS = Number of scans, Temp = 
Temperature (K).  HDEx = Hydrogen Exchange. The aroNOESY was a 13C-edited 1H1H NOESY optimised for aromatics.   
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6.2.2.3 HNCA, HNCACB and CBCA(CO)NH  
The HNCA, HNCACB and CBCA(CO)NH can be used in conjunction for backbone 
assignment. In the HNCA, magnetisation is passed from 1H to 15N via J-coupling and then 
via N-Cα J-coupling to the 13Cα, then back by the reverse pathway to 15N and 1H where 
detection takes place. A 3D spectrum is produced with chemical shifts for 1H, 15N and 
13Cα. Peaks for both the amide nitrogen’s own residue’s Cα resonance and for the Cα 
from the residue before are usually visible, because both N-Cα couplings are similar 
(Figure 6-1). Two Cα peaks should appear in each NH strip (Figure 6-4), and as coupling 
to the residues own Cα is stronger these peaks should appear with greater intensity. In the 
case of lpFC CCP12, the weaker peaks, belonging to the preceding residue were often 
buried in the noise.   
In the HNCACB experiment, magnetisation starts on 1H is transferred to 15N, 13Cα and 
13Cβ, and then back to 1H for detection. Magnetisation is transferred from both 13Cαi and 
13Cαi-1 to 15Ni, resulting in two peaks for Cα and two peaks for Cβ in each NH strip. 
Simultaneous evolution of the carbon signals correlated to an NH occurs meaning they 
will appear in one dimension, and the chemical shifts for 1H and 15N are evolved in the 
other two dimensions. The four peaks visible in each strip are Cαi, Cαi-1, Cβi and Cβi+1. 
Those from the NH’s own residue appear stronger.  
Magnetisation in the CBCA(CO)NH is initially transferred similarly to HNCACB, in that 
it occurs between 1Hα and 13Cα, and between 1Hβ and 13Cβ, and then from 13Cβ to 13Cα. It 
then transfers to 13CO, then to 15N and then for detection on 1H. Since CA-CO intra-
residue and CO-N inter-residue couplings are strong, only transfer via the directly bonded 
CACON route is seen and intra-residue cross-peaks are not. Again, simultaneous 
evolution of the signals results in them appearing in one dimension, however, no chemical 
shift is evolved on 13CO. Each strip displays Cαi-1 and Cβi-1.  
6.2.2.4 HNCO and HN(CA)CO  
The HNCO is the most sensitive of the triple-resonance experiments, and is used to obtain 
the CO chemical shifts and assist with backbone resonance assignment. Magnetisation is 
transferred between 1H and 15N and then selectively via the 15NH-13CO J-coupling to the 
13CO. It is then transferred back via 15N to 1H where the signal is detected. Chemical 
shifts evolve on all three nuclei. In each NH strip, COi-1 is visible.  
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The HN(CA)CO produces another 3D spectrum that is used for backbone assignment in 
combination with the HNCO. Transfer of magnetisation occurs from 1H to 15N, then 
through N-Cα J-coupling to 13Cα. It is then transferred via 13Cα-13CO J-coupling to the 
13CO. It is then transferred back from 13CO to 13Cα, 15N to 1H for detection. Chemical 
shifts are evolved on 1H, 15N and 13CO but not on 13Cα. The amide nitrogen is coupled to 
both Cαi and Cαi-1, meaning both transfers take place, which results in transfer to both COi 
and COi-1. Two peaks appear in the spectrum for COi and COi-1 with the peak that appears 
in both the HNCO and the HN(CA)CO spectra for a particular NH strip belonging to COi-
1.  
6.2.2.5 HBHA(CO)NH and HBHANH  
The HBHA(CO)NH is used for the detection of Hα and Hβ resonances. The transfer 
pathway is the same as that for the CBCA(CO)NH experiment, the only difference being 
the shifts that are evolved. Magnetisation transfer takes place from 1Hα and 13Cα, and 
between 1Hβ and 13Cβ, and then from 13Cβ to 13Cα. Next, transfer takes place to 13CO, 
then to 15N and then for detection on 1H. In this experiment, there is no chemical shift 
evolution on the carbon atoms, but 1Hα and 1Hβ, 15N and 1H evolution takes place. A 3D 
spectrum is produced with one nitrogen and two proton dimensions. In each NH strip, one 
Hα peak and one or two Hβ peaks are visible that correspond to the chemical shifts of the 
preceding residue’s resonances. This information cannot be used for sequential 
assignment on its own, as only the inter-residue correlations are visible, and not the 
corresponding intra-residue ones. Thus, the HBHANH, is used in conjunction to the 
HBHA(CO)NH to determine the intra-residue connections.   
6.2.2.6 15N and 13C NOESY-HSQC  
 In the 15N-NOESY-HSQC, magnetisation is first transferred between all hydrogens using 
the nuclear Overhauser effect (NOE). From the destination proteins 1H, it is then 
transferred to bonded 15N nuclei, selecting only amide and NH sidechain resonances, and 
back to those 1H for detection. Cross-peaks will therefore all be to NH or sidechain NHs. 
Cross-peaks observed in this spectrum can be interpreted to produce distance restraints for 
structure calculations. The NOESY mixing time was 120 ms. A longer mixing time gives 
stronger cross-peaks but risks more spin diffusion, which is a leakage of magnetisation to 
surrounding nuclei. NOEs from one NH group to all hydrogen atoms that are nearby are 
shown in each strip.  
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For the 13C-NOESY-HSQC, again, magnetisation is first transferred using the NOE 
between all hydrogens. From the destination proteins 1H, it is then transferred to bonded 
13C nuclei and back to those 1H for detection. Transfer is either between the aliphatic 13C 
or the aromatic 13C, and experiments can be optimised for either aliphatics or aromatics. 
This is dependent on the 13C frequency used in the pulse sequence, whether it is centred 
on the aliphatic or aromatic carbon region. The NOESY mixing time was 120 ms for the 
first experiment, which was repeated with a mixing time of 200 ms. The aroNOESY, 
focusing on the aromatics had a mixing time of 200 ms. NOE cross-peaks from one CH 
group to the hydrogens close by are shown in each strip and the NOESY centred on the 
aromatic region is very useful when assigning the aromatic residues as Hβ to Haro 
connections can be made. NOE cross-peaks were used to derive distance restraints for 
structure calculations.  
6.2.2.7 HCCH-TOCSY  
Two versions of an HCCH-TOCSY experiments were recorded: hCCH-TOCSY and 
HCcH-TOCSY, to be used for side-chain assignment. The magnetisation transfer pathway 
is the same for both HCCH-TOCSYs. Magnetisation starts on the side-chain hydrogen, is 
transferred to its attached 13C nucleus then to all the other 13Cs in the same sidechain 
using a DIPSI2 mixing sequence (13C-TOCSY) (Shaka et al., 1988). Magnetisation is then 
transferred from the 13C it has arrived on to its attached 1H. This happens simultaneously 
for all 13Cs in the residue. For the hCCH-TOCSY, the originating H chemical shift is not 
recorded, but the ‘CCH’ are, and for the HCcH-TOCSY, all but the ‘c’ are recorded. 
Strips are displayed for each carbon frequency in the side-chain.  
6.2.2.8 15N Relaxation Experiments  
Relaxation experiments were performed on a 15N-labelled sample at 298 K. 15N 
heteronuclear NOEs were measured, with and without 1H saturation (NOEref and 
NOEsat, respectively), by comparing the intensity of signal transferred from amide 15N to 
1H.  
6.2.2.9 Aromatics  
Two experiments are used for the assignment of the aromatic residues’ sidechains by 
connecting their aromatic Hs to their Cβs: hbCBcgcdHD and hbCBcgcdceHE (case rather 
than brackets indicates which chemical shifts are recorded). In these experiments, 
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correlations between side-chain 13Cβ and ring 1Hδ/ε chemical shifts are identified. 
Transfer of magnetisation occurs via J-coupling and the paths of magnetisation transfer 
are as follows:  
For 1Hδ detection:   Hβ → Cβ (t1) → Cγ → Cδ → Hδ (t2)  
For 1Hε detection:  Hβ → Cβ (t1) → Cγ → Cδ → Cε → Hε (t2)  
6.2.2.10 Hydrogen Exchange  
A hydrogen exchange experiment was carried out where an 15N labelled sample was 
lyophilised and then dissolved in D2O. This sample was placed quickly into the magnet 
and three back to back 15N-HSQCs were recorded. Most of the signals disappeared 
immediately, and were therefore unobservable in even the first one. Since the rate of 
exchange of backbone NHs with the solvent depends on how tightly they are hydrogen 
bonded, the signals that remained were interpreted as indicating the NHs involved in 
hydrogen bonds.   
6.3 Data Processing  
Most spectra were processed using Bruker’s Topspin™ v3.2 and MDD v1.6 (Orekhov 
et al., 2003) with the exception of the relaxation data which were processed using 
AZARA (http://www2.ccpn.ac.uk/azara/, Wayne Boucher).  
6.4 Assignment  
A key stage in determination of a protein’s structure from NMR data is the assignment 
of resonances observed from NMR spectra to their specific atom in the molecule of 
interest. This enables the use of the determined distance restraints for calculation of the 
structure. To use the NMR signals, the atoms giving rise to the individual signals need 
to be identified. Spectra are used in combination to establish sequential links between 
backbone amides, which are placed in their sequence context by the assignment of 
aliphatic sidechain atoms and the atoms of aromatics and longer sidechains. The 
CcpNmr Analysis software v2.4.1  was used for all spectra analysis prior to structure 
determination (Vranken et al., 2005) and referenceB (K. Bromek, unpublished) was 
used to determine the correct referencing for each spectrum (Wishart et al., 1995).  
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6.4.1 Backbone resonance assignment  
All cross peaks evident in the 15N-HSQC were picked and assigned to spin systems, 
which each represent an individual residue. Triple resonance peaks occurring at the 
same 1H and 15N chemical shift were assigned to the same spin system and atom type 
was determined from the specific triple resonance experiment the spectra had been 
produced from; the HNCA determined the position of the residues own Cαi, the 
HNCACB determined the Cβi position and the position of COi was established from the 
HNCO spectrum. Sequential links between backbone amides could be made by 
identifying the peaks that corresponded in the CBCA(CO)NH for Cα and Cβ and by 
using the HN(CA)CO to determine the position of the CO in the residue before (i-1) 
(Figure 6-4).  
Having assembled the Cα and Cβ chemical shifts, a judgement could be made about 
which residue type they belonged to. The references provided by Iwadate et al. 
alongside the ‘Protein Sequence Assignment’ function in CcpNmr analysis, helped with 
the specific identifications (Iwadate et al., 1999).  
Due to the fact that certain residues have atoms with very distinctive chemical shifts, a 
few residue type assignments can be made easily. Examples of this include serine and 
threonine residues whose Cβ’s have a chemical shift up-field of the Cα’s, and glycines 
that have a Cα but no Cβ’s. CcpNmr Analysis provides a ‘Link backbone resonances’ 
tool, which suggests residue type based on a comparison of the observed chemical shifts 
with statistical distributions harvested from BMRB/refDB, to help with amino acid 
identification (Ulrich et al., 2008; Zhang et al., 2003). Using this tool, the information 
obtained from the spectra and the amino acid sequence of CCP12, residues could be 
linked together and assigned. This method is effective until a proline is reached, as this 
residue does not have an NH and so a break is introduced in the amino acid chain.  
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Figure 6-4: Triple resonance assignment. Each vertical strip represents an individual spin system 
(residue). From left to right: 172Ser, 171Trp, 170Gln, 169Gly and 168Asn. The HNCA 
experiment gives rise to the green peaks and indicate the chemical shift of the residues own Cα, 
the pink peaks are from the HNCACB and show the chemical shift of the residues own Cβ, while 
the purple peaks arise from the CBCACONH and indicate the chemical shift for the preceding 
residues Cα and Cβ. The residues own CO is indicated by the brown peak from the HNCACO and 
the preceding residues CO is shown by the blue peak from the HNCO.  
To elucidate the position of the Hα’s and Hβ’s, the HBHANH was used to identify the 
chemical shifts of a residue’s own atoms while the HBHA(CO)NH spectrum helped to 
confirm a sequential link by revealing Hα and Hβ peaks at the chemical shifts for the 
residue before.  
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6.4.2 Sidechain Assignment  
Backbone assignments were extended into the sidechain by use of the 3D HCCH-
TOCSY experiments. The spectra produced from these experiments allowed for 13C 
side chain resonances to be correlated with all other 13C and 1H resonances in a spin 
system. Known Cα and Cβ shifts were used to identify cross-peaks in planes 
corresponding to the Hα and Hβ shifts of a residue, and additional 13C resonances could 
then be identified (Figure 6-5). The Hα’s of many residues have their chemical shift 
near 4.7 ppm, which is the approximate shift of the solvent water. This region of the 
spectrum contains many artefacts due to incomplete solvent suppression and it was 
therefore often difficult to distinguish and pick peaks. Furthermore, this spectrum often 
showed regions of overlap, particularly at δ and γ chemical shifts but this could in some 
cases be resolved by navigating to the chemical shift position in the HCcH-TOCSY. 
The quality of the data shown by Figure 6-5 highlights the sensitivity problem faced 
with some experiments, due to the low sample concentration, as peaks are missing and 
often poorly resolved. The α and β chemical shifts were used to get an indication of 
where the γ and δ peaks were, so the whole residue could be pieced together. In some 
cases, signals that were degenerate in the shifts of one nucleus (e.g. 1H) could now be 
resolved due to correlation with another (e.g. 13C), as they were displayed at different 
shifts for the different groups.  
6.4.3 Proline Assignments  
Proline is the most difficult residue to assign, as this residue is lacking an NH. For 
CCP12, some assignments could be made by using the α and β from the residues that 
followed prolines. However, there were a number of cases where this could not be 
achieved due to there being two prolines together in the sequence or because the 
residues after had not been identified themselves. Thus, in order to complete the proline 
assignments and identify the cis-peptidyl proline bonds, the Hαi to Hαi+1 and Hαi to 
Hδi+1 NOEs were used. This was achieved, for example, by identifying the δs at the α 
chemical shift for prolines. This allowed for peaks to then be identified at the chemical 
shift of carbon and from here it was possible to build up the whole picture. Peaks that 
were at the chemical shift for proline δs but were otherwise unexplained, were 
investigated and the atoms could, for some, be linked in this way. The peptide bond 
almost always adopts the trans configuration, which is energetically favoured over the 
cis configuration. However, the cyclic nature of the proline side-chains mean--s that cis-
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peptidyl configurations are more likely to occur than in other residues. In the cis 
configuration, the omega torsion angle will be close to 0°, in comparison to the trans 
configuration where it will be 180°. These conformational differences affect the pattern 
of NOE signals seen, as the conformation of the peptide bond determines whether the 
NH of the preceding residue is close to the Hδs (trans) or the Hαs (cis) of the proline 
(Joseph et al., 2012). 
 
Figure 6-5: hCCHTOCSY spectrum for 207Arg. These strips are displayed vertically as the 1H 
detected dimension appears along the x-axis and the 13C dimension appears along the y-axis.  
6.4.4 Role of NOESY in Assignment  
The 15N-NOESY gives strong αi – NHi+1 and NHi – NHi+1 NOEs, which can be used to 
confirm or establish sequential connectivity. The aromatic side chains were assigned by 
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using hbCBcgcdHD, hbCBcgcdceHE and the 13C-NOESY experiments (Wang et al., 
1994). The 13C-NOESY helps connect the aromatics by linking NOEs such as β – δ.  
  
6.4.5 Assignment Summary  
120 of the 121 (99.17 %) residues from CCP12 were at least partially assigned, from the 
experiments described. A summary of the assignments is shown in Table 6-2 and the 
chemical shift assignments are summarised in Appendix E.  
Resonance Type  Available  Assigned  % Assigned  
Overall residues  121  120  99.17  
Carbon atoms  563  483  85.79  
Hydrogen atoms  719  640  89.01  
Nitrogen atoms  158  108  66.46  
Backbone amides  108  102  94.44  
Backbone non-H  363  338  93.11  
Side-chain H  480  407  84.79  
Side-chain non-H  358  250  69.83  
Table 6-2: CCP12 assignment completeness.  
6.5 Summary 
NMR experiments were recorded on samples of CCP12 in an attempt to characterise the 
structure of this di-domain. Several spectra were recorded in order to be able to fully 
assign the resonances to their specific atoms. A near complete resonance assignment was 
achieved allowing structure calculations to be carried out for CCP12, as described in 
Chapter 7. 
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7 Structure Calculation  
NOESY cross-peaks were picked semi-automatically in the 3D NOESY spectra for all 
assigned resonances. Care was taken to avoid artefacts, noise and overlapped regions. 
The number of cross peaks was relatively low for a protein of this size, due to a low 
sample concentration and therefore a low signal to noise. This was also potentially due 
to anisotropic tumbling due to the elongated nature of the di-domain.  
7.1 Structure Calculation by ARIA  
ARIA 2.3 (Ambiguous Restraints for Iterative Assignment) was used for structure 
calculations of lpFC CCP12 (Rieping et al., 2007). This software uses a mathematical 
way of summing up the various interatomic distances’ contributions to individual 
ambiguous restraints. After each round of structure calculation, the level of ambiguity 
can be refined based on the structures calculated by excluding the longest interatomic 
distances (lowest contributors) that contribute to an ambiguous restraint. In this work 
the standard ARIA protocol was applied but with deviations that include the number of 
steps in the molecular dynamics stages (Table 7-1), violation thresholds for exclusion of 
consistently violated restraints, ambiguity thresholds, and the number of structures 
calculated in the iterations (Table 7-2).  
When structures are calculated, many structures will typically satisfy the restraints, but all 
with slight differences. Structure calculations are repeated from randomised starting states 
to produce an ensemble of structures from which those that fit the data best and have the 
lowest restraint energy can be selected. If the structures that have low energy show a high 
level of structural similarity, this indicates the calculations have converged and the 
restraints define the structure well.  
Step  Temperature (K)  Steps  
High temperature  10,000  20,000  
Refine  2,000  20,000  
Cool 1  1,000  20,000  
Cool 2  50  16,000  
Table 7-1: Molecular dynamics conditions.  
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Iteration  Number of  Structures   
Violation Tolerance 
(Å)  
Partial Assignment 
Filter  
0  20  1000  1.0  
1  20  5.0  0.999  
2  20  3.0  0.999  
3  20  1.0  0.99  
4  20  1.0  0.98  
5  20  1.0  0.97  
6  100  0.5  0.96  
7  100  0.3  0.95  
8  100  0.3  0.95  
Table 7-2: Iterative strategy for CCP12 structure calculations. Strategy of later structure 
calculations after inclusion of disulphide and hydrogen bond restraints.   
7.1.1 Disulphide Bonds  
Previous studies of complement control proteins have determined a conserved pattern of 
disulphide bonds from Cys1 – Cys3 and Cys2 – Cys4 for each module (Reid and Day, 
1989). Calculations were first run with NOE restraints, and when it was clear that this 
pairing of the cysteines was compatible with the NOE only structures, they were 
imposed as additional distance restraints between the Cys sulphurs.    
7.1.2 Hydrogen Bonds  
The cross peaks for twenty-six NH groups were visible in the first of the deuterium 
exchange HSQC spectra. Twenty of these could be assigned unambiguously with the 
other six unresolved in the HSQC. Preliminary structures calculated with NOE 
restraints alone were examined using PyMOL to identify the likely hydrogen bonding 
partners, based on the proximity and relative orientation of potential hydrogen bond 
acceptors to the NHs identified as slowly exchanging. Slowly exchanging amides and 
their identified hydrogen bond partners are shown in Table 7-3.  
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Slowly exchanging NH  Hydrogen bond acceptor  
134Val  131Asp  
135Gln  150Ser  
146Thr  139Asn  
148Asp  137Val  
149Tyr  161Ala  
150Ser  135Gln  
155Phe  152Ser  
156Lys  179Ile  
166Leu  170Gln  
170Gln  166Leu  
171Trp  126Pro 
173Ser  -  
177Lys  158Lys 
179Ile  156Lys  
208Phe  220Glu  
209Ser  192Lys  
214Tyr  211Asp 
215Tyr  238Gln  
222Leu  206Leu  
230Trp  183Ser 
Table 7-3: Hydrogen bond restraints. The HDex spectra identified donor amide groups and well 
defined structures were analysed to identify the acceptor carbonyl groups.  
7.1.3 Dihedral Angle Restraints  
Predictions of backbone dihedral angles were carried out using the Dihedral Angles 
from Global Likelihood Estimates (DANGLE) software in CcpNmr analysis (Cheung et 
al., 2010). Sequence data and backbone chemical shifts are used to analyse secondary 
structure and predict possible phi (ɸ) and psi (Ψ) angles. The software uses a stretch of 
sequence, not just an individual amino acid, to compare the sequence with a database of 
protein structures, with known chemical shifts. This identifies a number of similar 
structures that can be analysed and used alongside known angles for specific residues 
such as prolines (that have a locked ɸ angle) and glycines (that often have a positive ɸ 
angle), for dihedral angle predictions. The dihedral angle restraints derived from the 
DANGLE predictions were used to help with convergence of the structure calculations. 
However, since these restraints are only indirectly based on the experimental data, they 
were only used in the high temperature and not in the refinement stage of each iteration.  
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7.1.4 NOE Restraints  
The most important restraints used for structure determination in this study were 
derived from the NOESY experiments. These restraints, derived from the observation of 
individual cross-peaks in the NOESY spectra, provide information on long range 
connectivities with defined distances. However, many cross-peaks cannot be assigned 
unambiguously as representing the distance between a particular pair of atoms. ARIA’s 
algorithm is designed to deal with ambiguous distance restraints, so most peaks were 
left at least partially unassigned to avoid the structure calculations being biased by 
incorrectly assigned peaks. ARIA was instructed to use all the cross-peaks from the 
NOESY spectra to generate distance restraints by matching each cross-peak to the 
resonances whose chemical shifts lie within a defined tolerance of the peak centre. 
ARIA initially calibrates the distances according to a normalised 1/distance6 distribution 
and subsequently by matrix relaxation refinement that allows for spin diffusion effects 
(Linge et al., 2003a). After the first few rounds of calculation in which missing and mis-
assignments were identified and rectified, the log-normal potential and restraint 
weighting were also tried (Nilges et al., 2008).  
7.1.5 Analysis of Restraints  
After each round of structure calculations violated distance restraints that were rejected 
by ARIA were re-analysed in CcpNmr analysis, to determine the reason for the 
violation. This allowed for incorrectly assigned peaks to be amended, peaks that had 
been picked in the noise to be deleted, and at times highlighted unassigned resonances, 
that could in some cases be assigned. This analysis was followed by subsequent 
structure calculations until the structures showed good convergence and low 
experimental energies indicating that the experimental restraints were self-consistent.  
7.1.6 Water Refinement  
The final stage of the structure calculations is refinement in explicit solvent with a more 
realistic force field. Earlier in the calculation, for speed, structures are calculated in 
vacuo with no electrostatic conditions set and with a more simplistic representation of 
the Van der Waals interactions. The 18 structures with the lowest restraint energy (of 
100) from iteration 8 were used for refinement in explicit solvent, according to the pre-
defined protocol (Linge et al., 2003b).  
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7.2 Structure Validation  
Measures can be taken to determine the quality of the structures that are calculated by 
ARIA. This ensures that the structures give a reasonable representation of the protein 
being studied. Multiple structures are produced as a result of a range of values being 
used, accounting for distances and angles. Thus, a number of structures are arranged 
into an ensemble, each fitting the experimental restraints to an approximately equal 
standard.  
7.2.1 Quality of Ensemble Structures  
The total number of restraints and the quality of these restraints used in the structure 
calculation can be used to determine the quality of the structures calculated for the 
ensemble. The quality of the calculated structures generally improves with the more 
restraints that are used. 18 water refined structures were used to calculate statistics of 
the restraints, shown in Table 7-4. Ramachandran plots can be useful to visualise 
dihedral angles, however, as the structures are still at a preliminary stage, this analysis 
is not yet justified.  
NOE distance restraints 
Ambiguous 477 
Unambiguous 725 
Intra-residue 396 
Sequential (i-j = 1) 197 
Short-range (i-j = 2 – 4) 36 
Long-range (i-j ≥ 5) 96 
Violations > 0.5 Å 0.72 
Violations > 0.3 Å 1.33 
Violations > 0.1 Å 20.39 
Distance restraint RMSD 0.032 Å 
Other restraints 
Hydrogen bonds 20 
Dihedral angle restraints 206 
Disulphide bonds 4 
RMSD from the ideal geometry 
Bond length (Å) 0.00345992 ± 0.0001455667 
Bond angle (°) 0.460842 ± 0.0219091 
Improper angle (°) 1.35534 ± 0.13369 
Table 7-4: Statistics of the experimental restraints. Averages were calculated from the 18 water refined 
structures in the ensemble.   
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7.3 CCP12 Structure  
The UWMN program (Leo Caves, unpublished) calculates an unbiased average 
structure, then fits all the structures to this and calculates the root-mean-square 
deviation (RMSD). Results are shown for Cα’s and for backbone heavy atoms (N, Cα, 
CO). In the structure calculations, the CCP1 domain is well defined with a Cα RMSD 
of 0.828 Å, however, the CCP2 domain is not, with a Cα RMSD of 2.305 Å. This could 
be because CCP2 has residues with unassigned atoms including Ser186, Ser195, Ser197 
and Gly226, that are all lacking their NH, and Pro196 and Ser212 that are lacking their 
CO. It is clear that the CCP1 module is better defined, with more distinct secondary 
structure in comparison with CCP2.  
Stereo-views of both the CCP1 and CCP2 modules illustrate the convergence seen for 
each domain and the similarities and differences between them (Figure 7-1). For CCP1, 
all eighteen structures superimpose well, with little variability. The β-strands are well 
defined and it represents a typical CCP module structure. CCP2 on the other hand 
shows more variability, as expected from the higher RMSD. There is poorer definition 
of the β-strands, and more variation than can be seen for CCP1. As the structures are 
not completely refined, final conclusions may differ.  
 
Figure 7-1: Stereo-view of CCP1 and CCP2 domains. The eighteen CCP12 structures in the 
ensemble are superimposed on the Cαs of each of CCP1 and CCP2. The backbone nitrogens are 
coloured blue.  
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Figure 7-2 and Figure 7-3 show the relative orientation between the two modules. The 
structure is superimposed on the CCP1 module of the structure with the lowest energy.   
 
    
Figure 7-2: Cartoon representation of the representative CCP12 structure. Image shows the 
relative orientation of the two modules. The bottom image has been rotated 90° on the x-axis.  
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Figure 7-3: Cartoon representation of CCP2 β-strands orientation relative to CCP1. CCP2 shows 
the backbone cartoon for residues 203 – 210.  
In the cartoon representation shown in Figure 7-3 the central β-strand of the β-sheet of 
CCP2 is shown for all the structures in the ensemble, with all structures superimposed 
on CCP1, to illustrate the range of orientations seen. One structure of CCP1 is shown as 
a full cartoon representation. The relative orientation of the two modules is not 
completely defined by the experimental data used so far, which may reflect real inter-
module flexibility.  
Electrostatic contact potential at the surface of the protein was analysed (Figure 7-4). At 
a glance, it is not obvious where a lipid A binding site would be. However, the CCP1 
module shows a fairly positive patch close to the inter-module linker. This could 
suggest a possible binding region for the negatively charged phosphate groups of lipid 
A. Hydrophobic regions would recognise the acyl chains, and a small pocket adjacent to 
the positively charged patch gives an indication of where this could occur. The pocket is 
present in all eighteen structures. However, the pocket does not seem big enough for a 
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whole acyl chain to fit in. The CCP2 module also displays a positive patch, but this 
region is not very big.   
  
Figure 7-4: CCP12 with surface electrostatics. Positive regions are displayed in blue, negative 
regions are displayed in red. The CCP12 structure with the lowest energy was used to produce this 
image. 
Figure 7-5 shows the tryptophan residues for both CCP1 and CCP2. In both modules, it 
can be seen that these residues are buried in the module and stacked against the 
disulphides, a feature typical to CCPs. This confirms that they are playing a key 
structural role, and are unlikely to function in lipid binding.  
 
Figure 7-5: CCP1 and CCP2 tryptophans. The tryptophan residues are highlighted by the spheres 
and disulphide bonds are indicated by the sticks.  
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7.4 Summary 
Overall, it is clear that the structure calculations have not yet produced a well-defined 
structure for CCP12. The low protein concentration, and thus low signal to noise, resulted 
in a low number of NOESY cross-peaks, meaning that limited data was available to 
provide long range distance restraints. However, from the data available, the 
combinations of residues forming the two disulphide bonds in each module were 
identified, and 25 out of 26 slowly exchanging amides were assigned to specific hydrogen 
bonds. Analysis of the consistently violated restraints helped to improve the consistency 
of the assignment resulting in better convergence of the calculations, and water 
refinement further enhanced the structures. CCP1 shows similarities to known CCP 
modules and is better defined in the calculated structures than CCP2, but it is likely that 
further NMR experiments with higher concentration samples will provide the additional 
restraints required to bring this domain in line with CCP1 to calculate the overall 
structure. 
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8 Discussion  
This project aimed to identify and understand how Factor C binds LPS; to characterise 
the conformational changes induced by binding LPS at the molecular level; and to 
identify why Factor C binding to LPS is so specific to lipid A. However, throughout this 
project, difficulties faced with protein expression and purification frustrated attempts to 
achieve a high enough concentration of cleaved, soluble protein. Thus, although 
promising results were obtained for a number of Factor C protein fragments, further 
investigation is required in order to draw firm conclusions.  
8.1 Evaluation of the Results Obtained from E. coli Expressed 
Fragments 
For each of the E. coli expressed Factor C constructs, inferences can be made about 
their degree of folding and involvement in LPS binding, supported by results from 
circular dichroism (CD) and nuclear magnetic resonance spectroscopy (NMR). CD 
analysis of the Cys-rich domain displayed a large proportion of unordered structure, 
with the presence of a small amount of α-helix and β-sheet. This was supported by the 
NMR data, that suggested this domain was only partially folded. To determine if correct 
Cys-rich folding is condition dependent, further experiments are required. This could 
include altering the pH and observing any changes to the structure by NMR. Disulphide 
bond mapping would also be valuable for assessing whether a particular fold is 
consistently adopted by the recombinantly produced protein, and for comparison with 
the native protein. Cys point mutants could be produced to eliminate the unpaired Cys 
which may improve the behaviour of the protein. The assumption that the Cys-rich 
region is a domain may not be true as there is no evidence of similarity at the sequence 
level to other domains of known 3D structure.  
The EGF-like domain appeared highly unordered in results from CD. This was 
confirmed by the NMR spectra, where peaks that were suggestive of folded EGF-like 
protein in the fusion protein became largely disordered upon cleavage from Trx. This 
suggests that the EGF-like domain requires help for correct folding. The CysEGF di-
domain fragment was particularly difficult to obtain in soluble form. For the material 
that was obtained, CD implied a slight conformational change might occur upon the 
addition of LPS, suggesting that this fragment encompasses a potential LPS-binding 
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site. If this is an LPS binding fragment, that could account for the problems encountered 
during expression, as endogenous LPS could have affected the protein’s behaviour and 
solubility. NMR data of a Trx-CysEGF sample shown to contain protein by both SDS-
PAGE and UV-Vis spectroscopy did not reveal any cross-peaks. This could be due to 
the protein being bound to LPS micelles, causing the protein to tumble slowly in 
solution such that its signals are broadened beyond detection. As the combination of 
Cys with EGF did not give rise to any clear results, expressing these two domains 
alongside another domain, for example CCP1, may help with protein folding. A di-
domain including the EGF-like domain and CCP1 may also give more information as to 
the requirements for correct EGF-like domain folding.  
As a result of precipitation in the CCP1 and CCP2 single domain samples, CD analysis 
was not possible due to excessive light scattering. However, 15N-HSQC NMR spectra of 
the two domains individually before precipitation showed a good dispersion of peaks 
implying the presence of correctly folded protein. Low sample concentrations and the 
difficulty faced when attempting to separate the domains from the fusion protein meant 
studies with these fragments were not taken any further. If the CCP12 domain was 
validated as a site for LPS binding, it would be useful to optimise protein expression 
and purification of the individual domains, to localise the binding site more precisely. 
This would also confirm whether the presence of a single domain is sufficient for LPS-
binding, or if the di-domain is required for correct function.  
For the more tractable CCP12 di-domain, the results from CD and NMR analysis were 
in agreement, with both showing a high β- strand content and very low helical 
contributions, in line with what is already known about the structure of CCP modules. 
CCP12 displayed well-dispersed peaks in NMR spectra, indicating good folding of the 
fragment, and allowing the structure to be calculated for this fragment as described in 
Chapter 7. As expected for CCP domains, the conserved tryptophan residues’ side 
chains were shown to be buried within the structure. More work to further refine the 
structure is required, but the initial structural studies are of sufficient quality to begin to 
draw conclusions. According to the CD data, a structural change occurs upon addition 
of LPS, implying the presence of an LPS binding site/s within this di-domain. However, 
the lack of sample at a high enough concentration meant these experiments could not be 
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reproduced. These results are very promising, and give rise to further scope for 
additional structure/function analyses.  
Expression of soluble CCP23 proved rather unsuccessful and thus, no NMR data was 
acquired for this di-domain. CD suggested the presence of rigidly held aromatics, but a 
poor NRMSD of the fits of the solution from DICHROWEB to the far UV CD spectrum 
suggests correct folding had not been achieved or it does not represent any structures 
present in the database. CCP123 appeared to produce correctly folded protein, as the 
CD spectra showed a high contribution from β-sheets, and low α-helical content, typical 
of CCP modules. However, 15N HSQC NMR spectra contained only a small number of 
peaks that could be attributed to CCP123, mostly in the random coil chemical shift 
region. This is consistent with the tri-domain fragment tumbling slowly in solution, 
perhaps due to the elongated conformation one would predict for a relatively rigid rod 
of CCP domains joined end to end. NMR experiments designed to detect signals from 
slowly tumbling molecules may enable this fragment to be studied, although 15N 
TROSY experiments were attempted unsuccessfully. Previous NMR studies of triple 
CCP domain fragments have often required the protein to be deuterated to improve its 
relaxation properties (Smith et al., 2002).  
In the UV spectra of a number of fragments, a higher A260 than A280 value was 
observed, suggestive of nucleic acid contamination. However, LPS also gives a higher 
A260 than A280, implying endogenous LPS may be bound to these fragments. Although 
RP-HPLC was used in most cases, this technique may not be sufficiently denaturing to 
strip tightly bound LPS molecules from the protein fragments.  
8.2 Comparison of CCP12 with other LPS Binding Proteins 
Comparisons between CCP12 and known LPS-binding proteins, namely recombinant 
anti-LPS Factor (rALF) (Yang et al., 2009) and the ferric hydroxamate uptake receptor 
(FhuA) (Ferguson et al., 2000) were made in an attempt to identify regions of similarity 
between the three, in an effort to locate the LPS-binding site within the CCP12 
modules. Figure 8-1 displays the three structures for comparison. Lipid A contains 
phosphate groups that are negatively charged, meaning the positively charged residues 
of CCP12 and other LPS binding proteins are likely to bind it. It is clear that rALF and 
FhuA have much more positively charged patches than CCP12, suggesting that, if this 
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is indeed the site for LPS binding, the molecular mechanisms of recognition between 
the three are different.  
  
Figure 8-1: Surface comparison of CCP12, rALF and FhuA. A. CCP12. B. rALF (PDB: 2JOB). 
C. FhuA (PDB: 1QFG). The blue patches on the surface of the structures indicate positive regions 
and the red patches signify negative regions. Very large areas of the rALF and FhuA are 
positively charged in comparison to CCP12. Although negative patches are evident, they are 
much smaller in size, suggesting that if this is the LPS-binding site, that the proteins have 
different mechanisms of recognition. Pictures made in PyMOL using protein contact potential tool 
and coloured at matching electrostatic potentials. Images are not to scale.  
Koshiba et al. identified a tripeptide motif in Factor C (Arg-Trp-Arg) thought to play an 
important role in LPS-binding (Koshiba et al., 2007). They demonstrated that this 
feature is conserved amongst other LPS binding proteins, including human LPS-binding 
protein and Limulus anti-LPS factor (Figure 8-2). CCP12 was examined to establish 
whether or not this motif was present. While CCP12 does not exhibit a conserved 
tripeptide motif  of the form basic-aromatic-basic, there is a surface exposed Phe next to 
a positive patch that could potentially function in the same way.  
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Figure 8-2: The inferred conserved tripeptide-motif for LPS-binding. Comparisons are made 
between hLBP, human LPS binding protein; hBPI, human bactericidal permeability-increasing 
protein; hMD-2, human MD-2’ lALF, Limulus anti-LPS factor; and rCAP18, rabbit cationic 
antimicrobial protein, identifying a conserved basic-aromatic-basic motif. Figure reproduced from 
Koshiba et al.. (Koshiba et al., 2007). 
Based on their conclusion that CCP1 from Carcinoscorpius rotundicauda was sufficient 
for LPS binding, Tan et al. designed a 34 amino acid peptide (S1) from residues of the 
N-terminal sushi domain region in Factor C, and claimed it was a functional LPS-
binding peptide (Tan et al., 2000). For comparison, the amino acids in CCP12 
corresponding to those that made up this peptide are highlighted on the CCP12 structure 
(residues 154 – 187, Figure 8-3). As illustrated in the figure, the peptide comprises just 
the two C-terminal extended strands of CCP1 and the intervening loop, and then 
extends through the linker and a few residues into CCP2. It seems unlikely that this 
peptide would adopt its native conformation in isolation since it represents less than half 
of a CCP domain and would expose several normally buried hydrophobic residues in 
this state. It also contains two cysteine residues that would usually form disulphide 
bonds with other Cys residues in the two domains. In the absence of their normal 
partners and under oxidizing conditions, they would very likely form non-native intra- 
or inter-molecular disulphides. Thus, it seems questionable that the peptide would adopt 
the same 3D structure as it does in CCP1, making it an unlikely candidate for an LPS 
binding site.  
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Figure 8-3: CCP12 displaying the S1 peptide. Indicated by sticks, the peptide is shown to extend 
from CCP1 into CCP2 (Tan et al., 2000).  
8.3 Overall Conclusions 
Overall, no clear conclusions can yet be drawn as to the mechanism of Factor C binding 
to LPS, but, as shown by the results, there is plenty of scope to investigate this further.  
8.3.1 Recombinant Expression in E. coli 
This project determined that production of Factor C fragments in E. coli is possible and 
that at least some adopt well defined 3D conformations. However, it was not determined 
to what extent the presence of endogenous LPS affected the fragments produced. 
Optimised recombinant protein expression in E. coli would allow an easy means to 
produce samples from which a more thorough understanding of the way in which Factor 
C binds to LPS could be gained. 
8.3.2 Recombinant Expression in Alternative Expression Systems 
Identifying the L. polyphemus gene sequence and consequently cloning full-length Factor 
C into the different eukaryotic expression systems has paved the way for future 
experiments. Optimising expression of Factor C in mammalian, insect and yeast 
expression systems and identifying which is the most suitable for full-length protein 
expression will enable attempts to be made to characterise the overall structure of Factor 
C, and thus the structural change that occurs as a result of LPS binding This will result in 
a better understanding of the mechanism of Factor C binding to LPS. 
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Further investigations into the use of Brevibacillus choshinensis for protein expression, to 
determine the advantages this expression system has over other recombinant expression 
systems, will help to identify the role this system could play in the search to understand 
the endotoxin sensing nature of Factor C. 
8.3.3 Lipid Binding Investigations 
Structural changes were observed by CD in a few of the domains upon addition of LPS, 
indicating where further investigations should focus as discussed in Chapter 5. Increasing 
the concentration of purified, cleaved protein will enable more experiments to be carried 
out, improving reliability of the results observed. Employing other biophysical techniques 
such as isothermal titration calorimetry (ITC) could be useful for measuring the binding 
affinity between LPS and fragments of or full-length Factor C protein, which would assist 
in identifying the lipid binding domain. 
8.3.4 Towards the structure of Factor C 
From a CCP12 sample of relatively low concentration, valuable information has been 
garnered in the search to understand the mechanism of LPS binding to Factor C. Although 
the overall findings from the project only produced a preliminary NMR-based structure 
for one fragment, initial investigations into several other Factor C fragments produced 
results that suggest the acquisition of further structural data will be possible. 
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10 Appendices  
Appendix A: Supercontig and Contig identifiers 
Supercontigs in the order they appear in Figure 2-1: 
Unique Identifier Number of appearances 
No_name-221 42 
No_name-1 4 
No_name-74 6 
No_name-139 3 
No_name-34 11 
No_name-6 3 
No_name-207 4 
No_name-249 4 
No_name-30 3 
No_name-31 5 
No_name-222 2 
No_name-247 4 
No_name-90 2 
No_name-333 9 
No_name-404 3 
No_name-414 1 
No_name-617 1 
No_name-531 2 
No_name-582 3 
No_name-44 2 
No_name-501 1 
No_name-36 1 
No_name-343 2 
No_name-542 1 
No_name-669 1 
No_name-340 1 
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Contigs in the order they appear in Figure 2-2: 
Unique Identifier Number of appearances 
gnI|BL_ORD_ID|244097 1 
gnI|BL_ORD_ID|367470 1 
gnI|BL_ORD_ID|177838 9 
gnI|BL_ORD_ID|245208 4 
gnI|BL_ORD_ID|244098 4 
gnI|BL_ORD_ID|235822 1 
gnI|BL_ORD_ID|235823 2 
gnI|BL_ORD_ID|319222 3 
gnI|BL_ORD_ID|107887 1 
gnI|BL_ORD_ID|265992 5 
gnI|BL_ORD_ID|235820 1 
gnI|BL_ORD_ID|254037 1 
gnI|BL_ORD_ID|107355 1 
gnI|BL_ORD_ID|146844 1 
gnI|BL_ORD_ID|65600 1 
gnI|BL_ORD_ID|330773 2 
gnI|BL_ORD_ID|392740 1 
gnI|BL_ORD_ID|353121 2 
gnI|BL_ORD_ID|262060 1 
gnI|BL_ORD_ID|253599 2 
gnI|BL_ORD_ID|273536 4 
gnI|BL_ORD_ID|264064 3 
gnI|BL_ORD_ID|177839 3 
gnI|BL_ORD_ID|319162 1 
gnI|BL_ORD_ID|32197 40 
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Appendix B: Amino Acid and DNA Sequences of Limulus polyphemus 
Factor C  
Amino acid sequence:  
MVLASFLVSGLVLGLLAQQMHPVQSRGVDLGLCDDTRFECKCGDPGYVFNVPAKQCTYFYRW
RPYCKPCDKLEAKDVCPKYKRCQECRAGLDSCVSCPPNKYGTWCSGECQCKNGGICDQRTGAC
TCRDRYEGVHCEILQGCPLLQSDPQVQEVKNPPNDPQTIDYSCSPGFKLKGVARITCLPNGQWSS
FPPKCIRECSMVSSLEHGKVNSPSADLIEGATLRFSCDSPYYLIGQETLTCQGNGQWSGQIPQCQK
LVFCPDLDPVSHAEHQVKIGLEQKYGQFPQGTEVTYTCTGNYFLMGLDTLKCNPDGSWSGTQPS
CVKVADREVNCDSKAVDFLDDVGEAVRIHCPAGCSLTAGTVWGTAIYHELSSVCRAAIHAGKV
PNSGGAVHVVNNGPYSDFLASDLNGIKSEELKSLAQSFRFDYVSSSTAGRKSGCPDGWFEIEENC
VYVTSKQRAWERAQGVCTNMAARLAVLDKDVIPSSLTETLRGKGLATTWIGLHRLDADNHFIW
ELMDRSSVALSDSLTFWAPGEPGSETNCVYLDIQDQLQPVWKTKSCFQPSSFVCMMDLSDKNK
AKCKDPGPLENGHAKLHGQSIDGFYAGSSVRYSCEVLHYLSGTETVSCTSSGTWSAPKPRCIKVI
TCQTPPVPSYGSVDIKPPSRTNSISRIGSPFLRLPRLPLPLARAAKPPPKARSSPPSTVDLASKVKLP
EGHYRVGSRASYTCESRYYELLGSQGRRCNSNGKWSGRPASCIPVCGRSDSPRSPFIVSGSSTEIG
QWPWQAGISRWLADHNMWFLQCGGALLNEKWIITAAHCVTYSATAEIIDPSQFKFYLGKYYRD
DSKDDDYVQVREALEIHVNPNYDPGNLNFDIALIQLKTSIALTTRVQPICLPTDLTTRENLKEGTL
AVVTGWGLSESNTYSEMIQQAVLPVVAASTCEQGYQDSGSPLTVTENMFCAGYKQGRYDACS
GDSGGPLVFADDSRTDRRWVLEGIVSWGSPNG CGKPNQYGGFTKVNVFLSWIRQFI*  
 
cDNA sequence:  
ATGGTACTCGCTAGCTTTCTCGTAAGCGGACTGGTCTTGGGTCTGTTGGCTCAGCAGATGCA
CCCAGTGCAGAGTCGGGGAGTAGACCTCGGCCTGTGCGACGACACCCGCTTCGAGTGTAAA
TGCGGCGATCCTGGCTACGTGTTCAATGTTCCGGCAAAGCAATGTACCTACTTCTACCGCTG
GCGGCCTTATTGCAAACCATGTGATAAACTGGAGGCGAAGGATGTGTGCCCCAAGTATAAG
CGCTGCCAAGAATGCCGGGCAGGCCTCGATTCCTGTGTAAGCTGCCCACCAAACAAATACG
GCACTTGGTGCAGTGGCGAATGCCAATGCAAAAACGGCGGTATCTGCGACCAAAGGACCGG
TGCGTGCACCTGTCGTGACCGATATGAAGGCGTTCATTGTGAGATACTCCAGGGCTGCCCGT
TGCTGCAAAGCGACCCTCAAGTACAAGAGGTTAAGAACCCGCCCAACGACCCCCAGACAAT
AGATTATAGCTGCTCCCCTGGTTTCAAACTGAAGGGCGTAGCACGCATAACATGCCTCCCGA
ATGGCCAATGGTCGTCGTTTCCCCCGAAGTGCATCAGGGAATGCAGCATGGTGAGCAGCCT
GGAGCACGGCAAGGTTAACAGCCCCAGCGCCGATCTGATCGAGGGCGCTACCTTGCGCTTC
AGCTGCGATTCCCCGTATTACCTGATCGGACAGGAGACCTTGACGTGCCAGGGCAACGGCC
AGTGGAGTGGTCAAATTCCCCAATGCCAGAAACTCGTTTTCTGCCCAGACTTGGACCCGGTA
AGCCATGCCGAGCACCAGGTAAAGATAGGCCTGGAACAGAAGTACGGTCAGTTCCCCCAGG
GAACGGAAGTGACCTACACCTGCACCGGAAACTATTTTCTCATGGGCTTGGATACTCTCAAA
TGTAACCCAGACGGCTCCTGGTCCGGAACTCAGCCCAGCTGTGTGAAAGTAGCTGACCGGG
160  
  
AGGTCAACTGTGATTCGAAAGCCGTAGATTTCCTCGACGACGTGGGCGAAGCTGTTCGCATC
CACTGCCCTGCGGGTTGCTCCCTCACGGCGGGAACAGTTTGGGGTACAGCCATATACCACGA
GCTGAGCTCGGTGTGTCGCGCAGCCATTCATGCCGGTAAAGTCCCGAACTCGGGCGGTGCTG
TGCACGTTGTGAACAATGGCCCCTACAGCGACTTTTTGGCATCGGACTTGAACGGCATCAAA
AGCGAGGAATTGAAGAGCCTGGCTCAATCGTTCCGATTCGATTATGTCTCCAGCAGCACTGC
TGGCCGGAAGTCCGGATGCCCGGATGGATGGTTCGAAATAGAGGAAAACTGCGTGTACGTC
ACGAGCAAGCAGCGGGCATGGGAACGCGCCCAGGGTGTATGTACTAACATGGCCGCACGTC
TGGCTGTGCTCGATAAAGACGTGATCCCGAGCAGTCTGACAGAGACCCTGCGTGGTAAGGG
CCTGGCGACCACCTGGATTGGCCTCCATCGATTGGATGCCGACAATCATTTCATTTGGGAGC
TCATGGATAGGAGCAGTGTGGCACTCTCCGACTCGTTGACATTTTGGGCACCGGGTGAACCG
GGAAGCGAAACCAATTGCGTCTACCTCGACATACAGGATCAGCTCCAACCGGTCTGGAAGA
CCAAAAGCTGCTTTCAGCCTTCGAGCTTCGTTTGCATGATGGATTTGAGCGATAAGAACAAA
GCCAAATGCAAGGACCCCGGACCGCTCGAAAACGGACACGCAAAGTTGCACGGCCAAAGC
ATCGACGGTTTTTACGCTGGAAGCTCCGTGCGCTACTCGTGCGAGGTCCTCCACTATTTGTCC
GGCACGGAAACCGTGAGCTGCACCTCCTCCGGTACATGGTCCGCACCGAAACCGCGCTGTA
TCAAGGTGATAACCTGCCAGACACCACCCGTCCCAAGCTACGGCAGCGTGGACATTAAACC
TCCGTCCCGCACTAACTCCATCAGCCGCATCGGTTCCCCTTTCCTGCGCCTCCCTAGGCTGCC
TCTGCCCCTGGCGCGTGCCGCCAAACCACCCCCTAAGGCTCGCAGCAGCCCCCCAAGCACA
GTCGATTTGGCGTCGAAAGTGAAACTGCCCGAGGGACACTATCGCGTCGGCTCCCGGGCTTC
GTATACCTGTGAGTCCCGGTACTACGAATTGCTGGGAAGTCAAGGCAGGCGCTGCAACTCC
AACGGAAAGTGGAGCGGCCGACCCGCTAGTTGCATCCCAGTGTGCGGTCGCTCCGATAGTC
CACGATCCCCCTTCATCGTGAGCGGCTCGTCCACTGAAATTGGACAGTGGCCTTGGCAAGCT
GGCATCTCCCGATGGCTCGCGGATCATAATATGTGGTTCCTGCAATGTGGCGGAGCCCTCCT
GAATGAGAAGTGGATCATCACTGCCGCGCACTGCGTTACATACTCGGCCACCGCGGAGATT
ATCGACCCGAGCCAATTCAAGTTCTACCTGGGTAAGTACTACCGCGATGATAGCAAAGACG
ATGATTACGTACAAGTACGCGAGGCGTTGGAAATCCACGTTAACCCAAATTACGACCCAGG
CAACCTCAACTTCGATATTGCTCTGATTCAGCTCAAAACTAGTATCGCCCTGACCACACGGG
TACAACCCATCTGCCTGCCGACTGACCTGACTACGCGGGAGAATCTCAAAGAGGGAACCCT
CGCGGTTGTGACCGGCTGGGGACTCTCGGAGTCCAACACTTATAGCGAGATGATTCAACAG
GCTGTTTTGCCAGTAGTGGCAGCTAGCACATGCGAGCAGGGATACCAAGATTCGGGTAGTC
CTCTCACCGTAACTGAGAATATGTTTTGTGCCGGCTACAAACAGGGCCGCTATGATGCCTGC
TCCGGTGACAGCGGTGGACCACTGGTGTTTGCGGACGACAGCCGTACAGATCGTCGCTGGG
TATTGGAAGGCATTGTGTCGTGGGGTAGCCCCAACGGCTGCGGCAAACCCAACCAGTACGG
CGGCTTTACCAAGGTAAACGTATTCCTGAGTTGGATCAGGCAGTTCATC  
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Appendix C: Primer Sequences  
Tachypleus tridentatus Cys-rich, EGF-like and CysEGF amplification 
primers for ligation independent cloning.  
Construct  Primer Sequences  
Melting 
temperature  
(Tm)  
Cys-rich 5’  TACTTCCAATCCCAGCAGATGCGTCCGGTTC  60.6°C  
Cys-rich 3’  TATCCACCTTTACTGTCATTTGTTCGGTGGGCAGGTAAC  61.5°C  
EGF-like 5’  TACTTCCAATCCAACAAATACGGTACCTGGTG  56.8°C  
EGF-like 3’  TATCCACCTTTACTGTCAACCTTCGTAACGGTCAC  59.4°C  
LIC complementary overhangs are underlined.  
  
Limulus polyphemus complement control protein primers for ligation 
independent cloning.  
Construct  Primer Sequence  
Melting 
temperature  
(Tm)  
CCP1 5’  TACTTCCAATCCATGGAGATACTCCAGGGCTGC  60.6°C  
CCP1 3’  TATCCACCTTTACTGTTCCCTGATGCACTTCGG  59.3°C  
CCP2 5’  TACTTCCAATCCATGATCAGGGAATGCAGCATG  58.1°C  
CCP2 3’  TATCCACCTTTACTGTTTCTGGCATTGGGGAATTTG  58.2°C  
CCP3 5’  TACTTCCAATCCATGCAGAAACTCGTTTTCTGC  56.8°C  
CCP3 3’  TATCCACCTTTACTGCTCCCGGTCAGCTAC  59.3°C  
CCP3 5’ v2  TACTTCCAATCCATGAAACTCGTTTTCTGC  53.8°C  
LIC complementary overhangs are underlined.  
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Oligonucleotides for Thermodynamically Balanced Inside-Out PCR  
Number Oligonucleotide sequences  
1  CCATGGAAATTTTGAAGGGGTGCCCG  
2  TTGAAGGGGTGCCCGCTGCTGCCGAGCGACAGCCAGGTGCAGGAA GTGCGTAATC  
3  TGCAGGAAGTGCGTAATCCGCCGGATAACCCGCAGACCATTGATTA TAGCTGTAG  
4  AGACCATTGATTATAGCTGTAGCCCGGGTTTCAAATTGAAAGGTGT GGCGCGTAT  
5  AGGTGTGGCGCGTATTAGCTGCCTTCCGAATGGCCAGTGGAGTAGC TTTCCGCCG  
6  GAGTAGCTTTCCGCCGAAGTGCATTCGTGAGTGCGCGAAAGTGAGC AGCCCTGAA  
7  AAGTGAGCAGCCCTGAACATGGCAAAGTTAATGCGCCGTCTGGGAA CATGATTGA  
8  CGTCTGGGAACATGATTGAAGGCGCGACACTGCGTTTTTCGTGCGA TAGCCCGTA  
9  TTGCCCTGGCAGGTCAGTGTCTCCTGTCCAATCAGATAGTACGGGCT ATCGCACG  
10  CAGTTTCTTGCACTGCGGAATCTGGCCGGACCACTGTCCATTGCCCT GGCAGGTC  
10v2  CAGTTTCTTGCACTGCGGGATTTGGCCTGACCACTGCCCATTGCCCT GGCAGGTC  
11  TCTGCATGATTCACGGGGTCCAGATCCGGGCAAAAAACCAGTTTCT TGCACTGCG  
12  GCCCATATTTCTGTTCCACGCCAATTTTCACCTGATGTTCTGCATGA TTCACGGG  
13  AGCAGGTGTAGGTAACTTCCGTACCCTGGGGAAACTGCCCATATTT CTGTTCCAC  
14  TCAGGGTATTAAAGCCCATCAGAAAATAGTTGCCCGAGCAGGTGTA GGTAACTTC  
15  CTGGCTGCCTGACCAGCTGCCGTCCGGATTGCATTTCAGGGTATTAA AGCCCATC  
16  CTCGAGCTATTCACGATCCGCCACTTTCACGCAGCTCGGCTGGCTGC CTGACCA  
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Appendix D: Buffer Recipes  
M9 Minimal Media  
To make 1 L of 5X M9 stock solution:  
 Na2HPO4     34.08 g 
 KH2PO4     15 g 
 NaCl     2.5 g 
 
  Make to ~800 ml with dH2O 
  Adjust pH to 7.0 
  Make to 1 L with dH2O 
  Autoclave 
 
For 1 L 1X M9 minimal media: 
 dH2O     800 ml 
 5X M9 stock solution   200 ml 
 MgSO4 (1 M)    1 ml 
 CaCl2 (1 M)    50 µl 
 Thiamine (50 mg/ml)   400 µl 
 D-glucose    1.5 g 
 (NH4)2SO4    0.5 g 
 Antibiotic    50 µg/ml 
 
For 15N-labelled media, (NH4)2SO4 is replaced with 15NH4Cl 
For 13C-labelled media, D-glucose is replaced with 13C6-glucose 
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2xYT media  
For 1L:  
  Tryptone          16 g  
  Yeast Extract        10 g  
  NaCl          5 g  
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Appendix E: CCP12 chemical shift assignments 
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